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 PREFACE 
During the second year of PhD, I spent six months at Bristol University, in Prof. Varinder 
Aggarwal’s laboratory. In order to broaden my skills and competences in a wide science such 
as Organic Chemistry, there I developed a topic that was different from the one I was studying 
in Milan. For this reason, the thesis will be articulated in two principal parts (namely Section 
A and Section B) corresponding respectively to the work performed in Milan 
(“Stereoselective synthesis of -amino acids -substituted with a 4,5-dihydroisoxazole 
nucleus”) an the one performed in Bristol (“Stereoselective synthesis of tertiary and 
quaternary allylsilanes”).  
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1 INTRODUCTION  
-Hydroxy--amino acids are an important class of amino acids. They are found within 
the twenty natural amino acids (threonine, serine, and -hydroxy proline) and as 
constituents of more complex natural products. For example, -hydroxy tyrosine and -
hydroxyphenylalanine derivatives are found in clinically important glycopeptide 
antibiotics, such as Vancomycin, discovered in 1956 by Eli Lilly, and Teicoplanin 
(Figure 1).
1, 2
 
 
 
Figure 1: Structure of Vancomycin and Teicoplanin  
Vancomycin and Teicoplanin are the progenitors of glycopeptides antibiotics and 
elucidation of their structures led to the development of new antibiotics.
2
 Today, both 
Vancomycin and Teicoplanin are used in the treatment of patients infected with drug-
resistant Gram-positive bacterial strains. Glycopeptides antibiotics are toxic for bacteria 
because they interfere with the synthesis of peptidoglycan layer of the bacterial cell 
wall. Peptidoglycan is a polymer consisting of sugars and amino acids that forms a 
mesh-like layer outside the plasma membrane of eubacteria. The sugar component 
consists of alternating residues of -(1,4) linked N-acetylglucosamine (NAG) and N-
acetylmuramic acid (NAMA) residues. Attached to the N-acetylmuramic acid is a 
peptide chain of three to five amino acids. The peptide chain can be cross-linked to the 
peptide chain of another strand forming the 3D mesh-like layer. Peptidoglycans serve an 
  
4 
 
important role in the bacterial cell wall, especially in Gram-positive organisms, giving 
structural strength as well as counteracting the osmotic pressure of the cytoplasm.  
In Gram-positive bacteria the glycopeptides antibiotics easily diffuse through the 
peptidoglycan layer and reach the periplastic space where the peptidoglycan 
polymerization takes place. By binding onto the L-Lys-D-Ala-D-Ala tails of the 
monomers the antibiotic positions itself to inhibit the transglycosidase from joining the 
carbohydrate ends as shown in Figure 2.
2
  
 
Figure 2: Mechanism of action of Vancomycin 
Other -hydroxy--amino acids can be found in antibiotics: D-threonine is present in 
Katanosins (Figure 3),
3, 4
 while -hydroxyleucine in lysobactin.5 Both are highly active 
against Gram-positive bacteria that have shown resistance to Vancomycin.
6 
 
  
5 
 
 
Figure 3: Structure of Katanosins A and B 
Another -hydroxy--amino acid, L-threo--(3,4 dihydroxyphenyl) serine, acts itself as 
a drug, being used in the treatment of Parkinson’s disease.7  
-Hydroxy--amino acids have also played a key role in the synthesis of other 
important compounds. For example, Miller and co-workers
8
 used -hydroxy--amino 
acid 1 in the synthesis of carbacephem 2, a -lactam (Figure 4(a)), Vederas and co-
workers
9
 converted protect -hydroxy--amino acids 3 into -fluoro amino acids 
(Figure 4(b)) 4, and Corey and co-workers
10
 used a -hydroxy--amino acids 5 as a 
chiral building block for the synthesis of -Methylomuralide (Figure 4(c)).  
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Figure 4: Use of -Hydroxy--amino acids in synthesis 
Within the twenty human amino acids, two of them, tryptophan and histidine, are -
substituted with an heterocyclic ring (Figure 5). Also in the natural product this is a 
common scaffold, and amino acid -substituted with an heterocycle can be found, for 
instance, in the structure of ()-Kaitocephalin (Figure 5),11 a molecule active on 
glutamate receptors.  
OH
Cl Cl
NHO
HO2C N
H2
+
CO2
OH
H3N CO2
()-Kaitocephalin
N
H
NH2
COOH
HN
N COOH
NH2
Tryptophan Histidine  
Figure 5: Structures of -amino acids -substituted with an heterocycle 
Among the different heterocycles, isoxazole and isoxazoline rings play a pivotal in 
molecule that show activity towards glutamate receptors.
12-14
 As shown in Figure 6, 
isoxazole ring is found in both agonists and antagonists of AMPA receptor, one of the 
ionotropic glutamate receptors.  
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Figure 6: Structures of AMPA agonists and antagonists 
The acidic amino acid glutamate (Glu) is the major neurotransmitter of the fast 
excitatory synapses in the central nervous system (CNS) and plays a key role in 
physiological processes ranging from learning and memory to control of movements 
and pain sensitivity.
15,16 
Several mental diseases like epilepsy, cerebral ischemia, 
Parkinson and Alzheimer are due to overstimulation of Glu receptors by endogenous or 
exogenous substances. Glu activity is mediated by different type of receptor and for this 
reason it is really important to develop molecules that are selective only towards one 
type, in order to minimize the side effects. For example compounds 6 and 7 reported in 
Figure 7 show a neuroprotective activity, due to their action as antagonists of NMDA 
receptors, one of the ionotropic glutamate receptors.
17
 In both molecules it is 
identifiable the chain of glutamate, one atom longer in the case of 6 and two in the case 
of 7. 
N
O
HOOC
COOH
NH2
N
O
HOOC
COOH
NH2
6 7  
Figure 7: Molecules containing a 
2
- isoxazoline ring that show activity as NMDA antagonists 
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1.1 Synthetic Methodologies for the Synthesis of -Hydroxy--
amino Acids 
As a consequence of the essential role played by -hydroxy--amino in biological 
systems and their utility as synthetic building blocks, a number of useful strategies have 
been devised for their preparation in enantiomerically pure form. These include 
Sharpless asymmetric epoxidation,
18-20
 Sharpless asymmetric dihydroxylation,
21-23
 
electrophilic amination,
24
 hydroxylation,
25
 stereoselective hydrolysis of aziridine 
carboxylate esters,
26-30
 and the aldol reaction.
31, 32
 Among these methods, the focus of 
this section will be on aldol reactions of glycine equivalents with aldehydes. This 
reaction, in fact, provides an effective and direct access to -hydroxy--amino acids 
derivatives, because the process involves the formation of a C-C bond and construction 
of vicinal stereogenic centres. There are two possible methods to synthesize 
enantiomerically pure -hydroxy--amino acids through aldol reaction. One utilises a 
chiral catalyst, whilst the other uses a chiral auxiliary often build into the glycine 
equivalent. 
A few elegant methods for the aldol strategy have been described employing only 
catalytic amount of chiral sources. In 1999 Corey and co-workers used the 
cinchonidine-derived bifluoride salt 8, shown in Figure 8, as catalyst in the reaction 
between the silyl enol ether 9 and different aldehydes, obtaining the desired -hydroxy-
-amino acids in good yield, good d.r. (up to 13:1 syn:anti) and excellent 
enantioselectivity (e.e.: 95%).
33
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N
Ph
Ph
OTMS
OtBu
R H
O
+ R
COOtBu
OH
NH2
R
COOtBu
OH
NH2
+
N
H
H
OBn
H
HF2
-
8
8 (10%mol)
CH2Cl2/hexane
syn anti
d.r. up to 13:1 syn:anti
e.e. up to 95%
yield up to 89%
9
 
Figure 8: Corey’s synthesis of -hydroxy--amino acids 
In 2001 Evans and co-workers reported the aldol reaction of aromatic aldehydes and 5-
alkoxyoxazoles 10 catalyzed by the chiral aluminium complex 11 shown in Figure 9.
34
 
This methodology allows the synthesis of masked -hydroxy--amino acids in excellent 
yield, d.r.(up to 99:1 cis:trans) and e.e. (up to 99%). 
N
OAr OMe toluene, 25 °C 
20h
Ar'CHO
11 (5-10%)
N
O Ar'Ar
CO2Me
N
O Ar'Ar
CO2Me
+
10 cis trans
d.r. up to 99:1 cis: trans
e.e. up to 99%
Yield up to 99%  
Figure 9: Evan’s synthesis of masked -hydroxy--amino acids 
The first direct aldol condensation for the synthesis of -hydroxy--amino acids was 
reported by Shibasaki in 2002.
35
 Heterobimetallic asymmetric complex (S)-LLB 
catalyzed the reaction between glycinate Schiff base 12 with different aliphatic 
aldehydes with a moderate d.r. (up to 86:14 anti:syn) and e.e. (up to 76% of the anti 
diastereoisomer) (Figure 10). 
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O
O
Li
Li
O
La
O
O
Li
O
LiOH
N
Ph
Ph
CO2tBu +
1. (S)-LLB (20 mol %) 
LiOH (18 mol %)
H2O (22mol%), THF
2. citric acid, THF-H2O
40 °C
R
OH
CO2tBu
NH2
R
OH
CO2tBu
NH2
+
(S)-LLB
12
RCHO
anti syn
d.r.: up to 86:14anti:syn
e.e (anti): up to 76%
yield: up to 93%
 
Figure 10: Shibasaki’s synthesis of -hydroxy--amino acids 
A big improvement in the direct aldol reaction was made in 2004 by Maruoka and co-
workers.
36
 The use of their chiral phase transfer catalyst 13 under organic/aqueous 
biphasic conditions (Figure 11), provided the -hydroxy--amino acids in excellent 
diastereoselectivity (96:4 anti:syn ratio) and enantioselectivity (e.e. 98%). 
N
Ar
Ar
Br-
R H
O
N
Ph
Ph
+ R
COOtBu
OH
NH2
+ R
COOtBu
OH
NH2
CO2tBu
(R,R)-13
(R,R)-13
(2 mol %)
1% NaOH
(15 mol %)
NH4Cl (10 mol%)
Toluene, 0 °C
anti syn
d.r.: up to 96:4 anti:syn
e.e (anti): up to 98%
yield: up to 81%
 
Figure 11: Maruoka’s synthesis of -hydroxy--amino acids 
Another possibility for synthesizing -hydroxy--amino acids involves an aldol type 
reaction between a chiral glycine synthon and an aldehyde. Several glycine chiral 
equivalent have been described in the literature.
37
 Evans and co-workers were the first 
describing the chiral oxazolidinone 14 as a chiral glycine equivalent.
38
 The 
isothiocyanate unit build in the molecule acts as a masked amino group, while the 
stereochemical control is provided by the oxazolidinone unit. The aldol reaction 
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between this chiral auxiliary and different aldehydes proved to be highly 
diastereoselective, providing the desired syn adduct in a d.r. up to 99:1.
38
 Several -
hydroxy--amino acids were synthesized using this useful chiral auxiliary,39-41 
including MeBmt shown in Figure 12.
38
  
O N
Bn
O O
N C S
14
+ Me
CHO
Me
1.N-ethylpiperidine
Sn(OTf)2
THF, - 78 °C
HN
O
S
Xc
O Me
Me
CH3OMg2
CH3OH
HOOC
MeHN
OH
Me
Me
MeBmt
Xc =
O N
Bn
O
 KOH 2M
80 °C
HN
O
S
MeO
O Me
Me
1. (CH3)3O
+BF4
-, base
CH2Cl2
N
O
O
MeO
O
Me
Me
2.H2O
15
16
 
Figure 12: Evan’s synthesis of MeBmt 
Recently Frank
42
 and co-workers proposed a modification of the isothiocyanate unit of 
oxazolidinone 14. In fact in the reaction with aldehydes, the isothiocianate group reacts 
with the newly formed alcolate, providing the oxazolidin-2-thione 15, that has to be 
hydrolysed in order to release the free -hydroxy--amino acids. However hydrolysis is 
not a straightforward step, as prior transformation of the oxazolidin-2-thione 15 into the 
more easily hydrolyzed oxazolidin-2-one 16 is needed (Figure 12).
38
 For this reason, in 
order to avoid laborious steps, Frank and co-workers envisaged that the isothiocyanate 
group could be replaced by an azido group. In particular they showed how the reaction 
between the enolate derived from azide 17, and differently substituted aldehydes 
provided the syn aldol products 18 in good yield and diastereoselectivities (Figure 13). 
The transformation of the -hydoxy--azido ester into the desired amino esters 19 is 
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more straightforward, requiring only the removal of thiazolidin-2-thione followed by 
the reduction of the azido group.  
S N
S O
N3
TiCl4, iPrNEt2
NMP, CH2Cl2
-78 °C
S N
S O
Ph
Ph
Ti
ClCl
N3
RCHO S N
S O
Ph
N3
R
OH
1)MeOH
imidazole
O
NH2
R
OH
MeO
18
d.r. >98:2
Yield up to 70%
17 19
2) Reduction
 
Figure 13: Frank’s synthesis of -hydroxy--amino esters 
Xu and co-workers
43
 developed an aldol reaction between aldehydes and the enolates of 
tricyclic iminolactones 20 and 21, which are derived from natural (1R)-(+)-camphor as 
chiral glycine templates to generate optically pure -hydroxy--amino acids in good 
yield and high diastereoselectivity (d.r. up to > 25:1) (Figure 14). The formation of just 
two of the four possible diastereoisomers is due to the exclusively endo addition of the 
nucleophile to the aldehyde with the C12-methyl blocking the attack from the exo-face 
of the enolate. The -hydroxy--amino acids was then easily released through an acid 
hydrolysis and the chiral auxiliary recovered in excellent yield.
43  
O
N
O O
N
O
HO
R
H
O
N
O
H
R
OH
1. LDA (1.1 equiv), THF
2. LiCl (6equiv), RCHO
-78 °C
+
syn anti
N
O
1. LDA (1.1 equiv), THF
2. LiCl (6equiv), RCHO
-78 °C syn antiO
N
O
O
R
H
OH
H
N
O
O
R
OH
H
H
20
21
+
 
Figure 14: Xu’s synthesis of precursors of -hydroxy -amino acids 
Within the different chiral glycine equivalents, Schöllkopf’s bislactim ether 22 is 
particularly attractive because it has proved to be highly diastereoselective in aldol-type 
reactions and is commercially available in both enantiopure (R)- and (S)-forms.
44-46
 
Schöllkopf’s reagent is selectively deprotonated at C-2 providing the azaenolate 23 The 
attack of this latter to an electrophile compound, such as an alkyl halide, occurs only 
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from the face opposite to the isopropyl group, leading to products where C-2 and C-5 
substituents are in trans relationship (Figure 15). 
N
NCH3O
OCH3
BuLi
N
NCH3O
OCH3Li
RCH2X
N
N
RH2C
CH3O
OCH3(R)-22
2 5
HH
(R)-23  
Figure 15: Reaction between Schöllkopf’s reagent and alkyl halides 
When the electrophile is a carbonyl group of an aldehyde, a second stereocenter is 
formed on C-1’. However, in this case the formation of the epimer 2,5-trans-2,1’-syn is 
preferred over the 2,5-trans-2,1’-anti ones (Figure 16). 
N
NMeO
OMe
BuLi
N
NMeO
OMeLi
RCHO
N
N
MeO
OMe
R
HO
(R)-22
N
N
MeO
OMe
R
HO
2 5 2 5
1' 1'+
2,5-trans-2,1'-syn 2,5-trans-2,1'-anti
(R)-23
 
Figure 16: Reaction between Schöllkopf’s reagent and aldehydes 
This is due to a more favourable transition state, in which the aldehyde substituent is far 
from the methoxy group and from the metal atom (Schöllkopf’s model) (Figure17).44 
N
N
OCH3
CH3O
H
O
H
R
M
H
N
N
OCH3
CH3O
H
HO
H
R
H
(R)
5
1'
2
 
Figure17: Schöllkopf’s model  
The acid catalyzed opening of pyrazine ring leads to the formation of enantiomerically 
pure amino esters (alanines or serines) in high yields (Figure 18). At this stage the 
valinate methyl ester can be easily recovered through distillation and used to synthesise 
new Shöllkopf’s reagent. 
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N
NMeO
OMe
BuLi
N
NMeO
OMeLi
RCH2X
RCHO
N
N
N
N
RH2C
MeO
OMe
MeO
OMe
R
HOCOOMe
NH2RH2C
H H3O
+
H3O
+
(R)-22
R
COOMe
NH2H
OH
H2N
COOMe
+
H2N
COOMe
+
(R)-23
 
Figure 18: Synthesis of -amino acids using Schöllkopf’s reagent  
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1.2 Previous Work Overview 
The research group where I performed the PhD, has been interested for several years in 
the stereoselective synthesis of non-proteinogenic -amino acids containing an 
heterocyclic ring using the Schöllkopf’s reagent as chiral glycine equivalent. In 
particular, our early interest concerned the synthesis of alanine and serine type amino 
acids bearing in position 3 an heteroaromatic ring. Initial studies looked at the reaction 
between the Schöllkopf’s reagent and halogenomethyl derivatives of heteroaromatic 
systems, as shown in Scheme 1.
47
 The reaction proved to be highly stereoselective, 
providing only two of the four possible diastereoisomers with a anti:syn ratio of up to 
91:9. This stereochemical outcome was explained considering the model shown before 
(Figure 15). The two adducts were easily separated through chromatographic column, to 
give, after the hydrolysis of pyrazine ring, enantiomerically pure 3-heteroaromatic-
substituted-alanines. 
N
N
OCH3
CH3O
M
N
N
OCH3
CH3O
Het-CH2-X Het
O
H2N
OCH3
NH2
OCH3O
Het
+
H3O
+
N S
N
S O
N
OHeterocycles:
(S)-23
N
N
OCH3
CH3O
Het+
trans cis
 
Scheme 1: Synthesis of 3-heteroaromatic-substituted-alanines 
In order to synthesise the more synthetically useful -hydroxy--amino acids, we 
started studying the reaction between heteroaryl aldehydes and Schöllkopf’s azaenolate 
23. Again just two of the four possible diastereoisomers were formed as shown in 
Scheme 2.
48
 These products were epimers on the newly formed alcoholic carbon, while 
the C-2 and C-5 substituents maintained a trans relationship, as previously described.  
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N
N
OCH3
CH3O
Het-CHO Het
OH
N
N
OCH3
CH3O
Het
OH
+
N
N
OCH3
CH3O
M
NH2
OCH3O
Het
OH
H3O
+
N S
N
S
N
O
N Ph
O
N Me
PMP
Heterocycles:
(S)-23
anti syn
24 25 26 2927 28  
Scheme 2 Synthesis of -hydroxy--amino acids -substituted with an heterocyclic ring 
 
 
 
 
 
Table 1: Optimization of reaction of heteroaldehydes with Schöllkopf’s reagent 
The syn/anti ratio depends on the nature of the counterion (Table 1). The titanium 
derivative of azaenolate 23 reacts with high diastereoselectivity giving a preference for 
syn attack product owing to a tight transition state
44
 promoted by coordination of 
titanium to the aldehyde oxygen. Moreover, the predominance of the (R)-epimer of the 
alcoholic carbon atom comes from an energetically more favored transition state in 
which the aldehyde substituent R is far from the methoxy group and the metal atom. 
To evaluate the effect of a stereocenter at the  position of the aldehyde on the 
stereochemical course of the reaction, we studied the reaction between Schöllkopf’s 
reagent and non-aromatic enantiopure aldehydes 30a-c (Scheme 3).
49
  
Heterocycle anti:syn ratio Yield (%) Counterion 
24 90:10 17 Ti 
25 65:35 26 Li 
26 100:0 43 Ti 
27 70:30 87 Ti 
28 80:20 60 Ti 
29 87:13 95 Ti 
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nBuLi
N
NCH3O
OCH3 THF
-78°C
N
NCH3O
OCH3
Li
X
N CHO
Boc
30a-c
N CHO
Boc
(R)-30c
63%
N
N
OCH3
CH3OX
N
Boc
N CHON CHO
Boc
S
N CHO
Boc Boc
Heterocycle:
(S)-30a (R)-30b (S)-30c
(R)-22
N
N
OCH3
CH3O
+
OHH
N
H
Boc
N
N
OCH3
CH3O
HHO
N
Boc
syn anti
syn anti
H OH
N
N
OCH3
CH3OX
N
Boc
H
HO H
+1' 1'
1'1'
2 2
22
5 5
55
(R)-23
 
Scheme 3: Reaction of Schöllkopf’s reagent and non-aromatic enantiopure aldehydes  
 
 
 
 
 
 
Table 2: Optimization of the reaction between Schöllkopf’s reagent and enantiopure aldehydes  
Also in these cases both lithium and titanium were used as counterion. However, unlike 
the previous results,
48, 50
 the diastereoselectivity was not enhanced except in one case 
(Table 2, entry 2) and at the expense of the yield. In the other cases, no reaction 
occurred in the presence of titanium (Table 2, entry 4), or it occurred with a decreased 
yield and, surprisingly, also less stereoselectivity (Table 2, entry 6). These findings 
differ from our previous results obtained using heteroaromatic aldehydes
48
 and -
heteroaryl-,-unsaturated aldehydes,50 presumably because, in this case, titanium may 
competitively interact also with the carbonyl group of the Boc-protecting group. 
Entry Aldehyde 30 Counterion Yield (%) Ratio syn:anti 
1 a Li 66 75:25 
2 a Ti 31 84:16 
3 b Li 56 61:39 
4 b Ti -- -- 
5 (S)-30c Li 75 64:36 
6 (S)-30c Ti 27 51:49 
7 (R)-30c Li 63 64:36 
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The stereochemical outcome at the C-1’ and C-2 of the pyrazine ring is in line with the 
previous results
48,50
 and the widely accepted model for the aldol-type addition of 22 to 
aldehydes (Figure17). As chiral aldehydes have diastereotopic carbonyl faces, the 
reactions of Schöllkopf’s reagent with aldehydes 30a-c raise the problem of “double 
asymmetric induction”. In our case, the stereodifferentiation due to the chiral aldehyde 
(substrate control) clearly does not have a greater effect than Schöllkopf’s pyrazine 
(reagent control) as both (S)-30c and (R)-30c lead to similar stereochemical results with 
a syn:anti ratio of 1.8:1 (Table 2 entry 5 and 7). This result was quite surprising, 
because, considering the transition states, we would have presumed a better 
diastereoselectivity for the reaction between (R)-22 and (R)-30c. In this case, we 
predicted the major diastereoisomer would have derived from a positive combination of 
both Felkinh-Ahn
51
 and Schöllkopf models (Figure 19, transition state A) whereas the 
minor diastereoisomer would have been the result of an unfavourable transition state, 
where the more cumbersome substituent is pseudoaxial (Figure 19, transition state B).  
H
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CH2
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OCH3
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H
H
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2
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5
N
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Li O
H
O
N
H
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Boc
Boc
H3C
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Figure 19: Models for the reaction between aldehyde (R)-30c and Schöllkopf’s reagent 
Conversely, we expected the reaction between (R)-22 and (S)-30c should have been less 
diastereoselective because both the major (Figure 20, transition state A) and the minor 
(Figure 20, transition state B) diastereoisomers would have derived from half-matched 
transition states.
44
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Figure 20: Models for the reaction between aldehyde (S)-30c and Schöllkopf’s reagent 
However, it is well-known that the lithium salts of the -azaenolates are generally not 
very selective.
44,52,53
 It is therefore very difficult to rationalise the observed 
stereochemical results fully. The only clear thing that can be deduced is that the 
azaenolate reacts through the standard Schöllkopf model.  
More recently we have focus our attention on 4,5 dihydroisoxazole-3-carbaldehydes. 
The choice of this heterocycle stems from its peculiar features. In fact it is easy to 
synthesise through a 1,3-dipolar cycloaddition reaction between nitrile oxides and 
alkenes (Scheme 4).
54 
  
R C N O R1+ O
N
R
R1
 
Scheme 4: Synthesis of 
2
-isoxazolines through 1,3-dipolar cycloaddition 
From the synthetic point of view, the 4,5-dihydro-isoxazole ring proves to be a very 
versatile heterocycle: in fact it can be converted into a number of useful synthetic units, 
such as -hydroxy ketones55-57 or -amino alcohols,58 depending on the experimental 
conditions used for reductive ring cleavage. 
Initial studies concerned the reaction between Schöllkopf’s reagent and aldehydes 31a-c 
5,5-disubstituted with two identical groups.
59
 The absence of a racemic stereocenter in 
the isoxazoline ring allowed us to minimise the total number of diastereoisomers that 
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result from the reaction with Schöllkopf’s reagent. These substrates were synthesised 
according to a recently reported method
60
 that involves a base-catalysed condensation 
between ethyl nitroacetate and alkenes 34 (vide infra). The methodology was extended 
to 1,1-disubstituted alkenes in this study.
59
 The esters 32a-c were then converted into 
the corresponding aldehydes (Scheme 5) 
O
N
CHO
R'
R
31a-c
79-81%
MnO2
CH2Cl2
25°C
O
N
CH2OH
R'
R
33a-c
70-92%
NaBH4
EtOH
0-25°C
O
N
COOEt
R'
R
32a-c
70-80%
DABCOcat
EtOH
80°C
COOEt
NO2
+
R R'
DABCO =
N
N
a: R = R' = Ph
b: R = R' = CH3
c: R = R' = -(CH2)5 -
34
 
Scheme 5: Synthesis of aldehydes 31a-c 
Aldehydes 31a-c underwent reaction with Shöllkopf’s anion 23 (Scheme 6), providing 
just two of the possible four diastereoisomers, with an excellent d.r as reported in Table 
3. The reaction was extremely diastereoselective despite the use of lithium as 
counterion. The structures of the major diastereoisomers 35 were determined using 
NMR analysis and on the base of Schöllkopf model. 
N
N
OCH3
CH3O
(R)-22
O
N
HO
N
N
H3CO
OCH3
N
NCH3O
OCH3
Li
nBuLi
THF
-78 °C
31a-c
H
H
35a-c
R'
R
O
N
CHO
R'
R
a: R = R' = Ph
b: R = R' = CH3
c: R = R' = -(CH2)5 -
(R)-23
 
Scheme 6: Reaction between Schöllkopf’s reagent and aldehydes 31a-c 
Aldehyde 31 Total yield (%) d.r. 
a 66 93:7 
b 64 90:10 
  c 68 95:5 
Table 3: Yields and d.r of the reaction between Schöllkopf’s reagent and aldehydes 31a-c 
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Adducts 35a-c were hydrolysed under mild conditions, which allowed the isolation of 
the -hydroxy--amino esters 36a-c and the dipeptides 37a-c (Scheme 7 and Table 4). 
35a-c
O
N
HO
N
N
H3CO
OCH3
H
H
R
R
HCl 0.2N
CH3OH
25°C O
N
HO
NH2
COOCH3H
H
36a-c
R
R
+
O
N
HO
HN
COOCH3H
H
R
R
O
NH2
37 a-c
H
a: R = R' = Ph
b: R =  CH3
c: R = R' = -(CH2)5 -  
Scheme 7: Hydrolysis of pyrazine ring 
 
35 R 
Yield (%) 
36 37 
a Ph 20 48 
b CH3 20 63 
c -(CH2)5- 28 42 
Table 4: Hydrolysis of pyrazine ring 
The formation of these dipeptides was due to the partial hydrolysis of the pyrazine ring 
that often occurs during the hydrolysis reaction.
49,61-63
 We were unable to avoid this 
despite changing solvent (methyl alcohol, acetonitrile or THF), temperature (from 0 °C 
to room temperature), the acid (HCl or TFA) or its concentration (from 0.2N to 2N). 
Products 36 and 37 were easily separated by means of column chromatography and 
their structure was assigned using exhaustive NMR analysis. Finally, we carried out a 
hydrogenolysis-hydrolysis of the 4,5-dihydroisoxazole ring of the amino esters 36 and 
of the dipeptides 37 using 1 atmosphere of hydrogen and Raney-Ni as the catalyst.
64
 
Hydrogenolysis of 36b and c, was not successful due to a complete degradation of the 
starting material. The same result was observed using HCl instead of B(OH)3 or Pd/C as 
a catalyst. On the contrary, cleavage of dipeptides 37b and c allowed us to obtain the 
corresponding -dihydroxy--oxo -amino acid derivatives 38b and c in good yields 
(Scheme 8). In no case we were able to detect any loss of stereochemical purity. These 
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-amino acids derivatives have a highly functionalized structure which makes them 
extremely attractive as potential peptidomimetics. 
H2
CH3OH/H2O
B(OH)3O
N
HO
HN
COOCH3
H
H
R'
R
O
NH2
H
Raney-Ni
37b, c 38b, c
R
OR' OH
HO H
HN
COOCH3
H
O
NH2
H
68-86%
b: R = R' = -(CH2)5 -
c: R = R' = CH3  
Scheme 8: Synthesis of polifunctionalized dipeptides through 
2
-isoxazoline ring opening 
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1.3 PhD Thesis Program 
In connection with previous results and with the aim of synthesizing new -hydroxy--
amino acids -substituted with an isoxazoline ring, the program of this PhD thesis 
tackles the following points: 
A) Study of the synthesis of enantiomerically pure 5-substituted-2-isoxazoline-3-
carbaldehydes and of the reaction with Schöllkopf’s reagent (R)-22 in order to 
obtain -hydroxy--amino acids with a supplementary stereocenter on 
isoxazoline ring (Scheme 9). 
O
N
O
O
N
HO
NH2
COOMeHN
N
OCH3
OCH3
(R)-22
H
*
*
R R*
*
 
Scheme 9: Reaction between Schöllkopf’s reagent and 5-substituted-
2
-isoxazoline-3-
carbaldehydes 
B) Extention of the methodology to the more challenging reaction between 
Schöllkopf’s reagent (R)-22 and 3-acyl-2-isoxazolines. In particular initially 
we will focus our attention on achiral ketones as 39 (Scheme 10). The presence 
in position 5 of the isoxazoline of two identical groups, avoids the doubling of 
the number of the stereoisomers in the reaction with Schöllkopf’s reagent. After 
reaction with Schöllkopf’s reagent and hydrolysis of pyrazine ring, -hydroxy-
-amino acids 40, with a  quaternary stereocentre, will be obtained (Scheme 
10). The choice of different R groups on the ketones is made in order to 
evaluate the steric encumbrance on diastereoselectivity. 
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Scheme 10: Synthesis of -hydroxy--amino acids through reaction between Schöllkopf’s 
reagent and 3-acyl-
2
-isoxazolines 
C) Further investigation of the reaction with ketones bearing an acetyl group in 
position 5 of isoxazoline ring. The presence of a stereocenter in the molecule 
will require the investigation of a suitable method to obtain 5-acetyl-2- 
isoxazolines 41 and 42 as single enantiomers before reaction with Schöllkopf’s 
reagent (R)-22 (Scheme 11). 
O
N
R
H3C
O
NH2
COOMe
N O
R
CH3HO
*
41: R = CH3
42: R = COOEt
N
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OCH3
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* *
43
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Scheme 11: Synthesis of -hydroxy--amino acids through reaction between 
Schöllkopf’s reagent and 5-acetyl-
2
-isoxazolines 
D)  Study of the best cleavage conditions of -isoxazolines, in order to use them 
in the cleavage of more complex substrates as 43 to obtain polifunctionalized 
-hydroxy-a-amino acids 44 (Scheme 12).  
NH2
COOMe
N O
R
CH3HO
R
NH2 OH
COOMe
NH2
CH3HO
* ** * * *
43 44  
Scheme 12: Synthesis of polifunctionalized -hydroxy--amino acids through 
isoxazoline ring opening 
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E) Preliminary study will be run on the reaction between simple imines 45 and 
Schöllkopf reagent (R)-22 (Scheme 13). This will allow us to obtain, after 
pyrazine cleavage, ,-diamino acids 46.  
R1
N
R2 N
N
OCH3
OCH3
nBuLi
THF, -78 °C
R1
NH
N
N
R2
OMe
OMe
+ R1
NH2
COOMe
NH2
45
46
(R)-22  
Scheme 13: Study of the reaction between imines and Schöllkopf’s reagent  
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2 RESULTS AND DISCUSSION 
2.1 Synthesis of 4,5-Dihydroisoxazole-3-carbaldehydes  
31c, d, f 
As previously mentioned, aldehyde 31c was synthesised starting from the corresponding 
ester 32c obtained by means of a base-catalysed condensation between ethyl 
nitroacetate and methylencyclohexane in accordance with a recently reported method.
60
 
The same methodology was also applied in the synthesis of new isoxazolines 31d-f 
monosubstituted in position 5. According to the described procedure, a mixture of 
alkene 34c-f and ethylnitroacetate reacted in presence of DABCO to give the desired 
isoxazolines in excellent yields and with total regioselectivity (Scheme 14 and Table 5). 
The esters 32c, d, f were converted into the corresponding aldehydes 31 through a 
reduction
65
-oxidation sequence (Scheme 14 and Table 5). 
O
N
CHO
R
R'
31c,d,f
79-81%
MnO2
CH2Cl2
25°C
O
N
CH2OH
R
R'
33c,d,f
70-92%
NaBH4
EtOH
0-25 °C
O
N
COOEt
R
32c-f
70-80%
DABCO cat
EtOH or CHCl3
80 °C
COOEt
NO2
+
R R'
DABCO =
N
N
c: R = R'= -(CH2)5-
d: R = -C6H11, R' = H
e: R = Py, R' = H
f:  R = Ph, R' = H
34c-f
R'
 
Scheme 14 Synthesis of aldehydes 31c,d,f 
 32 (%) 33 (%) 31 (%) 
c 70 89 79 
d 77 77 60 
e 55   
f 84 94 83 
Table 5: Yields of esters 32, alcohols 33 and aldehydes 31 
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The proposed mechanism by De Sarlo and co-workers, reported in Figure 21, discards 
the formation of nitriloxide as intermediate.
60
 The tertiary amine, present in the reaction 
in a catalytic amount, promotes the dehydration of the nitrocompound that is already 
formed upon addition to alkene (intermediate  
 
Figure 21 Proposed mechanism for the synthesis of 
2
-isoxazolines via base-catalyzed 
condensation reaction 
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2.2 Synthesis of Enantiomerically Pure 5-Phenyl-4,5-
dihydroisoxazole-3-carbaldehyde 31f 
2.2.1 Organocatalyzed Synthesis  
In order to minimize the number of diastereoisomers deriving from the reaction between 
Schöllkopf’s reagent and aldehyde 31f, it was necessary to study an enantioselective 
synthesis of it. Because of the good results obtained with the base catalyzed reaction 
between styrene and ethyl nitroacetate (Scheme 14), we thought that the use of a chiral 
tertiary amine could preferentially form a single enantiomer. However the temperature 
required for this reaction (60-70 °C) doesn’t match with a possible organocatalysis. 
Therefore we started studying the feasibility of the reaction at lower temperature using 
DABCO as base. As shown in Table 6 the reaction run at room temperature doesn’t 
afford the desired product (Table 6 entry 2), neither when it is carried out using 
ultrasound or molecular sieves in order to try to shift the dehydration equilibrium (Table 
6, entry 3 and 4). 
O
N
COOEt
Ph
32f
COOEt
NO2
+
Ph
Base, 
conditions,
Metal additives
34f  
Entry Solvent T(°C) t 
(h) 
Base 
(0.2%) 
Metal 
additive 
Yield(%) D Conditions 
1 CHCl3 80 72  DABCO - 70 - - 
2 CHCl3 20 120 DABCO - 0 - - 
3 CHCl3 30 48 DABCO - 4 - ultrasound 
4 CHCl3 20 144 DABCO - 0 - molecular 
sieves 
5 CHCl3 80 24 Quinine - 10 0 - 
6 CHCl3 20 120 Quinine - 2 74.5 - 
7 CHCl3 20 144 Quinine Cu(OAc)2 0 - - 
Table 6: Attempts of synthesis of enantiomerically pure 32f using organocatalysis 
Despite these results, we tried to use quinine as chiral base. When the reaction was 
  
29 
 
carried out at 80 °C, the product was isolated, racemic, in 10% yield (Table 6, entry 5). 
The reaction at room temperature led to the formation of trace of product that was 
optically active (Table 6, entry 6). However because the results were not encouraging 
we used other approaches to obtain the isoxazoline 31f as single enantiomer. 
2.2.2 Classical Chemical Resolution  
Our next approach was to use classical chemical resolution. Through the transformation 
of the two enantiomers into separable diastereoisomers we could obtain the 
enantiomerically pure 31f. We tried three different procedures, in order to obtain a 
mixture of diastereoisomeric salts, amides or esters as shown in Scheme 15. Firstly ester 
32f was hydrolysed to the corresponding carboxylic acid
66
 47 and this was treated with 
(R)- or (S)-1-phenyl-ethylamine. However the resulted diastereoisomeric salts were not 
separable by crystallisation under a number of different solvent condition.  
Ester 32f was then transformed into a couple of diastereoisomeric esters 48a,b by 
means of trans-esterification with different chiral alcohols such as L-menthol or (S)-2-
methyl-1-butanol. However it was not possible to separate the obtained 
diastereoisomeric mixtures by chromatography. The same problem was encountered in 
transforming acid 47, after activation by the Mukaiyama’s reagent, into a couple of 
diastereoisomeric amides 49 by means of a reaction with (S)-methyl-(1-phenyl-ethyl)-
amine.  
O
N
COOEt
Ph
CH3Ph
KOH
H2O
O
N
COOH
Ph
NH2
(R) or (S) O
N
COO-
Ph CH3Ph
NH3
+
mix of diast. salts
R*-OH
O
N
COOR*
Ph
O
N
Ph
mix of diast. amides
NHCH3
Ph
49
48a,b
N+ ClI-
1)
2)
a : R*= b : R*=
(±)-32f
(±)-47f
mix of diast. ester
O
N Ph
CH3
 
Scheme 15: Attempts of classical chemical resolution of (±)-32f  
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2.2.3 Enzimatic Resolution  
After these approaches to enantiomers separation, we directed our attention to an 
enzymatic resolution. This work was conducted in collaboration with Dott.ssa Gandolfi 
from Dipartimento di Scienze Molecolari Applicate ai Biosistemi that provided us the 
more suitable microorganisms or enzymes. 
To obtain the enantiomerically pure aldehyde 31f it is possible to use two different 
biocatalytical approaches based on kinetic resolution: the reduction of aldehyde (±)-31f 
catalysed by yeasts or the hydrolysis of ester (±)-32f operated by the same 
microorganisms or isolated hydrolases (Scheme 16) 
O
N
COOEt
Ph
(±)-32f
O
N
COOEt
Ph O
N
COOH
Ph
+
O
N
CH2OH
PhO
N
CHO
PhDIBAL
Yest or isolated 
hydrolase/lipase
(+) or ()-32f (+) or ()-47
31f (+) or ()-33f
Yeast
O
N
CHO
Ph
(+) or ()-31f
+
 
Scheme 16: Enzimatic startegies for resolution of (±)-32f 
In the case of aldehyde reduction, the fifteen yeasts of different species used showed 
good activity but the alcohol 33f was obtained in racemic mixture. 
The hydrolysis of ester (±)-32f was preliminary screened using different types of 
microorganism or enzymes known to be able to hydrolyze racemic esters in good 
selectivity.
67
 All the biocatalysts tested hydrolysed the substrate with a good rate, but 
only pancreatic porcine lipase (PPL), Pichia etchellsii MIM and Saccaromyces 
cerevisiae Zeus enantioselectively hydrolysed the ester function of 32f (Table 7). 
Evaluation of the progress of the reaction showed that the enantiomerically pure ester 
could only be obtained by driving the reaction over 50% of molar conversion (Table 7).  
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(±)-32f
biocatalyst
O
N
COOEt
Ph
()-32f
O
N
COOEt
Ph O
N
COOH
Ph
(+)-47f
+
 
Biocatalyst e.e. 32f e.e. 47f Molar conversion 
 (%) 
E
a Time 
PPL 60 75 44 12 30 min 
PPL 96 52 65 11 45 min 
Pichia etchellsii MIM 44 47 48 4.2 2 h 
Pichia etchellsii MIM 70 45 61 5.3 3.5 h 
Saccharomyces 
cerevisiae Zeus 
23 46 33 3,4 4 h 
Saccharomyces 
cerevisiae Zeus 
92 33 74 5.7 24 h 
    a Conversion and enantioselectivity factor (E) were calculated from the ee of the substrate and the product  
Table 7: Screening of biocatalysts for enzymatic hydrolysis of (±)-32f  
The best results were obtained using PPL, which was also most active at a low 
concentration (5 gL
-1
).
68
 In this case it was possible to obtain the enriched unreacted 
ester ()-32f with 65% of molar conversion and 96 % e.e. The absolute configuration of 
ester ()-32f was not assigned at this stage, but was determined by means of X-ray 
analysis of the major adduct obtained after reaction with Schöllkopf’s reagent (vide 
infra) and proved to be (5R). Ester (−)-32f was then reduced by sodium borohydride65 
into the alcohol (−)-33f, and oxidation of the latter with manganese dioxide led to 
aldehyde (−)-31f (Scheme 14). 
The e.e. obtained using PPL was quite surprising, considering that the stereocentre is far 
from the functionality that is subjected to the action of the enzyme. For this reason we 
were interested in studying the influence of the substituent in position 5 of isoxazoline. 
In particular we envisaged to maintain the six member ring and, taking in consideration 
the commercial availability of alkenes necessary to synthesize the isoxazolines, we 
prepared the esters 32d and 32e (Figure 22) as previously described (see Scheme 14). In 
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this way we could evaluate the influence of a non planar ring as ciclohexyl and, through 
the isoxazoline substituted with pyridine, the influence of an heteroatom in the cycle. 
(±)-32d
O
N
COOEt
(±)-32e
O
N
COOEt
N
 
Figure 22: Structure of esters (±)-32d and (±)-32e 
Different microorganisms were used in the hydrolysis of esters 32d,e. Some of them 
proved to be able to hydrolyze the esters with a high reaction rate, even employing a 
very low concentration of biocatalyst, but unfortunately without any enantioselectivity. 
The only positive result in term of racemate resolution was obtained using 
Saccharomyces cerevisiae Zeus. Table 8 and Table 9 show how by using this yeast and 
stopping the reaction after 50% of molar conversion, we were able to obtain the esters 
32d,e and the corresponding acids 47d,e enantiomerically enriched. The presence of R 
substituent in position 5 with different geometry and electronic properties than phenyl 
seems to influence the selectivity. In fact if we consider the e.e of the leftover ester after 
24 hours, in the case of 32d and e, this is lower than the one of 32f (see also Table 7). 
Moreover in the case of ester 32e we observed a very low hydrolysis rate, presumably 
due to the presence of the heteroatom in the cycle, that may cause a change in the 
polarity of the molecule making the substrate less accessible to the enzymes.  
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(±)-32d
Biocatalyst
O
N
COOEt
()-or ()-32d
O
N
COOEt
O
N
COOH
(+)- or ()-47d
+
 
Biocatalyst e.e. 32d e.e. 47d Molar conversiona (%) Ea Time  
S. cerevisiae Zeus 10 37 21 2.4 2.5 h 
S. cerevisiae Zeus 12 28 30 2 4 h 
S. cerevisiae Zeus 81 37 69 5 24 h 
a Conversion and enantioselectivity factor (E) were calculated from the ee of the substrate and the product 
Table 8: Optimization of hydrolysis reaction of (±)-32d with S.cerevisiae Zeus 
 
(±)-32e
Biocatalyst
O
N
COOEt
()-or ()-32e
O
N
COOEt
O
N
COOH
(+)- or ()-47e
+N N N
 
Biocatalyst e.e. 32e e.e. 47e Molar conversiona (%) Ea Time 
S. cerevisiae Zeus 8 12 14 1.3 2 h 
S. cerevisiae Zeus 15 39 28 2.6 17 h 
S. cerevisiae Zeus 
S. cerevisiae Zeus 
S. cerevisiae Zeus 
28 
54 
61 
46 
61 
56 
38 
47 
52 
3.5 
7.0 
6.4 
24 h 
48 h 
72 h 
a Conversion and enantioselectivity factor (E) were calculated from the ee of the substrate and the product  
Table 9: Optimization of hydrolysis reaction of (±)-32e with S.cerevisiae Zeus 
The enantiomeric excess and molar conversion were determined through chiral HPLC.  
After having studied the reaction of hydrolase on esters 33d-f, being again supported by 
Dott.ssa Gandolfi, we wanted to explore if biocatalysts could selectively oxidize 
alcohols 33d, f to the corresponding acids (Scheme 17). In particular we were interested 
in testing as biocatalyst whole cells of Acetobacter aceti MIM 2000/28 In fact this 
microorganism, isolated in Dott.ssa Gandolfi’s laboratories, showed previously a certain 
efficiency in the transformation of primary alcohols.
69, 70
 Acetobacter aceti oxidizes the 
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alcohols into the corresponding acids in two steps: in the first one the enzyme alcohol 
dehydrogenase (ADH) converts the alcohol into the aldehyde (+)- or ()-31d,f that is 
subsequently transformed into the corresponding acid by aldehyde dehydrogenase 
(ALDH) (Scheme 17).  
 
O
N
CH2OH
R O
N
COOH
R
(±)-33d,f
Acetobacter aceti
O
N
CH2OH
R
(+) or ()- 33d,f
+
(+) or ()- 47d,f
d: R = Cyclohexyl
f: R = Ph
O
N
CHO
R
(+) or ()- 31d,f
 
Scheme 17: Enzimatic oxidation of (±)-33d,f 
The reactions were carried out in water using Acetobacter aceti grown 48 hours. Table 
10 summarizes the results obtained for the oxidation of 33f: the acid 47f was obtained 
with a very high e.e., while the leftover alcohol is racemic. Because, as previously said, 
the oxidation proceeds through two steps, we can hypothesize that the stereoselective 
one is the oxidation of the aldehyde to the acid.  
 
Entry e.e. 33f  e.e. 47f Time 
1 8 98 3 h 
2 11 98 6 h 
3 17 98 24 h 
4 22 98 72 h 
Table 10: Optimization of enzymatic oxidation of (±)-33f 
A similar outcome was observed for the alcohol 33d bearing a cyclohexyl in position 5. 
Table 11 shows that also in this case the acid 47d is obtained with a good e.e (even if 
lower than the corresponding 5-phenyl-2-isoxazoline 47f) while, similarly as before 
the leftover alcohol is racemic. 
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Entry e.e. 33d e.e. 47d Time 
 3 86 6 h 
 4 83 24 h 
 2 86 48 h 
Table 11: Optimization of enzymatic oxidation of (±)-33d 
In both cases it was not possible to isolate the intermediate aldehydes 31d,f and 
therefore evaluate their e.e. For this reason it was not possible to evaluate the 
conversion of the reaction. However the HPLC traces run after 72 hours and 48 hours, 
showed a large amount of leftover alcohol, suggesting that the reaction proceded very 
slowly. This may be due to the accumulation of the intermediate aldehydes 31d,f, that, 
even in small amount, are toxic for the microorganism and may cause an inhibition of 
the enzymatic activity.  
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2.3 Synthesis of 3-Acyl-4,5-dihydroisoxazoles 39a-d 
For the synthesis of compounds 39a-d, we envisaged three possible retrosynthetic 
approaches described in Figure 23. 
NO2
+
O
N
R
O
COOEt
NO2
+
O
N
O
R
O
H
COOEt
NO2
+
O
N
COOEt
C) Weinreb amide
    + Addition of Grignard reagent
     Oxidation
31c
32c
A
3 steps
39a-d
a: R = -CH3
b: R = -CH2CH3
c: R = -CH(CH3)2
d: R = -CH=CH2
O
N
HO
R
50a-d
B) Addition of 
Grignard RMgX
 
Figure 23: Retrosynthetic approaches for the synthesis of 39a-d 
The synthesis of 39a-d by strategy A was based on the cycloaddition between 
methyleneciclohexane and different nitro ketones. However these latter compounds are 
not commercially available and requires a four step synthesis to be obtained.
71
 In the 
strategy B the key intermediate aldehyde 31c, could undergo reaction with various 
Grignard, providing the alcohols 50a-d with different R group. Oxidation would give 
the corresponding ketones. This strategy, however, required 5 steps synthesis. The third 
possibility (C) envisaged the direct conversion of the ester of the isoxazoline 32c into 
the ketone via the corresponding Weinreb amide. This strategy was the more appealing 
because it would allow the synthesis of ketones 39a-d in just two steps.  
Our investigations started using strategy C with significant results summarized in Table 
12. Initially we thought that converting one pot the isoxazoline 32c, into the 
corresponding vinyl ketone 39d without isolating Weinreb amide would have been 
advantageous. For this reason we used an excess (8.3 equivalents) of vinylmagnesium 
bromide,
72
 which would act to neutralize the HCl salt and to deprotonate the amine 
  
37 
 
itself, and then act as nucleophile once the intermediate amide as been formed. The 
desired product 39d was not formed but instead from the complex reaction mixture, 51 
was isolated in 11% yield. This compound derived from the attack of one molecule of 
vinyl magnesium bromide on the intermediate vinylketone 39d. In addition, ketone 52 
in 26% yield arising again from the attack of the amine on the highly reactive 
,unsaturated ketone (Scheme 18 and Table 12, entry 1).  
O
N
COOEt
+
CH2=CHMgBr
O
N
O
THF
Conditions
O
N
O
 +
51 (11%)
52 (26%)
32c
O
N
O
N
OCH3
CH3
39d
NH2
+Cl-
CH3
H3CO
 
Scheme 18: Attempted transformation of ester 32c into vinyl ketone 39d 
We therefore tried to isolate the Weinreb amide, using methylmagnesium bromide as 
base. In a first attempt we mixed 3.5 equivalents of Grignard’s reagent73 with amine and 
ester 32c. However this procedure led to isolation of the corresponding methyl ketone in 
70% yield (Table 12 entry 2 and Scheme 19). Given this result, we decrease the 
equivalent of methylmagnesium bromide to 2.35 and inverted the order of the addition. 
We sought that allowing the formation of the deprotonated amine by mixing the 
Grignard reagent and N,O-dimethylhydroxilamine hydrochloride, would have favoured 
the formation of the amide. In fact we managed to isolate the desired amide 53 in 49% 
yield (Table 12 entry 3). 
O
N
COOEt
+
NH2
+ Cl -
OCH3
H3C
O
N
O
N
CH3
OCH3MeMgBr
O
N
O
CH3
THF
Conditions
39a5332c  
Scheme 19: Synthesis of Weinreb amide 53 
However the subsequent reaction of the amide 53 with vinylmagnesium bromide led to 
isolation of ketone 52 in 92% yield.  
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Table 12: Results obtained in the synthesis of ketones 39 using strategy C 
We then turned our attention to strategy B (Scheme 20). As shown in Table 13 the 
reaction of 32c with various Grignard’s reagents occurred with moderate to good yields. 
In particular when ethylmagnesium bromide and isopropylmagnesium bromide (Table 
13, entry 2 and 3) were used, the Grignard’s reagent acted as reducent74 on the aldehyde 
and it was possible to isolate the corresponding primary alcohol 33c, which, in one case, 
was also the main product. However the two products could be easily separated by 
column chromatography. 
O
N
CHO
32c
O
N
HO
R
O
N
O
R
RMgBr
THF, -78 °C
MnO2
CH2Cl2
50a-d 39a-d
a: R = -CH3 
b: R = -CH2CH3
c: R = -CH(CH3)2
d: R = -CH=CH2
 
Scheme 20: Synthesis of ketones 39 through strategy B 
 
Entry RMgBr Yield (%) 50a-d Yield (%) 39a-d 
1 CH3MgBr 73% 88 % 
2 CH3CH2MgBr 46% + 19% 33c 83% 
3 (CH3)2CHMgBr 25% + 43% 33c 59% 
4 CH2=CHMgBr 58% 53% + 26% 54 
Table 13: Yields of the reactions shown in Scheme 20 
 
Entry 
Equiv of 
CH3NOCH3∙HCl 
RMgBr (equivalents) Conditions Product (%) 
1 1.25 CH2=CHMgBr (8.3 
eq) 
-5 °C for 45 
min 
25 °C for 16 h 
60 °C for 4 h 
11% 51 
26% 52 
2 1.25 CH3MgBr (3.5 eq) -30 °C for 2h 70% 39a 
3 1.15 CH3MgBr (2.35 eq)   49% 53 
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The oxidation was carried out using MnO2 in good to excellent yield. In the reaction of 
of 39d the yield was not as high compared to the other examples due to the formation of 
side product 54 (Scheme 21 and Table 13, entry 4).  
O
N
HO
O
N
O
MnO2
CH2Cl2
50d 39d
+
O N
O
OH
54  
Scheme 21: Oxidation of 50d  
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2.4 Synthesis of 3-Substituted-5-Acetyl-4,5-dihydroisoxazoles 
41 and 42 
The racemic 5-acetyl-3-methyl-2-isoxazoline 41 was regioselectively synthesised by 
means of the 1,3-dipolar cycloaddition of acetonitrile oxide (generated from 
nitroethane) with methyl vinyl ketone (Scheme 22).
54 
N O
O
CH3
H3CPhNCO
Et3N
+
toluene
NO2
O
CH3
H3C
41 (75%)  
Scheme 22: Synthesis of 41 through 1,3-dipolar cycloaddition 
In the case of ketone 42, as the analogous 1,3-cycloaddition between ethyl nitroacetate 
and methyl vinyl ketone afforded the desired product in very poor yield, it was 
necessary to find an alternative route. Initially we tried to use the same base catalyzed 
methodology
60
 described above, between ethyl nitroacetate and methyl vinyl ketone. 
However the reaction run in presence of DABCO led to the isolation of just the Michael 
adduct (Scheme 23, pathway a). According to De Sarlo and co-workers, the same 
reaction carried out in presence of N-methyl-morpholine as base and 5% of Cu(OAc)2, 
shifted the reaction towards the desired isoxazolines (Scheme 23, pathway b).
75
 
However the autors reported also that the little amount of Michael adduct formed during 
the reaction proved not to be separable from the desired isoxazoline even after several 
columns.  
NO2
COOEt O
+ N
O
EtOOC
O
NO2MeOOC
MeOC
NMM (10 mol%)
Cu(OAc)2 (5 mol%)
CHCl3, 60 °C
DABCO (10 mol%)
CHCl3, 80 °C
a b
42  
Scheme 23: Base catalyzed reaction between ethyl nitroacetate and methyl vinyl ketone 
For this reason we discarded this route and we decided to follow the same base 
catalyzed reaction but using the 3-buten-2-ol instead of the corresponding ketone. This 
reaction afforded the desired mixture of syn/anti (57/43) isoxazolines 55 that was then 
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transformed into racemic 5-acetyl-isoxazoline 42 by oxidation of the alcohol function 
(Scheme 24).
76 
N O
OH
CH3
EtOOCDABCO
EtOH
80 °C
PCC/Al2O3
CH2Cl2
25 °C
N O
O
CH3
EtOOC
OH
NO2
MeOOC
+
55 (76%) 42 (90%)  
Scheme 24: Synthesis of 42  
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2.5 Synthesis of Enantiomerically Pure 3-Substituted-5-Acetyl-
4,5-dihydroisoxazoles 41 and 42 
2.5.1 Chemical Resolution 
Due to the presence of a stereocentre in position 5 of isoxazoline, 41 and 42 needed to 
be resolved into their enantiomers, in order to minimize the number of stereoisomers 
after reaction with Schöllkopf’s reagent. We envisaged to convert the racemic ketone 41 
into a couple of diastereoisomeric ketals that could have been then separated by 
chromatography (Scheme 25). Ketone 41 was treated with diethyl L-tartrate but no 
reaction occurred. The reaction with (R,R)-1,2-diphenyl-1,2 ethandiol gave a mixture of 
starting material and desired ketals 57b and 57’b. Unfortunately the diastereoisomers 
were not separable by column chromatography.  
O
N
CH3
O
O
N
CH3
O O
R' R'
+ O
N
CH3
O O
R' R'
PhCH3, PPTS o Tol-SO3H, 
R'
HO
R'
OH
a: R' = R': -COOEt
b: R' = R': Ph
41 57a,b 57'a, b
 
Scheme 25: Chemical resolution of 41 through formation of diastereoisomeric ketals 
Another chemical method to resolve 41 was attempted using the enantioselective CBS 
(Corey-Bakshy-Shibata) reduction of ketones.
77,78
 This would give anti-56 and syn-56, 
which, after chromatographic separation, would have been oxidised into the 
corresponding enantiomerically pure ketones. However the treatment of 41 with 10 mol 
% of (S)-()-o-tolyl-CBS-oxazaborolidine and 1.8 equivalent of BH3∙THF led to a 
mixture of the racemic alcohols syn and anti-56 (Scheme 26). 
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N
B
O
Ph
Ph
CH3
H
(S)-OAB (10%)
BH3THF
THF
OAB =
+
(±)-syn-56(±)-anti -5641
N O
H3C
N O
H3C
CH3
O
CH3
OH
N O
H3C
CH3
OH
Total yield: 30%
 
Scheme 26: Attempted enantioselective reduction of 41 
2.5.2 Enzimatic Resolution 
Because of the lack of success using chemical approaches, once again we shifted our 
attention to the enzymatic resolution. Ticozzi
79
 in 1988 reported an enzymatic reduction 
of 41 and 42 into the corresponding alcohols, though he did not report either the D or 
the enantiomeric excess of the products. Therefore, following their procedure, racemic 
isoxazolines 41 and 42 were treated with commercial baker’s yeast at 35 °C, in 
phosphate buffer, pH 5.5-6.0, in the presence of glucose. After continuous extraction of 
the aqueous solution with dichloromethane, 1:1 mixtures of the corresponding syn/anti 
diastereoisomeric alcohols 55 and 56 were obtained in 66-78% yield (Scheme 27).
76
  
Baker's yeast
35°C
(1S,5R)-()-anti-55, 56
(1S,5S)-(+)-syn-55, 56
(5R)-()-41, 42
(5S)-(+)-41, 42
(66-78%)
(75-81%)
(77-85%)
PCC/Al2O3
CH2Cl2
PCC/Al2O3
CH2Cl2
41, 56: R = CH3 
42, 55: R = COOEt
(±)-41 or (±)-42
N O
R
N O
R
CH3
O
CH3
OH
N O
R
CH3
OH
N O
R
CH3
O
N O
R
CH3
O
 
Scheme 27: Enzymatic resolution of (±)-41 and (±)-42 using baker’s yeast 
The two syn/anti alcohols 55 were separated by means of flash chromatography on 
silica gel, whereas the two syn/anti alcohols 56 required flash chromatography and a 
semi-preparative HPLC separation. Ticozzi reported that, if the reduction of the 
analogous isoxazoline 58 was performed in a mixture of 2-propanol/water, the kinetics 
and the stereoselectivity of the reaction was strongly dependent on the alcohol/water 
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ratio.
80
 In particular when the reduction of 58 was performed using a ratio of 2-
propanol/water of 4/1, it was possible to obtain the enantiomerically pure syn alcohol 59 
and the enantiomerically pure leftover ketone 58 (Scheme 28). 
Yeast 
2-propanol/water 4/1
(±)-58 58 59
N O
Ph
CH3
O
N O
Ph
CH3
O
N O
Ph
CH3
OH
+
 
Scheme 28: Kinetic enzymatic resolution proposed by Ticozzi
80
 
Based on these results and in order to avoid the laborious purification of syn/anti 56, we 
studied the enzymatic reduction of 41 using different ratio of 2-propanol /water. It was 
found that depending on the 2-propanol:water ratio used with our substrate, the 
reactions led either to the unreacted ketone or the completely reduced alcohol (Table 
14). However also Bhaduri and co-workers reported that reduction of 5-acetyl-3-phenyl-
isoxazoline 58 performed in different 2-propanol/water ratio led to recovery of 
unreacted starting material .
81
 
 
Entry H2O iPrOH 41 recovered 56 
1 1 3 100 0 
2 1 4 100 0 
3 1 5 100 0 
4 1 6 100 0 
5 3 1 100 0 
6 4 1 100 0 
7 5 1 0 100 
Table 14: Study of the kinetic enzymatic resolution of (±)-41 using different H2O/iPrOH ratio 
The relative syn/anti configuration of compounds 55 and 56 was assigned using 
1
H-
NMR spectra from the value of the coupling constant between H-5 and H-1 (J = 5.2-5.7 
for syn-55 and 56 and 3.3-3.2 Hz for anti-55 and 56). The enantiomeric excess of each 
alcohol was determined by HPLC to be > 98%. Absolute configurations were not 
assigned at this stage, but were determined by means of an X-ray analysis of the adducts 
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obtained in the following reaction with Schöllkopf’s reagent (vide infra), which allowed 
the assignment of configuration (1S,5S) to alcohols syn-55, 56 and (1S,5R) to anti-55, 
56. Finally, oxidation of the syn and anti alcohols 55 and 56 with PCC/Al2O3 
respectively led to (5S)- and (5R)- 42 and 41 (Scheme 27). The enantiomeric excess of 
the final ketones 42 and 41 was confirmed to be respectively > 98% and 92%.  
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2.6 Study of the Reaction with Schöllkopf’s Reagent 
2.6.1 Addition of Schollköpf’s Reagent Anion to (R)-5-Phenyl-4,5-
dihydroisoxazole-3-carbaldehyde (R)-31f 
As previously said, after having studied the reaction between Schöllkopf’s reagent and 
5,5-disubstituted-4,5-dihydroisoxazole-3-carbaldehydes (Scheme 6),
59
 we decided to 
extend this protocol to aldehyde (R)-31f. 
68
 
In accordance with the general procedure, a solution of aldehyde (R)-31f was added to 
Schöllkopf’s anion (R)-23 generated by nBuLi in THF at –78 °C. To evaluate the 
influence of the counter-ion on diastereoselectivity, the reaction was also performed in a 
parallel experiment in which the lithium azaenolate (R)-23 was treated with 
triisopropoxytitanium (IV) chloride
82 
to give the corresponding titanium azaenolate (R)-
23’ before the addition of aldehyde (R)-31f. 1H-NMR of the crude showed the presence 
of a mixture of diastereoisomers 60-63, whose ratio was determined by means of HPLC 
analysis ( Table 15). 
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Counterion Total 
Yield 
(%) 
Diastereomer Ratios 
60 
(2S,1’S) 
61 
(2R,1’R) 
62 
(2S,1’R) 
63 
(2R,1’S) 
60+62 / 
61+63 
60 / 62 
Li 60 56.8 21.9 19.5 1.8 3/1 3/1 
Ti 60 76.8 4.5 18.7 0.0 21/1 4/1 
Table 15: Optimization of the reaction between Schöllkopf’s reagent and aldehyde (R)-31f 
When the reaction temperature was raised to -20 °C, the yield of the adducts 60-63 was 
lower and compound 64
83
 was isolated in 20% yield (Figure 24). Therefore we 
hypothesised that, similarly to the reported decarboxylative ring-opening reaction of 3-
carboxyisoxazolines,
56
 the anion of the alcohol evolves and a fragmentation, via ring-
opening of the isoxazoline ring, takes place as shown in Figure 24.
 
O
N
N
N
H3CO
OCH3
+M-O
Ph
Ph
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C N
64
 
Figure 24: Formation of side product 64 
The structures 60-63 were assigned by NMR. The (2S)-configuration of compounds 60 
and 62 was established using the 
5
JH-2/H-5 coupling constant whose value of 3.6 Hz, 
corresponds to a trans relationship between the 2-H and 5-H protons of the pyrazine 
ring.
84, 85
 The absolute configuration of the major adduct 60 was determined through X-
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ray crystallographic analysis (Figure 25). This allowed the assignment of (R) 
configuration to C-5 of isoxazoline ring and therefore the configurations of compounds 
32f, 33f, 31f by analogy. The X-ray analysis assigned also the (S) configuration to both 
1’-C and C-2 of pyrazine ring. As a consequence, the (R) configuration was assigned to 
the 1’-C of the epimer 62. 
 
Figure 25: X-ray of 60 
On the contrary, the 
1
H-NMR spectra of diastereoisomers 61 and 63 showed a 
5
JH-2/H-5 
coupling constant value of 5.6 Hz, which corresponds to a cis relationship between the 
H-2 and H-5 protons of the pyrazine ring. The cis relationship was also confirmed by a 
positive NOE effect between the two protons. The (1’R) and (1’S) configurations were 
respectively assigned to diastereoisomers 61 and 63 taking into account the accepted 
model for the aldol-type addition of Schöllkopf’s enolate to aldehydes,44 which has also 
been extensively confirmed in our previous studies.
49, 59
 On the strength of this model, 
the azaenolate-pyrazine attacks the aldehyde by means of a more favourable transition 
state in which the aldehyde substituent is far from the methoxy group and the metal 
atom (Figure 26a). According to this model, the more cumbersome substituent of the 
aldehyde (the isoxazoline ring) occupies the equatorial position in a six member ring 
chair like transition state. This led to a predominance of the adduct (1’S)-60 when the 
attack takes place from the opposite side of the isopropyl group (Figure 26a). On the 
contrary, when the attack takes place from the same side as the isopropyl group, the 
most favourable transition state leads to compound (1’R)-61 (Figure 26b). This is the 
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first time we have observed the formation of products arising from an attack of the 
aldehyde from the more hindered side of the azaenolate (adducts 61 and 63).
44, 53
 The 
formation of adduct 61 in a comparable amount to 62 when Li is used as counterion (see 
Table 15) may be explained taking in consideration the two transition states. As shown 
in Figure 26c the transition state that leads to the formation of product 62 is more 
encumbered than the one that leads to 61 (Figure 26b), because of the phenyl pointing 
toward the pyrazine ring. We hypothesized the two transition states having comparable 
energy, leading to the formation of the two adducts in the similar amount. 
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Figure 26: Transition states for the formation of adducts 60, 61 and 62 
As shown in Table 15 the diastereoisomeric ratio increases when titanium is used as 
counterion. It is thought that titanium promotes a tight transition state
84
 and so the 
reaction proceeds more selectively than the one using lithium. As shown in Table 15, 
diastereofacial selectivity with respect to the pyrazine anion is enhanced (Σ(2S):Σ(2R) = 
21:1 vs 3:1) as is the facial preference of the carbonyl addition, albeit in a less marked 
manner (ratios (1’S):(1’R) = 4:1 vs 3:1). 
An involvement of the isoxazoline ring in the complex intermediate can be expected 
especially when TiCl(OiPr)3 is used.
86, 87
 However, in this case, the additional 
coordination of the titanium atom with the isoxazoline nitrogen should involve a less 
stable s-cis O=C-C=N conformation of the aldehyde, as well as a more encumbered 
transition state with the isoxazoline arrangement on the same side as the methoxy 
group. If a coordination would have taken place, the yield of 62 would have risen when 
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titanium was used as counterion. However the amount of product 62 was practically the 
same with the two counterions (Table 15), suggesting that the potential metal-
isoxazolidine coordination had a poor effect. 
2.6.2 Hydrolysis of Adducts 60 and 61 and Isoxazoline Cleavage of 66 
Adducts 60 and 61 were hydrolysed under controlled conditions, leading to the 
formation -substituted serine methyl esters 65, 66 and the dipeptides 66, 68 (Scheme 
29). These dipeptides, formed by a partially hydrolysis of pyrazine ring, were isolated in 
variable amounts during hydrolysis reaction, independent of the conditions used.
59
 
However they were separated by means of column chromatography and their structure 
was assigned using 
1
H-NMR analysis.
59, 62, 63
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Scheme 29: Hydrolysis of adducts 60 and 61 
Finally, the hydrogenolysis-hydrolysis of the 4,5-dihydroisoxazole ring of dipeptide 66 
using three equivalents of B(OH)3 in a mixture MeOH/H2O, with H2 and Raney-Ni as 
catalyst,
57
 led to the corresponding -dihydroxy--oxo -amino acid derivative 69 in 
good yield (Scheme 30). This -amino acid derivative, like the -disubstituted 
derivatives previously obtained by us, has a highly functionalised structure with a 
further stereocentre that makes it extremely attractive as a potential peptidomimetic.  
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Scheme 30: Synthesis of polifunctionalized dipeptide 69 
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2.6.3 Addition of Schollköpf’s Reagent Anion to 3-Acyl-4,5-
dihydroisoxazole 
With the aim of obtaining new -hydroxy--amino acids, -substituted with a 2-
isoxazoline ring that is potentially susceptible to further transformation, and containing 
an asymmetric, enantiomerically pure quaternary carbon in the  position, we extended 
the protocol previously studied for aldehydes, to ketones. One of the most interesting 
goals of organic synthesis is the asymmetric synthesis of quaternary carbon centres, and 
one of the most useful means of achieving it is the asymmetric addition of nucleophiles 
on ketones.
88-90 
In particular, the aldol reaction between a glycine equivalent and 
prochiral ketones provides access to -disubstituted--hydroxy--amino acids, which 
are of considerable interest in the synthesis of peptidomimetics because of their 
sterically constrained structure.
91
 There are very few published examples of the reaction 
between Schöllkopf’s reagent and prochiral ketones, most of which have involved 
acetophenone, chloroacetone and chloroacetophenone (Scheme 31).
92-96
 In all cases 
there is a completely stereocontrol in the formation of the stereocentre at C-2. Moreover 
when the ketone has two very different size substituents, a good syn/anti ratio can be 
achieved, as in the case of products 70/71 and 72b/73b. 
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Scheme 31: Literature examples of reaction between Schöllkopf ‘s reagent and ketones 
We decided to start our studies using 3-acyl-4,5 dihydroisoxazole 39a-d 5,5-
disubstituted with two identical group, in order to avoid the presence of a stereocentre 
that would have doubled the number of diastereomers after reaction with the 
  
52 
 
Schöllkopf’s reagent. Therefore compounds 39a-d were synthesised as previously 
described. We envisaged that having ketones substituted with different R groups (eg. 
methyl, ethyl, isopropyl), would give us the possibility of studying the influence of the 
steric encumbrance on diastereoselectivity. The vinyl ketone 39d was chosen to allow 
the synthesis of the pharmacologically interesting vinyl amino acids. Moreover this 
substrate gave us the possibility of studying the behaviour of Schollkopf’s reagent in the 
presence of two electrophilic carbons.  
Following the general procedure, a solution of ketone 39a-d was added to the anion of 
the bislactim ether (R)-23 generated by nBuLi in THF at –78 °C. 
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Table 16: Reaction between Schöllkopf’s reagent and 3-acyl-4,5-dihydroisoxazole 39a-c 
As shown in Table 16, the reaction occurred in good yield in the case of ketone 39a and 
in lower yield for compound 39b. In both cases 
1
H-NMR analysis of the crude material 
revealed the presence of two diastereoisomers in 1:1 ratio. However there was not 
reaction with ketone 39c. In this case the reaction didn’t occur presumably due to the 
large steric hindrance given by the isopropyl group.  
Counterion R1 d.r. Yield (%) 
Li
+ -CH3 50:50 61 
(iPrO)3Ti
+ -CH3 ― 0 
SnCl2 -CH3 ― 0 
Li
+ -CH2CH3 50:50 34 
Li
+ -iPr ― 0 
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The products 74a/75a and 74b/75b were separated through a chromatographic column 
and their structures were confirmed by NMR analysis. Through 
1
H-NMR analysis it was 
possible to assign the S configuration to C-2 of pyrazine. In fact for all the adducts the 
5
JH-2/H-5 coupling constant had a value of 3.5 Hz, that corresponded to a trans 
relationship between the 2-H and 5-H protons of the pyrazine ring.
84, 85
 The Schöllkopf 
reagent attacks the carbonyl group exclusively from the opposite side of the isopropyl 
group, however without any stereocontrol of the newly formed tertiary alcohol. 
Ongoing X-ray analysis will allow to determine the absolute configuration also at C-1’.  
In order to improve the diastereoselectivity, we studied the reaction between ketone 39a 
and Schöllkopf’s azaenolate with counterions other than lithium. Because in the 
reactions with aldehydes we observed an increased d.r. when titanium was used as the 
counterion,
48, 50
 we thought this metal might be suitable also in this case. However, as 
shown in Table 16, the reaction run with TiCl(iPrO)3 led to the recovery of unreacted 
starting material. The same result was obtained when tin was used as counterion. The 
lack of reactivity in the reaction with titanium, is presumably due to a too hindered 
transition state occurring when this metal is used.
44
 
The reaction of the vinylketone 39d led to the formation of inseparable diastereoisomers 
74d and 75d in a 1:1 ratio and in 29% yield. Together with these two expected adducts, 
ketone 76 derived from the 1,4 addition of Schöllkopf’s anion to ,-unsaturated ketone, 
was isolated in 47% yield (Scheme 32). 
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Scheme 32: Reaction between Schöllkopf’s reagent and vinyl ketone 39d 
1
H-NMR analysis showed that attack of Schöllkopf’s anion to the carbonyl group of 39d 
occurred only trans to isopropyl group, leading again to the formation of adducts with S 
configuration at C-2 of pyrazine. Similarly, exclusive trans attack occurred in the case 
of 1,4 addition with product 76 having a 
5
JH-2/H-5 coupling constant of 3.5 Hz, 
confirming a trans relation between the two protons. The only other reported example 
of a similar 1,4 addition is the reaction of Schöllkopf’s azaenolate with nitroethylene, 
described by Schöllkopf himself.
84
 However in this case both diastereoisomers 77 and 
78 were isolated in a ratio of 65:35, showing that the attack of the anion on the double 
bond occurred from both sides of the isopropyl group (Scheme 33).  
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22
 
Scheme 33: 1,4-addition of Schöllkopf’s reagent to nitroethylene  
Finally the two adducts 74a and 75a were separately hydrolyzed with 0.2N HCl in THF 
providing the corresponding amino esters 79, 80 in moderate yield (Scheme 34). 
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Scheme 34: Hydrolysis of adducts 74a and 75a 
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2.6.4 Addition of Schöllkopf’s Reagent Anion to 5-Acetyl-4,5-
dihydroisoxazoles 
After we found that the reaction between prochiral ketone 39a-d and Schöllkopf’s 
reagent occurred without any stereocontrol of the newly formed tertiary alcohol, we 
were interested in studying the influence of a stereocenter  to the ketone on 
diastereoselectivity.
76
 Therefore the keto group was moved from position 3 to position 5 
of 2-isoxazolines and the two enantiomerically pure 5-acetyl-4,5-dihydroisoxazoles 
(5R)- and (5S)-41 and (5R)- and (5S)-42 were synthesized as previously described 
(Scheme 27). The methyl ketone is chosen to minimise the steric hindrance around the 
carbonyl group. We select the 3-methyl and 3-carbethoxy derivatives because the 
resolution of their corresponding racemate was approximately described as previously 
mentioned.
79
 Moreover the carbethoxy group, in addition to introducing another 
important functional group, allow us to consider the possible competition between the 
two carbonyl groups in the reaction with Schöllkopf’s reagent. 
Various experimental conditions were examined to optimise yields and evaluate the 
diastereoselectivity of the addition reaction. Under the best conditions, a THF solution 
of ketone 41 was added to the anion of the bislactim ether (R)-23 at -78 °C, and 
maintained at this temperature for four hours. It was found that longer times or higher 
temperatures led to lower yields due to the reversibility of the addition, as previously 
observed by ourselves and by Hayashi.
68, 97
 With the (5S)- or (5R)-3-methyl derivatives 
41, the reaction gave mixtures of two diastereoisomeric adducts 81/82 or 83/84 in ratios 
of respectively 76:24 and 69:31, as determined by integrating the doublet of the 
isopropyl groups in the 
1
H-NMR spectra of the crude reaction mixtures (Scheme 35 and 
Table 17). 
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Scheme 35: Reaction between Schöllkopf’s reagent and (S)- or (R)-41 
 
 
Entry 
ketone counter-ion total yield (%) 
81:82 or 83:84 
ratio 
1 (5S)-41 Li+
 
70 76 : 24 
2 (5S)-41 (iPrO)3Ti
+ Trace --- 
3 (5S)-41∙TiCl4 Li
+ 
48 87 : 13 
4 (5R)-41 Li+
 
65 69 : 31 
Table 17: Optimization of the reaction between Schöllkopf’s reagent and (S)- or (R)-41 
To evaluate the influence of the counter-ion on diastereoselectivity, the lithium 
azaenolate (R)-23 was treated with triisopropoxytitanium (IV) chloride
82 
to give the 
corresponding titanium azaenolate before the addition of (S)-41 (Table 17, entry 2). 
However a mixture of adducts 81/82 was obtained only in trace amounts. In another 
experiment in order to make the carbonile more reactive, titanium (IV) chloride was 
added to a THF solution of ketone (S)-41 before it was added to the anion of the 
bislactim ether (Table 17, entry 3). Compounds 81/82 were obtained with better 
diastereoselectivity (87:13) but a lower yield (48%). 
A different result was obtained using the (S)- and (R)- ketone 42 (Scheme 36). In this 
case, under the best experimental conditions, the reaction led to a mixture of 
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unidentified compounds and varying amounts (20-40%) of unreacted ketone 42. The 
1
H-NMR spectra of this mixture indicated the presence of a pair of adducts 85, but only 
in trace amounts. This different behaviour may have been due to competition between 
different electrophilic carbons, such as the ketone and the carbethoxy group, despite this 
latter should be less reactive than the ketone group. 
N
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Scheme 36 Reaction between Schöllkopf’s reagent and (S)- or (R)-42 
Diastereoisomers 81/82 and 83/84 were purified by means of flash chromatography on 
silica gel, and their structures were confirmed on the basis of mono and bi-dimensional 
1
H-NMR and X-ray analysis. The configuration at C-2 of pyrazine of compounds 82-84 
was established being S using the 
5
JH2/H5 which was 3.5-4.0 Hz.
84, 85
 Adducts 81 and 82 
were obtained as crystalline solids and underwent X-ray crystallographic analysis, 
which made possible to assign the configuration at C-1’ and at C-5” of both products 
and the configuration at C-2 of 81, which could not be determined through 
1
H-NMR 
analysis. As shown in Figure 27, the S configuration was assigned at C-5” and C-2 of 
both 81 and 82. The configuration at C-1’ was found to be R for 81 (Figure 27a) and S 
for 82 (Figure 27b), showing that the two diastereoisomers are epimer at C-1’.  
  
  
59 
 
 
QA006 QA007
N
N
OCH3
OCH3
2
5H
H
N O
H3C
CH3HO
1'
N
N
OCH3
OCH3
2
5H
H
N O
H3C
OHH3C
1'5''
5''
(2S, 1'R, 5"S) (2S, 1'S, 5"S)
a) b)
 
Figure 27: X-ray of adducts 81 and 82 
By analogy, we assigned the same (S) configuration to compound (+)-41 and the (R) 
configuration to ()-41 (Figure 28). 
(R)-()-41 (S)-(+)-41
N O
O
CH3
CH3
N O
O
CH3
CH3
 
Figure 28: Absolute configurations of ()-41 and (+)-41 
Compounds 83 and 84 couldn’t be obtained as suitable crystals for X-ray analysis, and 
so their absolute configurations at C-1’ were assigned by means of exhaustive 1H-NMR 
spectra and NOESY experiments.  
The NOESY spectra of the major diastereoisomer 83 (Figure 29) shows positive effects 
between H-2 and 1’-CH3, between isoxazolin H-5 and 1’-CH3, and between the H-2 and 
one of the H-4 protons. This last effect suggests an (S) configuration at C-1’ because, as 
shown by the Dreiding’s98 molecular models, these positive effects can’t all be observed 
at the same time with the opposite (R) configuration at C-1’. 
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Figure 29: NOESY spectrum of 83 
The NOESY spectra of the minor diastereoisomer 84 (Figure 30), shows positive effects 
between H-2 and 1’-CH3, and between isoxazolinic H-5 and 1’-CH3 but, instead of the 
positive effect between the H-2 and H-4 proton as in the case of 83, there is a positive 
effect between the H-4 protons and the 1’-CH3, thus confirming a (R) configuration for 
1’-C. 
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Figure 30: NOESY spectrum of 84 
 
2.6.5 Models of the Addition of Schöllkopf’s Reagent Anion to Ketones 
(5S)- and (5R)-41  
As previously mentioned, there are just few reported examples of the reaction between 
Schöllkopf’s reagent and ketones and none using prochiral ketones containing 
stereocenters. The reactions of Schöllkopf’s reagent with chiral ketone 41 raises the 
question of “double asymmetric induction”. The use of the enantiomeric forms of 
ketone 41 led to both matched ((R)-22 and (S)-41) and mismatched ((R)-22 and (R)-41) 
situations (Scheme 37), allowing us to evaluate the relative influence of both the 
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carbonyl -stereocentre (substrate control) and the azaenolate-pyrazine (reagent 
control) on reaction stereoselectivity.  
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Scheme 37: Matched and mismatched cases for reaction between Schöllkopf’s reagent and 
(S)-41 /(R)-41 
The reaction between (R)-22 and the ketone (S)-41 was more diastereoselective than the 
reaction with the ketone (R)-41, with the ratio of adducts 81/82 being 3.2:1 versus 2.2:1 
for 83/84 (Scheme 37). This result was for us quite surprising, because, considering the 
transition states, we would have presumed a better d.r. for the reaction between (R)-22 
and (R)-41.  
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 Figure 31: Transition state for reaction between Schöllkopf’s reagent and (R)-41 
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In the reaction between (R)-22 and (R)-41, we proposed the major diastereoisomer 83 
was derived from the preferential attack of the nucleophile from the favoured Si face of 
ketone (R)-41 which is favoured in both the Felkin-Anh
99, 100
 and Cornforth
101
 models. 
This situation allowed the less cumbersome methyl group to be in a pseudoaxial 
position, in agreement with Schöllkopf
44
 and Zimmerman- Traxler
102
 models (Figure 
31, transition state A and B). Therefore, in this case, the favoured diastereoisomer 83 
was a result of a positive combination of both substrate and reagent control. However, 
this favourable situation may be diminished by a negative steric effect between the 2-
isoxazoline ring and the pyrazine 3-methoxy group (Figure 31, transition state A), 
which could give rise to the moderate diastereomeric ratio. 
We proposed that in the reaction between (S)-41 and (R)-22, the major diastereoisomer 
81 was derived from the attack of the nucleophile from the Re face, favoured in both the 
Felkin-Anh and Cornforth models. However this approach places the more hindered 
isoxazoline ring in a pseudoaxial position, which is opposite to that normally observed 
in reactions using Schöllkopf’s reagent44, 49 (Figure 32, transition states E and F). 
However, in the Cornforth-like transition state F, the unfavourable steric interaction 
between the pyrazine 6-methoxy and the 2-isoxazolinic ring can be minimised by 
making this the preferred conformation. The attack from the Si face, which puts the 
more cumbersome isoxazoline ring in a pseudoequatorial position (Figure 32, transition 
states G and H), suffers from steric repulsions between the nucleophile and the 2-
isoxazoline ring. This negative interaction suggested that the transitions states E and F 
were favoured over G and H, thus explaining the preferential formation of adduct 81 
over 82. In conclusion, the diastereoselectivity of this mismatched case was presumably 
influenced to a greater effect by the chiral ketone than the Schöllkopf’s reagent as the 
reaction with the ketone (S)-41 leads to the “substrate control” adduct 81 as the major 
diastereomer. 
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Figure 32: Transition state for reaction between Schöllkopf’s reagent and (S)-41 
2.6.6 Hydrolysis of Adducts 81-83 
Adducts 81-83 were hydrolysed under mild conditions to give -substituted L-
threonines methyl esters 86-88 and the dipeptides 89-91 (Scheme 38). Amino esters 86-
88 were easily separated from their corresponding dipeptides 89-91 by means of column 
chromatography and their structure was assigned using 
1
H- and 
13
C-NMR analysis.
59, 62, 
63 
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Scheme 38: Hydrolysis of adducts 81-83 
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2.7 Study of the Cleavage of 2-Isoxazoline Ring 
In order to obtain polyfunctionalyzed -hydroxy--amino acids, we planned to cleave 
the isoxazoline ring of 88. Initially Ni-catalyzed hydrogenolysis, that we previously 
used,
59, 68
 run in hydrolytic conditions (a methodology developed by Curran),
64
 led to a 
mixture of undefined products (Scheme 39).  
NH2
H
N O
CH3
CH3HO
COOCH3
H2, Ni-Raney
5:1 MeOH:H2O
B(OH)3
O OH
CH3 COOCH3
NH2
HO CH3
X
88 92  
Scheme 39: Isoxazoline ring opening using Curran conditions 
This result prompted us to study the cleavage on more simple substrates. Although the 
opening of 2-isoxazolines has been extensively studied,
103
 this reaction remains still 
quite substrate-dependent. As a test substrate we chose the isoxazoline 32f. Therefore 
this compound was subjected to different set of reaction conditions as summarized in 
Table 18. 
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O
NPh
COOEt COOEt
OPh
OH
conditions
32f
COOEt
NH2Ph
OH
or
 
 
Table 18: Attempted cleavage of isoxazoline ring 
Initially, we tested again the conditions developed by Curran,
64
 that lead to -hydroxy-
ketone. However, also in this case we isolated a mixture of undefined products (Table 
18, entry 1). We therefore thought to change the reductant system, using a nickel 
salt/borohydride system. Using the conditions previously reported by Lakhvich,
104
 we 
again isolated a mixture of undefined products (Table 18, entry 2). By carrying out the 
same reaction in the presence of Boc2O anhydride (Table 18, entry 3)
105
 we thought that 
protection of the newly formed alcohol and amine might prevent subsequent reaction of 
polymerisation with the ester functionality. Unfortunately also in this case, although the 
thorough analysis carried out, we were not able to identify any useful product in the 
reaction mixture.  
Entry Conditions Result 
1 H2/Ni-Raney, MeOH/H2O 5/1, B(OH)3 Complex mixture 
2 NiSO4 (1eq)/NaBH4 (4.5 eq) Complex mixture 
3 NiCl2∙6H2O (3eq), NaBH4 (10eq), Boc2O (3eq), 
MeOH/THF 3/1 
Complex mixture 
4 DIBALH (3.3.eq), THF, -78 °C→60 °C Mixture of 33f and 
31f  
5 Mo(CO)6 (1 eq), CH3CN/H2O, reflux Decomposition 
6 PMHS (4 eq), Boc2O (1.1 eq), Pd(OH) (cat 2%), EtOH, 
reflux 
Complex mixture 
7 H2/Ni-Raney, AcOEt 94+ 95 (~10%) 
8 H2/Ni-Raney, AcOEt, Boc2O (1.1 eq) Starting material 
recovered 
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Scott and co-workers in 2006 reported a very simple method for the cleavage of the N-
O bond of isoxazolines.
106
 They found that DIBALH could reduce the C-N bond and 
cleave the N-O one, leading to amino alcohol in high yield and high diastereoselectivity. 
However when isoxazoline 32f was subjected to the same conditions, a mixture of 
aldehyde 31f and alcohol 33f was formed from reduction of ester (Scheme 40 and Table 
18, entry 4).  
O
NPh
COOEt
32f
O
NPh
CH2OH
33f
O
NPh
CHO
+
31f
 
THF
 -78 °C- 60 °C
DIBALH (3.3.eq)
 
Scheme 40: Cleavage of isoxazoline ring using DIBALH 
Another reagent widely used and studied for the cleavage of 2-isoxazoline is 
Mo(CO)6.
107, 108
 Treatment of our substrate with Mo(CO)6 in acetonitrile led to 
decomposition of the starting material (Table 18, entry 5). Kobayashi
109
 and co-workers 
reported some difficulties in the cleavage of 5-phenyl- 2-isoxazolines as well. In fact 
they only obtained the dehydrated product 93  and the benzaldehyde (Scheme 41) . 
O
NPh
R
Ph Ph
O
+
Ph H
OMo(CO)6
H2O/CH3CN
reflux 93  
Scheme 41: Kobayashi’s cleavage of isoxazoline ring with Mo(CO)6 
A more recent method used Pd(OH)2 as catalyst and the polimer 
polymethylhydrosiloxane (PMHS) as the reductant.
110
 This methodology is used also in 
presence of Boc anhydride to protect the newly formed amine. However, when reacting 
ester 32f under these conditions, complex mixture was obtained (Table 18, entry 6). 
Finally we decided to go back to the Ni-catalyzed hydrogenolysis but run in anhydrous 
conditions. The reaction afforded a mixture of the two expected syn and anti amino 
alcohols 94 together with the two cyclic products 95 deriving from the lactonization 
between the alcohol and the ester functionality (Scheme 42 and Table 18, entry 7). The 
amount of 95 rose from 10% to 30% after the column chromatography, due to the 
acidity of the silica that catalyzed the lactonization. 
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Scheme 42: Cleavage of isoxazoline ring with H2/Ni Raney in anhydrous conditions 
In order to avoid the formation of the close product, we tried running the hydrogenation 
reaction in presence of Boc anhydride to protect the newly formed alcohol and amine. 
Unfortunately we were able to recover just the unreacted starting material (Table 18, 
entry 8).  
It was possible to avoid lactonization due to column chromatography by treating the 
crude material after hydrogenation with two equivalents of acetic anhydride. 
Surprisingly we obtained the amino alcohol protected just on the amine functionality 96 
(Scheme 43). The amount of lactone detected in the crude NMR after hydrogenation 
(~10%) remained constant after acetylation and column chromatography, despite the 
alcohol not being protected. 
H2
AcOEt
Raney-Ni
O
N
COOEt
Ph
Ph COOEt
OH NH2
+
O
NH2
Ph O
94 95
Ph COOEt
OH NHAcAc2O (2eq)
CH2Cl2
96
O
NHAc
Ph O
97
+
32f syn + anti mix
total yield: 50%  
Scheme 43: Hydrogenation of isoxazoline of 32f ring followed by acetilation  
The Ni-catalyzed hydrogenolysis reaction was tested also on isoxazoline 32c (Scheme 
44). Also in this case, together with the expected amino alcohol 98, it was possible to 
identify the lactone 99 (~36%) in the crude NMR after hydrogenation. However, in this 
case, the treatment of the crude mixture with acetyl chloride was less successful. It was 
possible to isolate the N-acetylated lactone 100 and the N-acetylated amino ester 101, 
thought the latter proved not to be stable and cyclised to give 100. 
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Scheme 44: Hydrogenation of isoxazoline of 32c ring followed by acetilation 
Finally we used Ni-catalyzed hydrogenolysis in anhydrous condition to open the ring of 
isoxazoline 88, obtaining -hydroxy-3-amino-L-threonine derivative 92 in 25% yield 
(Scheme 45). In the 
1
H NMR spectra of crude reaction mixture it was possible to detect 
only one diastereoisomer. Spectroscopic data and HRMS (FT-ICR) confirmed the 
structure but it was not possible to obtain suitable crystals for X-ray analysis necessary 
to assign the absolute configuration of the newly formed stereocentre C-6. Despite the 
low yield of compound 92, this remains the only method to obtain this highly 
functionalized molecule. 
H2
AcOEt
Raney-Ni H3C COOCH3
NH2 OH
HO CH3
NH2NH2
H
N O
CH3
CH3HO
COOCH3
88 92  
Scheme 45: Cleavage of isoxazoline ring of amino ester 88 with H2/Ni Raney in anhydrous 
conditions 
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2.8 Preliminary Studies on Addition of Schöllkpof’s Reagent 
Anion to Imines 
After having studied the reaction between Schöllkopf’s reagent and aldehydes and 
ketones, in the last part of my PhD we focussed our attention on a different electrophile, 
imines. Only one example has been reported in the literature by Schöllkopf himself 
about this reaction (Scheme 46).
111
 In that case azaenaolate (S)-105 reacted with the 
imine functionality of 102, providing the intermediate 103, that cyclised into product 
104. The attack on the imine occurred on the opposite face of isopropyl group. However 
nothing was reported about the diastereoselectivity of the newly formed C-N bond.  
N
NCH3O
OCH3
Li+
THF, -78 °C
6h
(R)-105Br
N Ph
Br
N
Ph
N
NCH3O
OCH3
Li+H3C
CH3
N
NPh
N
OCH3
OCH3
102
103
104  
Scheme 46: Reaction of azaenolate (S)-105 with an imine group 
In order to do a preliminary screening, we chose three imines 106-108, all commercially 
available, bearing three different R group on the nitrogen. Following the general 
procedure, a solution of imine 106 or 107 was added to the anion of the bislactim ether 
(R)-23 generated by nBuLi in THF at –78 °C. In the case of sulphonyl imine 106, the 
reaction occured with a low yield and provided all the four possible diastereoisomers 
(Scheme 47). Adducts 109 derived from the favourite attack of the Schöllkopf’s 
azaenolate (R)-23 from the opposite group of isopropyl, while for adducts 110 the 
attack occurred from the same side of isopropyl. However the four products couldn’t be 
separated by column chromatography.  
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Scheme 47: Reaction between Schöllkopf’s reagent and sulphonyl imine 106 
The reaction between benzyl imine 107 and Schöllkopf’s anion (R)-23 didn’t occur 
because (R)-23 deprotonated the benzylic hydrogen of 107, providing the unreactive 
poly-conjugated system 111 (Scheme 48). 
N
NCH3O
OCH3
Li
THF, -78 °C
6h
(R)-23
Ph
N
PhH2C
107
N N
N
111  
Scheme 48: Reaction between Schöllkopf’s reagent and sulphonyl imine 107 
The reaction between phenyl imine 108 and Schöllkopf’s azaenolate (R)-23 occurred in 
good yield and provided just two of the four possible diastereoisomers, 112 and 113. 
1
H-NMR of the products shown a trans relationship between H-2 and H-5, confirming 
the attack of Schöllkopf’s anion from the side opposite to isopropyl group. However the 
diastereoselection in the formation of the new stereocenter at C-1’ proved to be 
relatively low, as the two products were formed with a d.r. of 60:40. Ongoing X-ray 
analysis will assign the absolute configuration at C-1’of 112 and 113 allowing to 
establish which of the two is the major one. 
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Scheme 49: Reaction between Schöllkopf’s reagent and phenyl imine 108 
The hydrolysis of pyrazine ring to obtain the desired a,-diamino acids is object of 
ongoing researches.  
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3 CONCLUSION 
In summary, a simple method to obtain enatiomerically pure -hydroxy--amino acids 
-substituted with a 4,5-dihydroisoxazole nucleus was developed. This involved the 
reaction between Schöllkopf’s reagent and 2-isoxazoline ring bearing a carbonyl group 
(aldehyde or ketone) in position 3 or 5 of the ring (Scheme 50). Reaction between 
Schöllkopf’s reagent and enantiomerically pure 5-acetil-2-isoxazolines was throughly 
studied in order to explain the stereochemical outcome of the reaction.  
2-isoxazoline ring was further exploited and its cleavage led to the formation of 
polifunctionalized amino acids or dipeptides (see Scheme 50) that can be potentially 
incorporated in polypeptides with biological interest.  
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COOEt
R2
R1 Ph
R = H or alk
NH2
H
N O
CH3
OHCH3
COOCH3
*
*
*
R3 = H or valine
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Scheme 50: Transformation of 
2
- isoxazoline ring bearing a carbonyl group into 
polifunctionalized amino acids or dipeptides 
Moreover strategies to obtain enantiomerically pure 5-substituted isoxazoline through 
enzymatic resolution were developed (Scheme 51).  
  
  
75 
 
biocatalyst
O
N
COOEt
Ph O
N
COOEt
Ph
O
N
R
biocatalyst
H3C
O
O
N
R
H3C
O
O
N
R
H3C
O
+
 
Scheme 51: Enzymatic resolution of 5-substituted-2-isoxazolines 
A preliminary study on the synthesis of ,-diamino acids using the reaction between 
Schöllkopf’s reagent and imines was also started. The development of this project, with 
the aim to extend the methodology to more complex imines, is now ongoing.  
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4 EXPERIMENTAL 
4.1 General informations 
Melting points were measured using a Büchi B-540 apparatus and are uncorrected. 
1
H 
and 
13
C-NMR spectra were recorded in CDCl3 (unless otherwise specified) on a Bruker 
AMX 300 spectrometer; chemical shifts () are given in ppm relative to TMS and all of 
the coupling constants are in Hertz. Optical rotation values were measured at 25 °C on a 
Jasco P-1030 polarimeter. The MS spectra were determined using a VG Analytical 7070 
EQ mass spectrometer with an attached VG analytical 11/250 data system. The IR 
spectra were determined using a Jasco FT-IR-4100 spectrometer, in cm
-1
.  
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4.2 General procedure for the synthesis of compounds 32c-f 
A solution of alkene 34c-f (5 mmol, 1 equiv.), ethyl nitroacetate (10 mmol, 2 equiv.) 
and DABCO (0.5 mmol, 0.1 equiv.) in ethanol (20 mL) was heated at 80 °C for five 
days in a sealed tube. The organic solvent was evaporated off and the products were 
purified by column chromatography on silica gel (hexane/ethyl acetate: 80/20). 
4.2.1 Oxa-2-aza-spiro[4.5]dec-2-ene-3-carboxylic acid ethyl ester 32c 
O
N
COOEt
 
Colourless liquid (70%);  
1
H NMR:  1.37 (3H, t, J = 7.1, CH3); 1.40-1.90 (10H, m, -(CH2)5-); 2.89 (2H, s, H-4); 
4.31 (2H, q, J = 7.1, CH2).  
13
C NMR: CH3); 22.82, 24.48, 35.94 (-(CH2)5-); 43.0 (C-4); 61.4 (O-CH2); 
90.36 (C-5); 150.48 (C-3); 160.77 (C=O).  
MS-EI (m/z): 211 (M
+
).  
IR (nujol): 1717 (vC=N, C=N), 1740 (vC=O, C=O). 
4.2.2 Ethyl 5-cyclohexyl-4,5-dihydroisoxazole-3-carboxylate 32d 
O
N
COOEt
 
White solid (n-hexane) (77%) 
m.p.: 48.6 -49.5 °C 
1
H NMR: 1.38( 3H, t, J = 7.1, CH3); 2.00-2.09 (11H, m, C6H11); 2.94 (1H, dd, J = 
9.2, 17.6 H-4 isox); 3.16 (1H, dd; J = 11.1, 17.6, H-4 isox); 4.35 (2H, q, J = 7.1, OCH2); 
4.59 (1H, ddd, J = 9.2, 11.1, H-5 isox) 
13
C NMR: δ 14.04 (CH3); 25.54-26.13-28.02 (CH2(C6H11)); 35.74 (C-4isox); 42.08 
(CH(C6H11)); 61.78 (OCH2); 88.19 (C-5 isox); 151.26 (C=N); 160.80 (O-C=O). 
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MS-EI (m/z): 225 (M
+
), 152, 83 
IR (nujol) 1711 (vC=O, C=O). 
4.2.3 Ethyl 4,5-dihydro-5-(pyridin-2-yl)isoxazole-3-carboxylate 32e 
O
N
COOEt
N
 
Brown solid (diisopropyl ether) (55%) 
Spectroscopic and analytical data are in agreement with those previously reported. 
112
 
4.2.4 5-Phenyl-4,5-dihydroisoxazole-3-carboxylic acid ethyl ester 32f 
O
N
COOEt
 
Oil (84%) 
Spectroscopic and analytical data are in agreement with those previously reported.
65
  
4.3 General procedure for the synthesis of compounds 33c, d, f 
A solution of ester 32c, d, f (10 mmol, 1 equiv.) in ethanol (10 mL) (ethanol/CH2Cl2: 
1/1 for 32c) was added dropwise to suspension of NaBH4 (26 mmol, 2.6 equiv.) in 
ethanol (20 mL) at 0 °C. The reaction was stirred at room temperature for 6 hours. The 
organic solvent was evaporated off and the residue was poured into water. Acetic acid 
was added until pH=6, and the mixture was extracted with several portions of ethyl 
acetate. The combined extracts were dried (Na2SO4) and concentrated at reduced 
pressure. The crude alcohols were purified by column chromatography on silica gel 
(Hexane/AcOEt 6/4). 
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4.3.1 (1-Oxa-2-aza-spiro[4.5]dec-2-en-3-yl)-methanol 33c 
O
N
CH2OH
 
Colourless liquid (89%); 
1
H NMR:  1.46-1.82 (10H, m, -(CH2)5-); 2.54 (1H, broad, OH); 2.78 (2H, s, H-4 isox); 
4.39 (2H, s, CH2-O).  
13
C NMR: 23.81, 25.4, 36.74 (-(CH2)5-); 45.33 (C-4 isox); 58.86 (CH2-O); 87.47 (C-5 
isox); 158.51 (C-3). 
MS-EI (m/z): 169 (M
+
).  
IR (nujol): 3374 (vO-H, OH), 1625 ( vC=N, C=N). 
4.3.2 (5-cyclohexyl-4,5-dihydroisoxazol-3-yl)methanol 33d 
O
N
CH2OH
 
White solid (diisopropyl ether) (77%) 
m.p: 69.5-70.5 °C 
1
HNMR:  2.0-2.09 (11H, m, -C6H11); 2.17 (1H, s broad, OH); 2.77 (1H, dd, J = 8.9, 
17.1, H-4 isox); 3.00 ( 1H, dd, J = 10.5, 17.1, H-4 isox); 4.38 (1H, dd, J = 8.9, 10.5, H-5 
isox); 4.39 (2H, s, CH2OH) 
13
C-NMR:  25.65-26.20-28.40 (CH2 (C6H11)); 37.44 (C-4 isox); 42.21 (CH (C6H11)); 
57.96 (CH2OH); 85.37 (C-5 isox); 158.57 (C=N). 
MS-EI (m/z): 183 (M
+
).  
IR (nujol): 3377 (vO-H, OH), 1623 ( vC=N, C=N). 
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4.3.3 5-Phenyl-4,5-dihydroisoxazol-3-yl]-methanol 33f 
O
N
CH2OH
Ph  
Colourless solid (85%). Spectroscopic and analytical data are in agreement with those 
previously reported.
65
  
4.4 General procedure for the synthesis of compounds  
31 c, d, f  
Following a reported procedure,
59
 MnO2 (5/1 w/w) was added to a solution of alcohol 
33c, d, f (10 mmol) in CH2Cl2 (15 mL), and the reaction mixture was stirred at room 
temperature for 12 hours. The MnO2 was filtered through celite, and the organic solvent 
was evaporated off. The resulting aldehydes were purified through column 
chromatography (Exane/AcOEt 80/20) to remove MnO2 residues. 
4.4.1 1-Oxa-2-aza-spiro[4.5]dec-2-ene-3-carbaldehyde 31c 
O
N
CHO
 
Colourless liquid (79%);  
1
H NMR:  1.50-1.90 (10H, m, -(CH2)5-); 2.84 (2H, s, H-4 isox); 9.95 (1H, s, CHO).  
13
C NMR: 23.09, 24.71, 36.28 (-(CH2)5-); 40.13 (C-4 isox); 92.43 (C-5); 158.01 (C-3 
isox); 186.43 (CO).  
MS-EI (m/z): 167 (M
+
).  
IR (nujol): 1695 ( vC=O, C=O), 1573 ( vC=N, C=N). 
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4.4.2 5-cyclohexyl-4,5-dihydroisoxazole-3-carbaldehyde 31d 
O
N
CHO
 
Oil (60%) 
1
H NMR:  2.00-2.09 (11H, m, C6H11); 2.83 (1H, dd, J = 9.1, 17.5, H-4), 3.07 (1H, dd, 
J = 11.2, 17.5; H-4); 4.61 (1H, ddd, J = 9.1, 11.2, H-5), 9.91 (1H, s, CHO) 
13
C-NMR: δ 25.56-26.14-28.09 (CH2 (C6H11)); 32.51 (C-4 isox); 42.22 (CH (C6H11)); 
89.49 (C-5 isox); 159.39 (C=N); 185.84 (CHO). 
MS-EI (m/z): 181 (M
+
).  
IR (nujol): 1669 (vC=O, C=O) 
4.4.3 4,5-dihydro-5-phenylisoxazole-3-carbaldehyde 31f 
O
N
CHO
Ph  
Oil (83%). Analytical and spectroscopic data are in agreement with those previously 
reported.
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4.5 Enzimatic resolution of (±)-32f 
4.5.1 (5R)-5-Phenyl-4,5-dihydroisoxazole-3-carboxylic acid ethyl ester  
(R)-32f 
O
N
COOEt
Ph  
Compound (R)-32f was obtained by biotransformation, with 3.57 g of ester (±)-32f 
dissolved in DMSO and 3.75 g of Lipase from hog pancreas (PPL) being added to 700 
ml of 0.1 M phosphate buffer, pH 7. The biotransformation was carried out at 30°C 
under magnetic stirring. After 45 min (HPLC monitoring), the reaction was extracted 
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three times with ethyl acetate to recover ester (R-)-32f. The aqueous phase was brought 
to pH 2 with HCl and extracted three times with ethyl acetate to recover the acid (S)-
47f. The organic extracts were dried over Na2SO4 and the solvent was removed under 
reduced pressure. The crude (R)-32f was purified by means of flash chromatography on 
silica gel (hexane/ethyl acetate: 90/10). Colourless oil (30%); 
[
25
D]  -285.3 (c 0.95, CHCl3).  
4.5.2 [(5R)-5-Phenyl-4,5-dihydroisoxazol-3-yl]-methanol (R)-33f 
O
N
CH2OH
Ph  
Alcohol (R)-33f was prepared starting from the ester (R)-32f as previously described for 
the racemic compound. Analytical and spectroscopic data are in agreement with those 
previously reported for the racemic compound.  
 [
25
D]  -166.3 (c 1.05, CHCl3) 
4.5.3 (5R)-4,5-dihydro-5-phenylisoxazole-3-carbaldehyde (5R)-31f 
O
N
CHO
Ph  
Aldehyde (R)-31d was prepared the ester (R)-32f as previously described for the 
racemic compound. Analytical and spectroscopic data are in agreement with those 
previously reported for the racemic compound.  
Colourless oil (83%);  
[
25
D] -459 (c 1.29, CHCl3). 
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4.6 General procedure for the synthesis of compounds 50a-d 
A solution of the appropriate Grignard reagent (7.5 mmol, 2.5 equiv) was added 
dropwise at -78 °C to a solution of aldehyde 31c (3 mmol) in 5 mL of anhydrous THF. 
The reaction mixture was stirred for 3 hours and allowed to warm at -20 °C. A saturated 
solution of NH4Cl (10 mL) was added to the reaction and the mixture was allowed to 
warm to room temperature. THF was removed under reduced pressure and the aqueous 
layer was extracted with AcOEt (3 × 3mL). The combined organic phases were dried 
(Na2SO4) and the solvent removed under reduced pressure. The product were purified 
by column chromatography (hexane/AcOEt: 75/25) to give alcohols 50a-d. 
4.6.1 1-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)ethan-1-ol 50a 
O
N
HO
CH3
 
Oil (73%) 
1
H NMR (3H, d, J = 6.6 CH3); 1.8-1.4 (10 H, m. cyclohexyl); 2.02 (1H, s broad, 
OH); 2.68 (1H, d J = 16.97, H-4); 2.75 (1H, d J = 16.97, H-4); 4.65 (1H, q, J = 6.6 CH) 
13
C NMR CH3); 23.27, 24.87, 36.10 (-(CH2)5); 43.12 (C-4); 63.75 (CH); 
86.55 (C-5); 161.5 (C=N) 
IR (nujol): 3397 (vO-H, OH), 1624 ( vC=N, C=N). 
MS-EI (m/z): 183 (M
+
), 166.  
4.6.2 1-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)propan-1-ol 50b 
O
N
HO
 
Liquid (46%) 
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1
H NMR : 0.95 (3H, t, J = 6.2, CH3); 1.4-1.8 (10H, m, cyclohexyl); 2.1 (1H, d, J = 4.5, 
CHOH), 2.6 (1H, d, J = 17.0, H-4); 2.75 (1H, d, J = 17.0, H-4); 4.45 (2H, dq, J = 4.5, 
6.2 CH2) 
13
C NMR : 9.32 (CH3); 23.27, 24.89 (-(CH2)5); 27.56 (CH2); 36.20 (-(CH2)5); 43.14 
(C-4); 68.89 (CHOH); 86.29 (C-5); 160.61 (C=N) 
IR (nujol): 3394 (vO-H, OH), 1623 ( vC=N, C=N). 
MS-EI (m/z): 197 (M
+
), 140 
4.6.3 2-methyl-1-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)propan-1-ol 50c 
O
N
HO
 
White solid (25%) 
m.p: 54-56 °C 
1
H NMR : 0.85 (3H, d, J = 6.7, CH3); 0.95 (3H, d, J = 6.7, CH3); 1.3-1.75 (10H, m, 
cyclohexyl); 1.75-1.85 (1H, m, CH(CH3)2); 2.55 (1H, d, J = 17.0 , H-4); 2.75 (1H, d, J = 
17.0, H-4); 3,3 (1H, s broad, OH); 4.05 (1H, d, J = 7.5, CHOH) 
13
C NMR : 17.85 (CH3); 18.56 (CH3); 23.33, 24.96 (-(CH2)5); 31.90 (CH(CH3)2); 
36.27, 36.41 (-(CH2)5); 43.59 (C-4); 73.01 (CHOH); 86.31 (C-5); 160.45 (C=N) 
MS-EI (m/z): 212 (M
+
), 194 
IR (nujol): 3394 (vO-H, OH), 1623 ( vC=N, C=N). 
4.6.4 1-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)prop-2-en-1-ol 50d 
O
N
HO
 
Liquid (58%) 
1
H NMR : 1.4-1.8 (10H, m, cyclohexyl); 2.65 (1H, d, J = 17.0, H-4); 2.75 (1H, d, J = 
17.0, H-4); 4.95 (1H, d, J = 5.8, CHOH); 5.25 (1H, d, J = 10.4, CH=CH2); 5.45 (1H, d, 
J = 17.2, CH=CH2); 5.9 (1H, ddd; J = 5.8, 10.4, 17.2, CH=CH2) 
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13
C NMR : 23.38, 25.02, 36.30 (-(CH2)5); 43.50 (C-4); 69.38 (CHOH); 87.14 (C-5); 
117.17 (CH=CH2); 136.28 (CH=CH2); 159.13 (C=N) 
MS-EI (m/z): 195 (M
+
). 
4.7 General procedure for the synthesis of compounds 39a-d  
Following a reported procedure,
59
 MnO2 (5/1 w/w) was added to a solution of alcohol 
39a-d (2 mmol) in CH2Cl2 (5 mL), and the reaction mixture was stirred at room 
temperature for 12 hours. The MnO2 was filtered through celite, and the organic solvent 
was evaporated under reduced pressure. The product was purified by column 
chromatography (hexane/AcOEt: 90:10) to give ketones 39a-d. 
4.7.1 1-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)ethan-1-one 39a 
O
N
O
CH3
 
White solid (exane) (88%) 
m.p.: 55-58 °C 
1
H NMR :1.4-1.8 (10H, m, cyclohexyl); 2.48 (3H, s, CH3); 2.81 (2H, s, H-4)  
13
C NMR : 23.12, 24.75 (-(CH2)5); 26.26 (CH3); 29.62, 36.31(-(CH2)5), 41.65 (C-4) 
91.46 (C-5) ; 157.89 ( C=N); 193.70 (C=O) 
IR (nujol): 1679 ( vC=O, C=O). 
MS-EI (m/z): 181 (M
+
), 164  
4.7.2 1-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)propan-1-one 39b 
O
N
O
 
Liquid (83%) 
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1
H NMR : 1.13 (3H, t, J = 7.4, CH3); 1.4-1.8 (10H, m, cyclohexyl); 2.82 (2H,s, H-4); 
2.9 (2H, q, J = 7.4, CH2)
 
13
C NMR : 7.60 (CH3); 22.87, 24.61 (-(CH2)5); 31.88 (CH2); 36.53 (-(CH2)5); 41.77 
(C-4); 90,67 (C-5); 157.00 (C=N); 196.43 (C=O) 
IR (nujol): 1682 ( vC=O, C=O). 
MS-EI (m/z): 195 (M
+
), 178 
4.7.3 2-methyl-1-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)propan-1-one 39c 
O
N
O
 
Liquid (59%) 
1
H NMR : 1.15 (6H, d, J = 6.9, 2 CH3); 1.8-1.4 (10H, m, cyclohexyl); 2.82 (2H, s, H-
4); 3.55 (1H, sept, J = 6.9, CH) 
13
C NMR : 18.60 (CH3), 23.26, 24.77, 36.26 (-(CH2)5); 36.60 (CH); 42.11 (C-4); 
90.80 (C-5); 156.40 (C=N); 299.20 (C=O) 
MS-EI (m/z): 209 (M
+
), 192 
IR (nujol): 1680 ( vC=O, C=O). 
4.7.4 1-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)prop-2-en-1-one 39d 
O
N
O
 
Yellow solid (exane) (53%) 
m.p.: 45.2-48.6 °C 
1
H NMR : 1.4-1.8 (10H, m, cyclohexyl); 2.9 (2H, s, H-4), 5.83 (1H, dd, J = 1.6, 10.5, 
CH=CH2), 6.5 (1H, dd, J = 1.6, 17.3, CH=CH2); 7.21 (1H, J = 10.5, 17.3, CH=CH2) 
13
C NMR : 23.01, 24.62, 36.16 (-(CH2)5); 41.79 (C-4); 91.12 (C-5); 129.31 
(CH=CH2); 131.33 (CH=CH2); 157.85 (C=N); 184.01 (C=O) 
MS-EI (m/z): 193 (M
+
), 176 
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IR (nujol): 1607 ( vC=N, C=N), 1665 ( vC=O, C=O) 
4.8 Synthesis of 5-Acetyl-4,5-dihydroisoxazole 41 and 42 
In the case of 5-acetyl-4,5-dihydoisoxazole 41 and 42 a general procedure was not 
followed. Below are reported the single procedures that have been used in the synthesis 
of these compounds.  
4.8.1 1-(4,5-dihydro-3-methylisoxazol-5-yl)ethanone (±)-41  
O
N
CH3
H3C
O  
Compound 41a was prepared starting from 3-buten-2-one and nitroethane, according to 
the known procedure.
54 
Spectroscopic data were in agreement with those reported. 
4.8.2 Synthesis of 5-(1-Hydroxyethyl)-4,5-dihydro-isoxazole-3-carboxylic 
acid ethyl ester (±)-syn/anti- 55 
O
N
COOEt
HO
H3C
 
A solution of 3-buten-2-ol (1.04 mL, 12 mmol), ethyl nitroacetate (2.64 mL, 24 mmol, 2 
equiv) and DABCO (269 mg, 2.4 mmol, 0.5 equiv) in ethanol (30 mL) was heated at 80 
°C for five days in a sealed tube. The organic solvent was evaporated under reduced 
pressure and the mixture of diastereoisomers was purified and separated by means of 
flash chromatography (SiO2, hexane/ethyl acetate: 3/1), affording 1.7 gr of product 
(76%).
 
  
  
88 
 
1
st
 diast: anti-55 
1
H NMR:  1.16 (d, J = 6.5, 3H, CH3); 1.32 (t, J = 7.2, 3H, CH3); 1.87 (d, J = 3.6, 1H, 
OH); 3.08 (dd, J = 17.7, 11.5, 1H, H-4); 3.22 (dd, J = 17.7, 8.9, 1H, H-4); 4.06 (m, 1H, 
H-1); 4.30 (q, J = 7.2, OCH2); 4.68 (ddd, J = 11.5, 8.9, 3.3, 1H, H-5).  
13
C NMR:  13.9 (CH3); 17.8 (CH3); 32.8 (C-4); 61.95 (CH2); 66.8 (C-1), 87.5 (C-5); 
152.0 (C-3); 160.4 (C=O).  
IR (Nujol): 3433 (vOH, OH),1722 (νC=O, C=O),1591 (νC=N, C=N). 
Anal. Calcd for C8H13NO4: C, 51.33; H, 7.00; N, 7.48. Found: C, 51.19; H, 6.85; N, 
7.33. 
MS-FAB
+
 (m/z): 188 [M+H]
+
. 
 
2 
nd
 diast: syn-55 
1
H NMR:  1.28 (d, J = 6.5, 3H, CH3); 1.37 (t, J = 7.1, 3H, CH3); 1.99 (d, J = 6.2, 1H, 
OH); 3.06 (dd, J = 17.8, 8.2, 1H, H-4); 3.24 (dd, J = 17.8, 11.2, 1H, H-4); 3.78 (m, 1H, 
H-1); 4.33 (q, J = 7.1,OCH2); 4.67 (ddd, J = 11.2, 8.2, 5.2, 1H, H-5).  
13
C NMR:  14.1 (CH3);18.8 (CH3); 35.6 (C-4); 62.1 (CH2); 68.9 (C-1), 87.1 (C-5); 
152.0 (C-3);160.4 (C=O). 
IR (Nujol): 3430 (νOH, OH), 1720 (νC=O, C=O), 1593 (νC=N, C=N).  
Anal. Calcd for C8H13NO4: C, 51.33; H, 7.00; N, 7.48.Found: C, 51.22; H, 6.92; N, 
7.38.  
MS-FAB
+
 (m/z): 188 [M+H]
+
.  
4.8.3 Synthesis of 5-Acetyl-4,5-dihydro-isoxazole-3-carboxylic acid ethyl 
ester (±)-42 
O
N
COOEt
O
H3C
 
PCC/Al2O3 (3 equiv) was added to a solution of syn/ anti- 55 (1.7 g, 9.1 mmol, 1 equiv) 
in CH2Cl2 (40 mL), and the reaction mixture was stirred at reflux temperature for 24 h. 
The PCC was filtered through Celite, and the organic solvent was removed under 
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reduced pressure. The crude ketone was purified by column chromatography (SiO2, 
hexane/ethyl acetate: 8/2). Oil (1.5 g, 90%). Spectroscopic data of compound 42 were in 
accord with those reported.
75
 
4.9 Enzymatic resolution of (±)-41 and (±)-42  
Ketone 41
54
 or 42 (1 mmol) dissolved in the minimum amount of ethanol, was added to 
a suspension of commercial fermenting yeast (5 g) in tap water (30 mL) containing 
KH2PO4(60 mg), Na2HPO4 (30 mg), MgSO4 (30 mg) and glucose (10 g). If necessary, 
the pH of the mixture was kept at 5.5-6.0 by addition of diluted aqueous NaOH. The 
reaction was carried out at 35 °C under magnetic stirring for 24 h and monitored by 
TLC. The suspension was stirred with celite at 0 °C for 15 min and then filtered. The 
filtered water was extracted in continuous with CH2Cl2. The organic phase was dried 
over Na2SO4 and the solvent was evaporated at reduced pressure. The mixture of 
syn/anti-alcohols 56 (78% total yield) was purified by means of flash chromatography 
(SiO2, hexane/ethyl acetate: 8/2) and separated by semi-preparative HPLC (Waters-
Micropack, 10µ SiO2, hexane/i-PrOH: 95/5, flow rate: 7 mL/min). The mixture of 
syn/anti-alcohols 55 (66% total yield) was purified and separated by means of flash 
chromatography (SiO2, hexane/ethyl acetate: 85/15). 
4.9.1 (1S,5S)-1-(3-Methyl-4,5-dihydro-isoxazol-5-yl)-ethanol ((+)-syn-56) 
N O
CH3
OH
H3C
 
Oil. 
1
H NMR:  1.22 (d, J = 6.4, 3H, CH3); 1.98 (s, 3H, CH3); 2.09 (broad s, 1H, OH); 2.73 
(dd, J = 17.1, 7.4, 1H, H-4); 2.98 (dd, J = 17.1, 10.6, 1H, H-4); 3.68 (m, 1H, H-1); 4.39 
(ddd, J = 10.6, 7.4, 5.7,1H, H-5).  
13
C NMR:  12.9 (3-CH3); 18.7 (CH3); 40.6 (C-4); 68.9 (C-1), 83.6 (C-5); 155.75 (C-
3).  
IR (Nujol): 3419 (νOH, OH),1639 (νC=N, C=N). 
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Anal.Calcd for C6H11NO2: C, 55.80; H, 8.58; N, 10.84. Found: C, 55.62; H, 8.45; N, 
10.78.  
MS-EI
+
 (m/z): 129 (M
+
).  
Chiral HPLC data: e.e. >98% (Chiralcel OD analytical column, hexane/iPrOH: 98/2, 
flow rate 1.5 mL/min, retention time: major (1S,5S) 21.8 min, minor (1R, 5R) 22.3 min) 
[
25
D]  +148.2 (c 0.51, CHCl3) 
4.9.2 (1S,5R)-1-(3-Methyl-4,5-dihydro-isoxazol-5-yl)-ethanol (−)-anti-56 
N O
CH3
OH
H3C
 
Oil.  
1
H NMR: 1.13 (d, J = 6.5, 3H, CH3); 1.85 (broad s, 1H, OH); 1.97 (s, 3H, CH3); 2.80 
(dd, J = 17.1,10.7, 1H, H-4); 2.97 (dd, J = 17.1, 8.6, 1H, H-4); 4.05 (m, 1H, H-1); 4.46 
(ddd, J = 10.7, 8.6, 3.2, 1H, H-5).  
13
C NMR: 13.1 (3-CH3); 17.9 (CH3); 37.8 (C-4); 67.05 (C-1); 84.1 (C-5); 156.0 (C-
3).  
IR (Nujol): 3420 (νOH, OH), 1641 (νC=N, C=N).  
Anal.Calcd for C6H11NO2: C, 55.80; H, 8.58; N, 10.84. Found: C, 55.70; H, 8.49; N, 
10.74. MS-EI
+
 (m/z): 129 (M
+
). 
Chiral HPLC data: e.e. >98% (Chiralcel OD analytical column, hexane/iPrOH: 98/2, 
flow rate 1.5 mL/min, retention time: major (1S,5R)18.5 min and minor (1R,5S)19.5 
min.  
[
25
D]  −90.0 (c 0.54, CHCl3). 
4.9.3 (1S,5S)-5-(1-Hydroxyethyl)-4,5-dihydro-isoxazole-3-carboxylic acid 
ethyl ester (+)-syn-55. 
N O
CH3
OH
EtOOC
 
Oil.  
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Spectroscopic and analytical data are in agreement with those reported for the racemic 
compound. 
Chiral HPLC data: e.e. >98% (Chiralcel OD analytical column, hexane/iPrOH: 98/2, 
flow rate: 1 mL/min, retention time: major (1S,5S) 56.7 min and minor (1R,5R) 60.1 
min) 
[
25
D]  +164.1 (c 0.39,CHCl3) 
4.9.4 (1S,5R)-5-(1-Hydroxyethyl)-4,5-dihydro-isoxazole-3-carboxylic acid 
ethyl ester (−)-anti-55 
N O
CH3
OH
EtOOC
 
Oil. 
Spectroscopic and analytical data are in agreement with those reported for the racemic 
compound. 
Chiral HPLC data: e.e.: 95% (Chiralcel OD analytical column, hexane/i-PrOH: 95/5, 
and a flow rate: 1 mL/min, retention time: minor (1R,5S) 20.6 and major (1S,5R) 22.6 
min) 
[
25
D]  −134.5 (c 0.91,CHCl3) 
4.10 General procedure for synthesis of (R)- and (S)-41 and (R)- 
and (S)- 42  
PCC/Al2O3 (3 equiv) was added to a solution of alcohol (1 equiv) in CH2Cl2 (4mL), and 
the reaction mixture was stirred at reflux temperature for 24 h. The PCC was filtered 
through celite, and the organic solvent was evaporated off. The crude ketone was 
purified by column chromatography (SiO2, hexane/ethyl acetate: 8/2).  
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 (5S)-1-(3-Methyl-4,5-dihydro-isoxazol-5-yl)-ethanone (S)-41 
N O
CH3
O
H3C
 
 Spectroscopical data were in accord with those reported.
54 
Oil (81%).  
Chiral HPLC data: e.e.>98% (Chiralcel OD analytical column, hexane/i-PrOH: 98/2, 
flow rate: 1.5 mL/min, retention time: minor (R) 10.5 min, major (S)11.8 min. 
[
25
D]  +177.9 (c 0.62,CHCl3). 
4.10.1  (5R)-1-(3-Methyl-4,5-dihydro-isoxazol-5-yl)-ethanone (R)-41 
N O
CH3
O
H3C
 
Spectroscopical data were in agreement with those previously reported.
54 
Oil (85%) 
Chiral HPLC data: e.e.>98% (Chiralcel OD analytical column, hexane/i-PrOH: 98/2, 
flow rate: 1.5 mL/min, retention time: major (R) 10.5 min, minor (S)11.8 min. 
[
25
D]  -170.5 (c 0.59,CHCl3). 
4.10.2 (5S)-5-Acetyl-4,5-dihydro-isoxazole-3-carboxylic acid ethyl ester  
(S)-42 
N O
CH3
O
EtOOC
 
Spectroscopical data were in accord with those reported.
75 
Oil (75%). 
Chiral HPLC data:e.e.: 92% (Chiralcel AD analytical, hexane/i-PrOH: 95/5, flow rate: 
1 mL/min, retention time: major (S) 14.0 min, minor (R) 15.4 min) 
[
25
D]  +182.7 (c 0.45, CHCl3). 
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4.10.3 (5R)-5-Acetyl-4,5-dihydro-isoxazole-3-carboxylic acid ethyl ester  
(R)-42 
N O
CH3
O
EtOOC
 
Spectroscopical data were in accord with those reported.
75 
Oil (75%). 
Chiral HPLC data:e.e.: 92% (Chiralcel AD analytical, hexane/i-PrOH: 95/5, flow rate: 
1 mL/min, retention time: minor (S) 14.0 min, major (R) 15.4 min) 
[
25
D]  −187.9 (c 0.55, CHCl3). 
4.11 General procedure for the synthesis of compounds 60-63  
Butyllithium (0.81 mL of a 1.6 N solution in hexane, 1.3 mmol, 1.05 equiv.) was added 
to a solution of (2R)-22 (0.22 mL, 1.23 mmol, 1 equiv.) in anhydrous THF (5 mL) 
cooled at –78°C, and the mixture was stirred for 45 min. A solution of 
triisopropoxytitanium (IV) chloride
82
 (1.33 mmol, 1.075 equiv.), prepared by mixing 
titanium tetraisopropoxyde (1.0 mmol, 0.3 mL) in anhydrous hexane (2 mL) and 
titanium tetrachloride (0.33 mmol, 0.32 mL of a 1M solution in toluene), was added and 
stirring was continued for a further 45 min. Aldehyde (−)-31f (0.216 g, 1.23 mmol, 1 
equiv.) in THF (4 mL) was added, and the mixture was stirred at –78°C for 6 h. The 
reaction mixture was allowed to warm to -10°C, after which a pH=7 phosphate buffer 
solution (10 mL) was added, and the mixture was extracted with CH2Cl2. The organic 
phase was separated and dried with Na2SO4, and the solvent was evaporated in vacuo. 
Compounds 60-63 were purified by means of flash cromathography on silica gel 
(hexane/ethyl acetate: 80/20) and subsequently separated by means of flash 
cromathography on silica gel (Supelco, Versaflash
®
 station, CH2Cl2/ethyl acetate: 95/5). 
The diastereoisomeric ratio of compounds 60-63 was determined by means of HPLC 
analysis (Supelco Ascentis
®
 Si column, hexane/isoPrOH: 95/5, flow: 0.7 mL min
-1
). 
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4.11.1 (S)-[(2S,5R)-5-Isopropyl-3,6-dimethoxy-2,5-dihydropyrazin-2-yl]-
[(5R)-5-phenyl-4,5-dihydroisoxazol-3-yl]-methanol 60  
O
N
HO
N
N
OCH3
OCH3
2 5
H
H
Ph
1'
H
   
Colourless solid (diisopropyl ether) (77%) 
m.p. 92-94 °C  
1
H NMR:  0.75, 1.08 (6H, 2d, J = 6.8, CH(CH3)2); 2.29 (1H, m, CH(CH3)2); 2.84 (1H, 
d, J = 7.5, OH); 3.19 (1H, dd, J = 17.0, 8.0, H-4 isox); 3.59 (1H, dd, J = 17.0, 10.9, H-4 
isox); 3.66 (3H, s, OCH3); 3.77 (3H, s, OCH3); 4.04 (1H, t, J = 3.6, H-5 pyraz.); 4.26 
(1H, t, J = 3.6, H-2); 5.00 (1H, dd, J = 7.5, 3.6, H-1’); 5.67 (1H, dd, J = 10.9, 8.0, H-5 
isox.); 7.34-7.40 (5H, m, Ph); (by deuteration the signal at 2.84 disappeared and the 
signal at 5.00 turned into a doublet with J = 3.6).  
13
C NMR: CH(CH3)2); 31.94 (CH(CH3)2); 43.26 (C-4); 52.78 (3- and 6-
OCH3); 59.33, 61.02 (C-2 and C-5 pyr.); 68.90 (1’-C); 82.22 (C-5 isox.); 125.67, 
128.09, 128.62, 141.05 (Ph); 159.52, 160.33, 166.60 (C-3 and C-6 pyr., C-3 isox.).  
MS-FAB
+
 (m/z): 360 (MH
+
).  
Anal. Calcd for C19H25N3O4: C, 63.51; H, 6.96; N, 11.69. Found: C, 63.21; H 6.74; N, 
11.49. 
IR (nujol): 3378 (vOH, OH), 1646 (vC=N, C=N).  
[
25
D]  -149.35 (c 0.96, CHCl3). 
HPLC analysis: retention time: 11.2 min. 
Single crystals suitable for X-ray structure determination were obtained by precipitation 
from CH2Cl2/isoPr2O: 1/1.  
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4.11.2  (R)-[(2R,5R)-5-Isopropyl-3,6-dimethoxy-2,5-dihydropyrazin-2-yl]-
[(5R)-5-phenyl-4,5-dihydroisoxazol-3-yl]-methanol 61  
O
N
H
N
N
OCH3
OCH3
2 5
OH
H
Ph
1'
H
 
Oil (45%) 
1
H NMR:  0.79, 1.13 (6H, 2d, J = 6.8, CH(CH3)2); 2.37 (1H, m, CH(CH3)2); 2.79 (1H, 
d, J = 6.8, OH); 3.20 (1H, dd, J = 16.9, 8.1, H-4 isox); 3.59 (1H, dd, J = 16.9, 11.0, H-4 
isox); 3.69 (3H, s, OCH3); 3.78 (3H, s, OCH3); 4.00 (1H, dd, J = 5.6, 3.7, H-5 pyraz.); 
4.25 (1H, dd, J = 5.6, 4.0, H-2); 4.97 (1H, dd, J = 6.8, 4.0, H-1’); 5.70 (1H, dd, J = 11.0, 
8.1, H-5 isox.); 7.34-7.45 (5H, m, Ph); (by deuteration the signal at 2.79 disappeared 
and the signal at 4.97 turned into a doublet with J = 4.0).  
13
C NMR: CH(CH3)2); 30.95 (CH(CH3)2); 42.75 (C-4 isox); 
52.49,52.58 (3- and 6-OCH3); 58.71, 60.60 (C-2 and C-5 pyr.); 68.92 (1’-C); 82.45 (C-5 
isox.); 125.79, 128.06, 128.51, 140.96 (Ph); 159.1, 159.18, 165.79 (C-3 and C-6 pyr., C-
3 isox.). MS-FAB
+
 (m/z): 360 (MH
+
).  
Anal. Calcd for C19H25N3O4: C, 63.51; H, 6.96; N, 11.69. Found: C, 63.37; H 6.69; N, 
11.54.  
IR (nujol): 3448 (vOH, OH), 1696 (vC=N, C=N).  
[
25
D]  -78.7 (c 1.41, CHCl3). 
HPLC analysis: retention time: 5.8 min. 
4.11.3 (R)-[(2S,5R)-5-Isopropyl-3,6-dimethoxy-2,5-dihydropyrazin-2-yl]-
[(5R)-5-phenyl-4,5-dihydroisoxazol-3-yl]-methanol 62  
O
N
H
N
N
OCH3
OCH3
2 5
OH
H
Ph
1'
H
 
Amorphous solid (18.7%) 
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1
H NMR:  0.74, 1.05 (6H, 2d, J = 6.8, CH(CH3)2); 2.28 (1H, m, CH(CH3)2); 2.93 (1H, 
dd, J = 17.0, 7.5, H-4 isox); 3.33 (1H, dd, J = 17.0, 10.9, H-4 isox); 3.59 (1H, d, J = 7.9, 
OH); 3.73 (3H, s, OCH3); 3.76 (3H, s, OCH3); 3.90 (1H, t, J = 3.5, H-5 pyraz.); 4.36 
(1H, broad t, J = 4.1, H-2); 4.95 (1H, dd, J = 7.9, 4.6, H-1’); 5.58 (1H, dd, J = 10.9, 7.5, 
H-5 isox.); 7.30-7.45 (5H, m, Ph); (by deuteration the signal at 3.59 disappeared and the 
signal at 4.95 turned into a doublet with J = 4.6).  
13
C NMR: CH(CH3)2); 32.05 (CH(CH3)2); 43.32 (C-4 isox); 52.60, 
52.84 (3- and 6-OCH3); 58.68, 61.26 (C-2 and C-5 pyr.); 69.07 (C-1’); 81.92 (C-5 
isox.); 125.67, 128.10, 128.68, 140.99 (Ph); 157.71, 160.22, 165.73 (C-3 and C-6 pyr., 
C-3 isox.).  
MS-FAB
+
 (m/z): 360 (MH
+
).  
IR (nujol): 3432 (vOH, OH), 1642 (vC=N, C=N).  
[
25
D]  -51.17 (c 0.65, CHCl3).  
HPLC analysis: retention time: 14.8 min. 
4.11.4 (S)-[(2R,5R)-5-Isopropyl-3,6-dimethoxy-2,5-dihydropyrazin-2-yl]-
[(5R)-5-phenyl-4,5-dihydroisoxazol-3-yl]-methanol 63  
O
N
HO
N
N
OCH3
OCH3
2 5
H
H
Ph
1'
H
 
This adduct was obtained only in the reaction with Li as counterion. 
Amorphous solid (1.8%) 
1
H NMR:  0.68, 1.08 (6H, 2d, J = 6.8, CH(CH3)2); 2.30 (1H, m, CH(CH3)2); 3.03 (1H, 
dd, J = 16.8, 8.6, H-4 isox); 3.50 (1H, dd, J = 16.8, 11.2, H-4 isox); 3.54 (1H, broad, 
OH); 3.59 (3H, s, OCH3); 3.72 (3H, s, OCH3); 3.93 (1H, dd, J = 5.5,3.5, H-5 pyraz.); 
4.22 (1H, broad t, J = 6.2, H-2); 4.72 (1H, broad t, J = 5.7, H-1’); 5.57 (1H, dd, J = 
11.2, 8.6, H-5 isox.); 7.23-7.40 (5H, m, Ph); (by deuteration the signal at 3.54 
disappeared and the signal at 4.72 turned into a doublet with J = 6.6).  
13
C NMR: CH(CH3)2); 30.78 (CH(CH3)2); 42.44 (C-4 isox); 52.75, 
52.95 (3- and 6-OCH3); 58.52, 60.87 (C-2 and C-5 pyr.); 70.39 (C-1’); 82.06 (C-5 
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isox.); 126.02, 128.10, 128.64, 141.26 (Ph); 158.16, 160.18, 164.99 (C-3 and C-6 pyr., 
C-3 isox.).  
MS-FAB
+
 (m/z): 360 (MH
+
). 
IR (nujol): 3432 (vOH, OH), 1640 (vC=N, C=N).  
[
25
D]  -41.44 (c 0.45, CHCl3).  
HPLC analysis: retention time: 10.7 min. 
4.12 General procedure for the synthesis of compounds 65-68  
Adducts 60 and 61 (0.5 mmoli) were dissolved in THF (7.5 mL) and a 0.2 N solution of 
HCl (7.5 mL, 1.5 mmoli, 3 equiv.) was added. The mixture was stirred for 24 h at room 
temperature, and then extracted with diethyl ether in order to remove non-basic organic 
compounds. It was then treated with 25% ammonia solution under stirring until pH=8-
10, and extracted with CH2Cl2 (5 × 20 mL). The combined organic layers were dried 
with Na2SO4, and the solvent was removed in vacuo. Compounds 65, 66 and 66, 68 
were separated by means of flash chromatography (SiO2, ethyl acetate:methanol: 98:2, 
developer: I2). 
4.12.1  (2S)-Amino-(3S)-hydroxy-3-[(5R)-phenyl-4,5-dihydroisoxazol-3-yl]-
propionic acid methyl ester 65 
O
N
OH
NH2
COOCH3
Ph
H
 
Oil (25%)  
1
H NMR:  2.30-2.80 (3H, broad, OH, NH2); 3.16 (1H, dd, J = 17.1, 7.9, H-4 isox.); 
3.47 (1H, dd, J = 17.1, 11.2, H-4 isox); 3.76 (3H, s, OCH3); 3.98 (1H, m, H-2); 4.72 
(1H, m, 3-H); 5.62 (1H, dd, J = 11.2, 7.9, H-5 isox.); 7.25-7.45 (5H, m, Ph).  
13
C NMR:  42.42 (C-4-isox.); 52.68 (OCH3); 56.28 (C-2); 68.42 (C-3); 82.52 (C-5-
isox.); 125.90, 128.26, 128.73, 140.55 (Ph); 157.16, 174.35 (C=N, C=O).  
MS-FAB
+
 (m/z): 265 (MH
+
).  
IR (nujol): 3374 (vOH, vNH, OH, NH2), 1741 (vC=O, C=O), 1677 (vC=N, C=N). 
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[
25
D]  -54.09 (c 0.77, CHCl3). 
4.12.2  (2S)-[(2R)-Amino-3-methyl-butyrylamino]-(3S)-hydroxy-3-[(5R)-5-
phenyl-4,5-dihydroisoxazol-3-yl]-propionic acid methyl ester 66  
O
N
OH
NH
COOCH3
Ph O
NH2
H
H
 
Amorphous solid (58%);  
1
H NMR:  0.86, 0.99 (6H, 2d, J = 6.8, CH(CH3)2); 2.24 (1H, m, CH(CH3)2); 2.51-2.70 
(3H, broad, OH, NH2); 2.96 (1H, dd, J = 17.0, 9.0, H-4 isox); 3.34 (1H, m, H-2’); 3.62 
(1H, dd, J = 17.0, 10.7, H-4 isox); 3.77 (3H, s, OCH3); 4.94 (1H, dd, J = 8.4, 2.3, H-2); 
5.00 (1H, broad d, J = 2.3, H-3); 5.60 (1H, dd, J = 10.7, 9.0, H-5 isox.); 7.25-7.50 (5H, 
m, Ph); 8.21 (1H, d, J = 8.4, NH-CO); (by deuteration the signals at 2.51-2.7 and 8.21 
disappeared and the signals at 3.34, 4.94 and 5.00 turned into three doublets with J = 
4.3, 2.3 and 2.3 respectively). 
13
C NMR: CH(CH3)2); 31.01 (CH(CH3)2); 42.88 (C-4-isox.); 52.87 
(OCH3); 54.66 (C-2’); 60.04 (C-2); 69.46 (C-3); 83.09 (C-5-isox.); 125.87, 128.28, 
128.71, 140.13 (Ph); 158.30, 169.89, 175.15 (C=N, C=O ester and amide).  
MS-FAB
+
 (m/z): 364 (MH
+
).  
IR (nujol): 3340 (vOH, vNH, OH, NH2), 1748 (vC=O, C=O), 1664 (vC=N, C=N). 
 [
25
D]  -80.72 (c 0.32, CHCl3). 
4.12.3 (2R)-Amino-[(3R)-hydroxy-3-(5R)-5-phenyl-4,5-dihydroisoxazol-3-yl]-
propionic acid methyl ester 67 
O
N
OH
NH2
COOCH3
Ph
H
 
Oil (56%) 
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1
H NMR:  2.45 (3H, broad m, OH, NH2); 3.03 (1H, dd, J = 17.3, 8.5, H-4 isox); 3.58 
(1H, dd, J = 17.3, 11.0, H-4 isox.); 3.78 (3H, s, OCH3); 4.03 (1H, m, H-2); 4.71 (1H, d, 
J = 2.9 3-H); 5.60 (1H, dd, J = 11.0, 8.5, H-5 isox.); 7.22-7.55 (5H, m, Ph).  
13
C NMR:  43.13 (C-4 isox.); 52.60 (OCH3); 56.24 (C-2); 68.55 (C-3); 82.41 (C-5 
isox.); 125.83, 128.23, 128.72, 140.57 (Ph); 158.87, 172.84 (C=N, C=O).  
MS-FAB
+
 (m/z): 265 (MH
+
). 
IR (nujol): 3435 (vOH, vNH, OH, NH2), 1723 (vC=O, C=O), 1641 (vC=N, C=N). 
[
25
D]  -99.74 (c 0.30, CHCl3). 
4.12.4 (2R)-[(2R)-Amino-3-methyl-butyrylamino]-(3R)-hydroxy-3-[(5R)-5-
phenyl-4,5-dihydroisoxazol-3-yl]-propionic acid methyl ester 68 
O
N
OH
NH
COOCH3
Ph O
NH2
H
H
 
Oil (34%) 
1
H NMR:  0.80, 0.97 (6H, 2d, J = 6.9, CH(CH3)2); 2.24 (1H, m, CH(CH3)2); 2.00-2.40 
(3H, broad, OH, NH2); 3.00-3.60 (3H, m, H-4 isox. and H-2’); 3.80 (3H, s, OCH3); 4.90 
(1H, dd, J = 8.7, 3.0, H-2); 4.99 (1H, broad d, J = 3.0, 3-H); 5.61 (1H, t, J = 10.4, H-5 
isox.); 7.25-7.40 (5H, m, Ph); 8.10 (1H, d, J = 8.7, NH-CO); (by deuteration the signals 
at 2.00-2.40 and 8.10 disappeared and the signals at 4.90 and 4.99 turned into two 
doublets with J = 3.0 and 3.0 respectively). 
13
C NMR: CH(CH3)2); 30.84 (CH(CH3)2); 42.30 (C-4 isox.); 52.98 
(OCH3); 54.63 (C-2’); 60.13 (C-2); 69.44 (C-3); 83.51 (C-5 isox.); 126.31, 128.43, 
128.69, 140.22 (Ph); 158.34, 170.07, 175.32 (C=N, C=O ester and amide). 
MS-FAB
+
 (m/z): 364 (MH
+
). 
IR (nujol): 3387 (vOH, vNH, OH, NH2), 1743 (vC=O, C=O), 1658 (vC=N, C=N). 
[
25
D]  -35.27 (c 0.15, CHCl3).  
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4.13 Synthesis of (2S,3S,6R)-2-[(2R)-2-Amino-3-methyl-
butyrylamino]-3,6-dihydroxy-4-oxo-6-phenyl-hexanoic acid 
methyl ester 69 
O
Ph
OH
OH
NH
O
H
COOMe
NH2
 
To a solution of 66 (0.4 mmol, 1 equiv.) in 5/1 methanol/water (10 mL), was added 
boric acid (1.2 mmol, 3 equiv.) and a spatula tip of Raney-Ni. The mixture was stirred 
vigorously under hydrogen for 3 hs, then filtered through celite. After evaporation of the 
solvent, the residue was treated with brine and extracted with ethyl acetate (5×10 mL). 
The combined organic layers were dried over Na2SO4 and concentrated in vacuo. 
Compound 69 were pure enough for the spectroscopic and analytical characterisation. 
Amorphous solid (55%); 
1
H NMR:  0.81, 0.96 (6H, 2d, J = 6.9, CH(CH3)2); 2.25 (1H, m, CH(CH3)2); 2.20-2.70 
(4H, broad, 2 OH, NH2); 3.10-3.21 (3H, m, H-5 and 2’-H); 3.81 (3H, s, OCH3); 4.79 
(1H, broad d, J = 1.8, 3-H); 5.16 (2H, m, H-2 and 6-H); 7.20-7.40 (5H, m, Ph); 7.90 
(1H, broad d, J = 9.1, NH-CO).  
13
C NMR: CH(CH3)2); 30.91 (CH(CH3)2); 47.24 (C-5); 53.04 (OCH3); 
53.54 (C-2’); 60.00 (C-2); 70.25 (C-6); 77.56 (C-3); 125.58, 127.86, 128.60, 142.64 
(Ph); 169.47, 174.79, 208.51 (C=O ester, ketone and amide).  
MS-FAB
+
 (m/z): 367 (MH
+
). 
IR (nujol): 3355 (vOH, vNH, OH, NH2), 1744, 1723, 1663 (vC=O, C=O ketone, ester, 
amide). 
[
25
D]  60.61 (c 0.42, CHCl3). 
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4.14 General procedure for the synthesis of compounds 74a,b 
and 75a,b and 76 
Butyllithium (1.6 N solution in hexane, 1.05 equiv.) was added to a solution of (R)-22 
(1 equiv.) in anhydrous THF (5 mL) cooled at –78°C, and the mixture was stirred for 45 
min. Ketone 39a or b or d (1 equiv.) in THF (4 mL) was added, and the mixture was 
stirred at –78 °C for 4 h. The reaction mixture was allowed to warm to -10°C, after 
which a pH=7 phosphate buffer solution (10 mL) was added, and the mixture was 
extracted with CH2Cl2. The organic phase was separated and dried with Na2SO4, and the 
solvent was evaporated in vacuo. Compounds 74a/b, 75a/b and 76 were purified by 
means of flash column chromatography.  
4.14.1 1-[(2S,5R)- 5-Isopropyl-3,6-dimethoxy-2,5-dihydropyrazin-2-yl]-1-(1-
oxa-2-azaspiro[4.5]dec-2-en-3-yl) ethan-1-ol 74a/75a 
O
N
HO
N
N
OCH3
OCH3
H
HCH3
 
Column chromatography eluent: hexane/AcOEt: 75/25 
1
st 
diast.  
White solid (hexane) 
m.p. 89.8-90.2 °C 
1
H NMR : 0.68 (3H, d, J = 6.8 CH(CH3)2); 1.05 (3H, d, J = 6.8 CH(CH3)2); 1.4 (3H; s, 
CH3); 1.4-1.8 (10H, m, cyclohexyl); 2.25-2.36 (1H, m, CH(CH3)2); 2.72 (1H, d, J = 
16.5, H-4 isox); 2.87 (1H, d, J = 16.5, H-4 isox); 3.7 (3H, s, OCH3); 3.99 ( 1H, t, J = 
3.6, H-5 pyr); 4.12 (1H, d, J = 3.6, H-2 pyr)  
13
C-NMR  16.51, 19.06 (CH(CH3)2); 22.33 (CH3COH) 23.48, 25.10 (cyclohexyl); 
31.31 (CH(CH3)2); 36.43, 36.54 (cyclohexyl),); 44.32 (C-4 isox) 52.43, 52.80 (3- and 6-
OCH3); 61.03 61.59 (C-2 and C-5 pyr); 73.93 (C-OH); 86.99 (C-5 isox); 160.39, 
161.09, 165.92 (C-3 and C-6 pyr., C-3 isox.). 
IR (nujol): 3449 (vOH, OH), 1694 (vC=N, C=N).  
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[
25
D]  40.51 (c 0.48, CHCl3). 
MS-EI (m/z): 366 (M
+
), 141 
 
2
nd 
diast. 
White solid (exane) 
m.p. 94-95 °C 
1
H NMR : 0.65 (3H, d, J = 6.8 CH(CH3)2); 1.05 (3H, d, J = 6.8 CH(CH3)2); 1.4-1.8 
(10H, m, cyclohexyl); 1.45 (3H; s, CH3); 2.25-2.36 (1H, m, CH(CH3)2); 2.65 (1H, d, J = 
16.6, H-4 isox); 2.85 (1H, d, J = 16.6, H-4 isox); 3.65 (3H, s, OCH3); 3.7 (3H, s, 
OCH3); 3.95 ( 1H, t, J = 3.7, H-5 pyr); 4.12 (1H, d, J = 3.7, H-2 pyr)  
13
C-NMR  16.53, 19.06 (CH(CH3)2); 22.83 (CH3COH); 23.43, 23.53, 25.11 
(cyclohexyl); 31.33 (CH(CH3)2); 36.39, 36.56 (cyclohexyl),); 44.51 (C-4 isox) 52.51, 
52.80 (3- and 6- OCH3); 60.92, 62.33 (C-2 and C-5 pyr); 74.12 (C-OH); 86.73 (C-5 
isox); 160.40, 160.93, 165.09 (C-3 and C-6 pyr., C-3 isox.). 
IR (nujol): 3449 (vOH, OH), 1697 (vC=N, C=N).  
[
25
D]  +20.10 (c 0.45, CHCl3). 
MS-EI (m/z): 366 (M
+
), 141  
4.14.2 1-[(2S,5R)-5-(Isopropyl)-3,6-dimethoxy-2,5-dihydropyrazin-2-yl]-1-(1-
oxa-2-azaspiro[4.5]dec-2-en-3-yl)propan-1-ol 74b/75b 
O
N
HO
N
N
OCH3
OCH3
H
H
 
Column chromatography eluent: hexane/AcOEt 95:5 
1
st 
diast.  
White solid (exane) (17%) 
m.p.: 97-99.5 °C 
1
H NMR : 0.63 (3H, d, J = 6.7 CH(CH3)2); 0.90 (3H, t, J = 7.2, CH2CH3); 1.05 (3H, d, 
J = 6.7 CH(CH3)2); 1.4-1.8 (11H, m, cyclohexyl and CH2CH3); 2.0 ( 1H, dq, J = 7.2, 
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14.5, CH2CH3); 2.3 (1H, m, CH(CH3)2); 2.6 (1H, d, J = 16.6, H-4 isox); 2.7 (1H, d, J = 
16.6, H-4 isox); 3.65 (3H, s, OCH3); 3.7 (3H, s, OCH3); 3.9 ( 1H, t, J = 3.3, H-5 pyr); 
4.1 (1H, d, J = 3.2, H-2 pyr)  
13
C-NMR  CH2CH3); 16.37, 19.22 (CH(CH3)2); 23.45, 25.03 (cyclohexyl); 
28.70 (CH2CH3); 30.62 (CH(CH3)2); 36.54, 36.62 (cyclohexyl); 45.03 8C-4 isox); 
52.47, 52.82 (3- and 6- OCH3); 60.64, 61.71 (C-2 and C-5 pyr); 78.07 (C-OH); 87.27 
(C-5 isox);160.23, 160.63, 166.07 (C-3 and C-6 pyr., C-3 isox.). 
IR (nujol): 3435 (vOH, OH), 1643 (vC=N, C=N).  
[
25
D]  1.88 (c 0.59, CHCl3). 
 
2
nd
 diast. 
White solid (exane) (17%) 
m.p.: 137-141 °C 
1
H NMR : 0.7 (3H, d, J = 6.7 CH(CH3)2); 0.95 (3H, t, J = 7.3, CH2CH3); 1.1 (3H, d, J 
= 6.7 CH(CH3)2); 1.4-1.8 (10H, m, cyclohexyl);1.9 (1H, dq, J = 7.3, 14.35 CH2CH3); 
2.1 ( 1H, dq, J = 7.3, 14.35, CH2CH3); 2.3 (1H, m, CH(CH3)2); 2.6 (1H, d, J = 16.7, H-4 
isox); 2.7 (1H, d, J = 16.7, H-4 isox); 3.72 (3H, s, OCH3); 3.75 (3H, s, OCH3); 3.98 
(1H, t, J = 3.5, H-5 pyr); 4.1 (1H, d, J = 3.5, H-2 pyr)  
13
C-NMR CH2CH3); 16.43, 19.16 (CH(CH3)2); 23.36, 23.50 25.03 
(cyclohexyl); 28.83 (CH2CH3); 30.90 (CH(CH3)2); 36.60, 36.77 (cyclohexyl); 45.56 (C-
4 isox); 52.35, 52.80 (3- and 6- OCH3); 60.71, 61.99 (C-2 and C-5 pyr); 77.40 (C-OH); 
87.10 (C-5 isox); 160.41, 165.77 (C-3 and C-6 pyr., C-3 isox.). 
IR (nujol): 3435 (vOH, OH), 1643 (vC=N, C=N).  
[
25
D]  109.48 (c 0.29, CHCl3). 
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4.14.3 3-[(2S,5R)-5-(Isopropyl)-3,6-dimethoxy-2,5-dihydropyrazin-2-yl]-1-(1-
oxa-2-azaspiro[4.5]dec-2-en-3-yl)propan-1-one 76 
O
N
O
N
N
OCH3
H3CO
H
H
 
Yellow oil (47%) 
1
H NMR : 0.68 (3H, d, J = 6.8 CH(CH3)2); 1.03 (3H, d, J = 6. CH(CH3)2); 1.4-1.8 
(10H, m, cyclohexyl); 2.0 (1H, dt, J = 7.3, 14.35 CH2-pyr); 2.35-2.2 ( 2H, m, CH(CH3)2 
and CH2-pyr); 2.8 (2H, s, H-4 isox); 2.95 (2H, t, J = 7.5, CH2CO); 3.62 (3H, s, OCH3); 
3.68 (3H, s, OCH3); 3.96 ( 1H, t, J = 3.5, H-5 pyr); 4.05 (1H, m, H-2 pyr)  
13
C-NMR 16.63, 19.00 (CH(CH3)2); 23.18, 24.80 (cyclohexyl); 28.38 (CH2-pyr); 
31.85 (CH(CH3)2); 34.48 (CH2CO) 36.35 (cyclohexyl); 41.98 (C-4 isox); 52.42, 
(OCH3); 54.45, 60.92 (C-2 and C-5 pyr); 91.05 (C-5 isox); 157.47, 163.19, 164.62 (C-3 
and C-6 pyr., C-3 isox.), 195.98 (C=O) 
[
25
D]  -10.93 (c 0.335, CHCl3). 
4.15 General procedure for the synthesis of  79 and 80 
Adducts 74a and 75a (0.2 mmoli) were dissolved in THF (3 mL) and a 0.2 N solution of 
HCl (3 mL, 1.5 mmoli, 2 equiv.) was added. The mixture was stirred for 24 h at room 
temperature, and then extracted with diethyl ether in order to remove non-basic organic 
compounds. It was then treated with 25% ammonia solution under stirring until pH=8-
10, and extracted with CH2Cl2 (5 × 20 mL). The combined organic layers were dried 
with Na2SO4, and the solvent was removed in vacuo. Compounds 79 and 80 were 
purified by means of flash chromatography (SiO2, AcOEt/MeOH: 96:4). 
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4.15.1 Methyl (2S)-2-amino-3-hydroxy-3-(1-oxa-2-azaspiro[4.5]dec-2-en-3-
yl)butanoate 79/80 
O
N
NH2
COOMe
H
OH
H3C
 
Amino ester deriving from 74a/75a (1
st
 diast) 
Oil (34%) 
1
H NMR : 1.4-1.8(13H, m, cyclohexyl and CH3); 2.8 (2H, s, H-4 isox); 3.72 (1H, d, J 
= 2.16 H-2); 3.8 (3H, s, OCH3) 
13
C-NMR 22.81 (CH3); 23.42, 25.06; 36.29 (cyclohexyl); 44.13 (C-4 isox); 55.22 
(OCH3); 60.49 (C-2); 72.65 (C-3); 86.90 (C-5 isox); 161.67 ( C-3 isox.); 173.68 (C=O) 
[
25
D]  44.75 (c 1.04, CHCl3). 
MS-EI (m/z):270 (M
+
) 
 
Amino ester deriving from 74a/75a (2
nd
 diast) 
Oil (38%) 
1
H NMR : 1.4-1.8(10H, m, cyclohexyl); 1.55 (3H, s, CH3); 2.7 (2H, s, H-4 isox); 3.55 
(1H, s,H-2); 3.75 (3H, s, OCH3) 
13
C-NMR 23.42 (cyclohexyl); 23.90 (CH3): 25.05; 36.24, 36.38 (cyclohexyl); 45.26 
(C-4 isox); 52.31 (OCH3); 61.23 (C-2); 72.10 (C-3); 86.81 (C-5 isox); 161.57 ( C-3 
isox.); 173.90 (C=O) 
[
25
D]  -17.57 (c 0.57, CHCl3). 
MS-EI (m/z):270 (M
+
) 
4.16 General procedure for synthesis of compounds 81-84  
Butyllithium (1.6 N solution in hexane, 1.05 equiv) was added to a solution of (2R)-22 
(1 equiv) in anhydrous THF (5 mL) cooled at -78 °C, and the mixture was stirred for 45 
min. Ketone (5S) or (5R)-41 (1 equiv) in THF (4 mL) was added, and the mixture was 
stirred at –78 °C for 4 h. The reaction mixture was allowed to warm to –10 °C, after 
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which a pH 7 phosphate buffer solution (10 mL) was added, and the mixture was 
extracted with CH2Cl2. The organic phase was separated and dried with Na2SO4, and the 
solvent was evaporated in vacuo. Compounds 81 and 82 and 83 and 84 were purified by 
means of column chromatography (SiO2, hexane/ethyl acetate: 8/2) and (hexane/ethyl 
acetate: 7/3), respectively. They were subsequently separated by means of flash 
chromatography (SiO2, Supelco-Versaflash® station, hexane/ethyl acetate: 75/25). 
4.16.1 (1R)-1-[(2S,5R)-5-Isopropyl-3,6-dimethoxy-2,5-dihydro-pyrazin-2-yl]-
1-[(5S)-3-methyl-4,5-dihydro-isoxazol-5-yl]ethanol 81 
N
N
OCH3
OCH3
H
H
N O
CH3
CH3HO
 
Colourless solid (hexane). (53%) 
m.p.: 79-81 °C  
1
H NMR:  0.67, 1.07 (2d, J = 6.8, 6H, CH(CH3)2); 1.2 (s, 3H,1-CH3); 1.95 (s, 3H, 3-
CH3); 2.29 (m, 1H, CH(CH3)2); 2.91 (dd, J = 17.0, 10.8, 1H, H-4 isox); 3.12 (dd, J = 
17.0, 8.9, 1H, H-4 isox); 3.34 (broad, 1H, OH); 3.67 (s, 3H, OCH3); 3.78 (s, 3H, 
OCH3); 3.99 (broad s, 2H, H-2 and H-5 pyraz.); 4.73 (dd, J = 10.8, 8.9, 1H, H-5 isox.).  
13
C NMR:  13.1 (3-CH3); 16.4, 19.0 (CH(CH3)2); 19.8 (1-CH3); 31.4 (CH(CH3)2); 38.9 
(C-4 isox); 52.5 (3- and 6-OCH3); 60.6, 61.6 (C-2 and C-5 pyr.); 75.1 (C-1); 83.5 (C-5 
isox.); 155.7 (C-3 isox.); 160.9, 164.7 (C-3 and C-6 pyr.).  
IR (Nujol): 3435 (νOH, OH), 1692(νC=N, C=N).  
Anal. Calcd for C15H25N3O4: C, 57.86; H, 8.09; N,13.49. Found: C, 57.67; H, 7.96; N, 
13.33. 
MS-FAB
+
 (m/z): 312 [M+H
+
]
+
. 
[
25
D]  +75.8 (c 0.8, CHCl3).  
Single crystals suitable for X-ray structure determination were obtained by precipitation 
from hexane/ethyl acetate: 1/1. 
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4.16.2 (1S)-1-[(2S,5R)-5-Isopropyl-3,6-dimethoxy-2,5-dihydro-pyrazin-2-yl]-
1-[(5S) 3-methyl-4,5-dihydro-isoxazol-5-yl]ethanol 82 
N
N
OCH3
OCH3
H
H
N O
CH3
OHCH3
 
Colourless solid (hexane). (17%);  
mp 85-86 °C  
1
H NMR:  0.69, 1.02 (2d, J = 6.7, 6H, CH(CH3)2); 0.99 (s, 3H, 1-CH3); 1.97 (s, 3H, 3-
CH3); 2.23 (m, 1H, CH(CH3)2); 2.87 (dd, J = 6.7,11.1,1H, H-4 isox); 3.12 (dd, J = 16.7, 
7.9, 1H, H-4 isox); 3.68 (s, 3H, OCH3); 3.74 (s, 3H, OCH3); 4.02 (t, J = 1H, H-5 
pyraz.); 4.3 (broad, 1H, OH); 4.33 (d, J = 4.1, 1H, H-2 pyraz.); 4.84 (dd, J = 11.1, 7.9, 
1H, H-5 isox.). 
13
C NMR:  13.0 (3-CH3); 16.7, 19.0 (CH(CH3)2); 20.9 (1-CH3); 32.0 (CH(CH3)2); 39.4 
(C-4 isox); 52.6 (3- and 6-OCH3); 59.0, 61.2 (C-2 and C-5pyr.); 75.3 (C-1); 82.5 (C-5 
isox.); 155.5 (C-3 isox.); 161.4,164.7 (C-3 and C-6 pyr.). 
IR (Nujol): 3418 (νOH, OH), 1697 (νC=N, C=N).  
Anal. Calcd for C15H25N3O4: C, 57.86; H, 8.09; N, 13.49. Found: C, 57.71; H, 7.94; 
N,13.38.  
MS-FAB
+ (m/z): 312[M+H]+. 
[
25
D]  +126.1 (c 0.63, CHCl3) 
Single crystals suitable for X-ray structure determination were obtained by precipitation 
from hexane/ethyl acetate: 1/1. 
4.16.3 (1S)-1-[(2S,5R)-5-Isopropyl-3,6-dimethoxy-2,5-dihydro-pyrazin-2-yl]-
1-[(5R)-3-methyl-4,5-dihydro-isoxazol-5-yl]ethanol 83 
N
N
OCH3
OCH3
H
H
N O
CH3
OHCH3
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Colourless solid (hexane).
 
(45%); 
m.p. 70-72 
°
C 
 
1
H NMR:  0.66, 1.06 (2d, J = 6.8, 6H, CH(CH3)2); 1.13 (s, 3H, 1-CH3); 1.98 (s, 3H, 3-
CH3); 2.32 (m, 1H, CH(CH3)2); 2.92 (dd, J = 16.9, 10.9, 1H, H-4 isox); 3.13 (dd, J = 
16.9, 8.5, 1H, H-4 isox); 3.65 (broad, 1H, OH); 3.7 (s, 3H, OCH3); 3.73 (s, 3H, OCH3); 
3.91 (d, J = 3.9, 1H, H-2 pyraz.); 4.00 (t, J = 3.6, 1H, H-5 pyraz.); 4.92 (dd, J = 10.9, 
8.5, 1H, H-5 isox.).  
13
C NMR:  13.1 (3-CH3); 16.4, 19.0 CH(CH3)2); 19.7 (1-CH3); 31.3 (CH(CH3)2); 
39.0 (C-4 isox); 52.4, 52.8 (3- and 6-OCH3); 60.6, 60.9 (C-2 and C-5 pyr.); 75.1 (C-1); 
84.1 (C-5 isox.); 155.3 (C-3 isox.); 160.4, 165.3 (C-3 and C-6 pyr.).  
IR (nujol): 3425 (vOH, OH), 1691 (vC=N, C=N).  
Anal. Calcd for C15H25N3O4: C, 57.86; H, 8.09; N, 13.49. Found: C, 57.82; H 7.93; N, 
13.25.  
MS-FAB
+
 (m/z): 312 [M+H]
+
. 
[
25
D]  -38.42 (c 0.39, CHCl3).  
4.16.4  (1R)-1-[(2S,5R)-5-isopropyl-3,6-dimethoxy-2,5-dihydro-pyrazin-2-yl]-
1-[(5R)-3-methyl-4,5-dihydro-isoxazol-5-yl]ethanol 84 
N
N
OCH3
OCH3
H
H
N O
CH3
CH3OH
 
Amorphous solid (20%).
  
1
H NMR:  0.69, 1.07 (2d, J = 6.8, 6H, CH(CH3)2); 1.06 (s, 3H, 1-CH3); 1.97 (s, 3H, 3-
CH3); 2.3 (m, 1H, CH(CH3)2); 2.82 (dd, J = 16.8, 11.0, 1H, H-4 isox); 3.07 (dd, J = 
16.8, 8.4, 1H, H-4 isox); 3.7 (s, 3H, OCH3); 3.72 (broad, 1H, OH); 3.75 (s, 3H, OCH3); 
4.00 (t, J = 3.7, 1H, H-5 pyraz.); 4.31 (d, J = 3.9, 1H, H-2 pyraz.); 4.8 (dd, J = 10.9, 8.5, 
1H, H-5 isox.). 
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13
C NMR:  13.0 (3-CH3); 16.6, 19.0 CH(CH3)2); 20.8 (1-CH3); 31.5 (CH(CH3)2); 
39.0 (C-4 isox); 52.5, 52.7 (3- and 6-OCH3); 60.4, 61.1 (C-2 and C-5 pyr.); 75.2 (C-1); 
83.0 (C-5 isox.); 155.4 (C-3 isox.); 161.5, 164.2 (C-3 and C-6 pyr.).  
IR (nujol): 3446 (vOH, OH), 1698 (vC=N, C=N).  
Anal. Calcd for C15H25N3O4: C, 57.86; H, 8.09; N, 13.49. Found: C, 57.76; H 7.91; N, 
13.15.  
MS-FAB
+
 (m/z): 312 [M+H]
+
. 
[
25
D]  -36.42 (c 0.78, CHCl3).  
4.17 General procedure for synthesis of compounds 86-88 and 
89-91 
Aqueous HCl 0.2 N (2.5 mL, 5.5 mmoli, 2 equiv.) was added to a solution of adduct 81, 
82, 83 (0.25 mmoli, 1 equiv.) in THF (1.5 mL). The mixture was stirred for 16-24 h at 
room temperature and then extracted with diethyl ether in order to remove non-basic 
organic compounds. It was then treated with 25% ammonia solution under stirring until 
pH=8-10, and extracted with AcOEt (4 × 5 mL). The combined organic layers were 
dried with Na2SO4, and the solvent was removed in vacuo. Compounds 86, 87, 88 and 
89, 90, 91 were separated by means of flash chromatography (SiO2, CH2Cl2/MeOH: 
98/2, for 86/89 and 87/90; AcOEt/MeOH: 98/2, developer: I2 for 88/91). 
4.17.1  (2S)-Amino-(3R)-hydroxy-3-[(5S)-3-methyl-4,5-dihydro-isoxazol-5-
yl]-butyric acid methyl ester 86.  
NH2
H
N O
CH3
CH3HO
COOCH3
 
Amorphous solid (46%).  
1
H NMR:  1.25 (s, 3H, CH3); 1.95 (s, 3H, 3-CH3); 2.4 (broad, 3H, OH, NH2); 2.91 (dd, 
J = 17.6, 11.0, 1H, H-4 isox); 3.07 (dd, J = 17.6, 7.5, 1H, H-4 isox); 3.41 (broad s, 1H, 
H-2); 3.78 (s, 3H, OCH3); 4.5 (dd, J = 11.0, 7.5, 1H, H-5 isox.).  
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13
C NMR:  12.9 (3-CH3); 18.4 (CH3); 39.7 (C-4 isox); 52.4 (OCH3); 59.7 (C-2); 73.6 
(C-3); 81.6 (C-5 isox.); 155.9 (C-3 isox.); 174.35 (C=O).  
IR (nujol): 3391 (vOH, vNH, OH, NH2), 1735 (vC=O, C=O), 1637 (vC=N, C=N).  
Anal. Calcd for C9H16N2O4: C, 49.99; H, 7.46; N, 12.96. Found: C, 49.87; H 7.28; N, 
12.75.  
MS-EI
+
 (m/z): 217 [M+H]
+
. 
[
25
D]  +92.8 (c 0.9, CHCl3). 
4.17.2  (2S)-Amino-(3S)-hydroxy-3-[(5S)-3-methyl-4,5-dihydro-isoxazol-5-
yl]-butyric acid methyl ester 87 
NH2
H
N O
CH3
OHCH3
COOCH3
 
Amorphous solid (46%).  
1
H NMR:  1.04 (s, 3H, CH3); 1.98 (s, 3H, 3-CH3); 2.5 (broad, 3H, OH, NH2); 2.88 (dd, 
J = 16.8, 10.9, 1H, H-4 isox); 3.12 (dd, J = 16.8, 8.2, 1H, H-4 isox); 3.79 (s, 3H, 
OCH3); 3.84 (broad s, 1H, H-2); 4.7 (dd, J = 10.9, 8.2, 1H, H-5 isox.).  
13
C NMR:  12.9 (3-CH3); 20.2 (CH3); 39.4 (C-4); 52.4 (OCH3); 58.2 (C-2); 73.9 (C-
3); 82.7 (C-5 isox.); 155.9 (C-3 isox.); 173.1 (C=O).  
IR (nujol): 3379 (vOH, vNH, OH, NH2), 1735 (vC=O, C=O), 1663 (vC=N, C=N). Anal. 
Calcd for C9H16N2O4: C, 49.99; H, 7.46; N, 12.96. Found: C, 49.90; H 7.35; N, 12.84.  
MS-EI
+
 (m/z): 217 [M+H]
+
. 
[
25
D]  +123.3 (c 0.15, CHCl3). 
4.17.3  (2S)-Amino-(3S)-hydroxy-3-[(5R)-3-methyl-4,5-dihydro-isoxazol-5-
yl]-butyric acid methyl ester 88 
NH2
H
N O
CH3
OHCH3
COOCH3
 
Amorphous solid (41%).  
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1
H NMR:  1.12 (s, 3H, CH3); 1.98 (s, 3H, 3-CH3); 2.3 (broad, 3H, OH, NH2); 2.95 (dd, 
J=17.4, 10.9, 1H, H-4 isox); 3.06 (dd, J = 17.4, 8.0, 1H, H-4 isox); 3.51 (broad s, 1H, 
H-2); 3.76 (s, 3H, OCH3); 4.69 (dd, J = 10.9, 8.0, 1H, H-5 isox.). 
13
C NMR:  12.9 (3-CH3); 18.1 (CH3); 39.2 (C-4 isox); 52.2 (OCH3); 58.9 (C-2); 73.6 
(C-3); 82.4 (C-5 isox.); 155.9 (C-3 isox.); 173.83 (C=O). 
IR (nujol): 3305 (vOH, vNH, OH, NH2), 1736 (vC=O, C=O), 1631 (vC=N, C=N).  
Anal. Calcd for C9H16N2O4: C, 49.99; H, 7.46; N, 12.96. Found: C, 49.89; H 7.37; N, 
12.88. 
MS-EI
+
 (m/z): 217 [M+H]
+
. 
[
25
D]  -48.9 (c 0.76, CHCl3). 
4.17.4 (2S)-[(2R)-Amino-3-methyl-butyrylamino]-(3R)-hydroxy-3-[(5S)-3-
methyl-4,5-dihydro-isoxazol-5-yl]-butyric acid methyl ester 89 
O
H
NH
H
N O
CH3
CH3HO
COOMe
NH2
 
Amorphous solid (28%).  
1
H NMR:  0.85, 0.99 (2d, J = 6.8, 6H, CH(CH3)2); 1.26 (s, 3H, CH3); 1.96 (s, 3H, 3-
CH3); 2.28 (m, 1H, CH(CH3)2); 2.65 (broad, 3H, OH, NH2); 2.97 (dd, J = 17.7, 10.7, 
1H, H-4 isox); 3.07 (dd, J = 17.7, 8.8, 1H, H-4 isox); 3.34 (broad d, J = 3.8, 1H, H-2 
val.); 3.77 (s, 3H, OCH3); 4.53 (dd, J = 10.7, 8.8, 1H, H-5 isox.); 4.66 (d, J = 8.6, 1H, 
H-2); 8.2 (d, J=8.6, 1H, NH).  
13
C NMR:  12.9 (3-CH3); 16.0 (CH(CH3)2); 19.6 (CH(CH3)2) and (CH3); 30.9 
(CH(CH3)2); 39.8 (C-4 isox); 52.7 (OCH3); 56.6 (C-2); 59.8 (C-2 val.); 74.8 (C-3); 83.3 
(C-5 isox.); 156.4 (C-3 isox.); 171.0, 175.0 (C=O). 
IR (nujol): 3415 (vOH, vNH, OH, NH2), 1734 (vC=O, C=O), 1647 (vC=N, C=N).  
Anal. Calcd for C14H25N3O5: C, 53.32; H, 7.99; N, 13.32. Found: C, 53.25; H 7.76; N, 
13.21.  
MS-FAB
+
 (m/z): 316 [M+H]
+
. 
[
25
D]  +63.1 (c 0.77, CHCl3).  
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4.17.5  (2S)-[(2R)-Amino-3-methyl-butyrylamino]-(3S)-hydroxy-3-[(5S)-3-
methyl-4,5-dihydro-isoxazol-5-yl]-butyric acid methyl ester 90 
O
H
NH
H
N O
CH3
CH3
COOMe
NH2
OH
 
Amorphous solid (14%). 
1
H NMR:  0.86, 1.0 (2d, J = 6.8, 6H, CH(CH3)2); 1.13 (s, 3H, CH3); 1.97 (s, 3H, 3-
CH3); 2.24 (broad m, 4H, CH(CH3)2 and OH, NH2); 2.92 (dd, J = 17.1, 10.8, 1H, H-4 
isox); 3.02 (dd, J = 17.1, 8.5, 1H, H-4 isox); 3.37 (broad d, J = 3.7, 1H, H-2 val.); 3.79 
(s, 3H, OCH3); 4.63 (dd, J = 10.8, 8.5, 1H, H-5 isox.); 4.85 (d, J = 8.7, 1H, H-2); 8.18 
(d, J = 8.7, 1H, NH). 
13
C NMR:  12.9 (3-CH3); 16.3 (CH(CH3)2); 19.6 (CH(CH3)2); 20.2 (CH3); 29.7 
(CH(CH3)2); 39.6 (C-4 isox); 52.7 (OCH3); 56.8 (C-2); 59.9 (C-2 val.); 75.4 (C-3); 83.0 
(C-5 isox.); 156.1 (C-3 isox.); 170.7, 174.2 (C=O).  
IR (nujol): 3346 (vOH, vNH, OH, NH2), 1740 (vC=O, C=O), 1655 (vC=N, C=N). 
Anal. Calcd for C14H25N3O5: C, 53.32; H, 7.99; N, 13.32. Found: C, 53.19; H 7.86; N, 
13.24.  
MS-FAB
+
 (m/z): 316 [M+H]
+
. 
[
25
D]  +99.0 (c 0.2, CHCl3).  
4.17.6 (2S)-[(2R)-Amino-3-methyl-butyrylamino]-(3S)-hydroxy-3-[(5R)-3-
methyl-4,5-dihydro-isoxazol-5-yl]-butyric acid methyl ester 91 
O
NH2
H
NH
H
N O
CH3
OHCH3
COOCH3
 
Amorphous solid (28%).  
1
H NMR:  0.87, 1.0 (2d, J = 6.9, 6H, CH(CH3)2); 1.19 (s, 3H, CH3); 1.98 (s, 3H, 3-
CH3); 2.15 (broad, 3H, OH, NH2); 2.29 (m, 1H, CH(CH3)2); 3.0 (m, 2H, H-4 isox); 3.38 
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(broad d, J = 4.0, 1H, H-2 val.); 3.76 (s, 3H, OCH3); 4.62 (m, 1H, H-5 isox.); 4.67 (d, J 
= 8.3, 1H, H-2); 8.29 (d, J = 8.3, 1H, NH).  
13
C NMR:  12.8 (3-CH3); 16.1 (CH(CH3)2); 19.1 (CH3); 19.5 (CH(CH3)2); 30.9 
(CH(CH3)2); 39.9 (C-4 isox); 52.6 (OCH3); 58.6 (C-2); 59.9 (C-2 val.); 74.0 (C-3); 82.6 
(C-5 isox.); 156.0 (C-3 isox.); 171.4, 174.9 (C=O).  
IR (nujol): 3365 (vOH, vNH, OH, NH2), 1739 (vC=O, C=O), 1658 (vC=N, C=N). Anal. 
Calcd for C14H25N3O5: C, 53.32; H, 7.99; N, 13.32. Found: C, 53.22; H 7.90; N, 13.20.  
MS-FAB
+
 (m/z): 316 [M+H]
+
. 
[
25
D] -45.4 (c 0.83, CHCl3). 
4.18 2-Isoxazoline ring opening 
4.18.1 2-acetamido-4-hydroxy-4-phenylbutanoate 96 
Ph COOEt
OH NHAc
 
 
A spatula of Raney-Ni was added to a solution of compound 31f (218 mg, 1 mmol) in 
ethyl acetate (4 mL). The mixture was stirred vigorously under hydrogen at room 
temperature for 24 h, then filtered through celite. The solvent was removed in vacuo. 
The residue was dissolved in dichloromethane (5 mL) and acetic anhydride (2.2 equiv, 
0.22 mL), pyridine (1.5 equiv, 0.13 mL) and 4-dimethylaminopyridine (01.equiv, 12 
mgr) were added. The reaction mixture was stirred at room temperature for 12 hours. 
The reaction mixture was washed with water (3×1.5 mL), dried over Na2SO4 and the 
solvent removed under reduced pressure. Column chromatography (hexane/AcOEt: 
30/70) afforded the syn and anti 96 in 51% total yield. 
1
st
 diast 
Oil (19%) 
1
H NMR:  1.3 (t, 3H, J = 7.1, -OCH2CH3); 1.8-1.9 (m, 1H, -CH2); 2.0 (s, 3H, -
COCH3); 2.0-2.1 (m, 1H, CH2); 4.2 (q, 2H, J = 7.1, -OCH2CH3); 4.6 (d, J = 9.7, -
CHOH); 4.8-4.9 (m, 1H, J = 4.0, 8.8 -CHNHAc,); 6.5 (d, 1H, J = 7.5, NHAc); 7.2-7.4 
(m, 5H, Ph) 
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13
C NMR 14.1 (-OCH2CH3); 23.1(-COCH3); 43.2 (CH2); 50.3 (-CHNHAc); 61.8 (-
OCH2CH3); 69.8 (-CHOH); 125.6, 127.4, 128.4, 143.4 (Ph), 171.4, 172.4 (C=O) 
MS-EI (m/z): 266, 248 [M-H2O] 
 
2
nd
 diast. 
Oil (32%) 
1
H NMR:  1.3 (t, 3H, J = 7.1, -OCH2CH3); 2.0 (s, 3H, -COCH3); 2.1-2.2 (m, 2H, 
CH2); 4.2 (q, 2H, J = 7.1, -OCH2CH3); 4.6 (q, 1H, J = 5.8, -CHNHAc); 4.85 (dd, 1H, J 
= 4.0, 8.8, -CHOH); 6.5 (d, 1H, J = 5.8, NHAc); 7.2-7.4 (m, 5H, Ph) 
13
C NMR 14.1 (-OCH2CH3); 23.0(-COCH3); 41.2 (CH2);50.9(-CHNHAc); 61.6 (-
OCH2CH3); 71.6 (-CHOH); 125.8, 127.7, 128.5, 143.9 (Ph), 170.3, 172.5 (C=O) 
MS-EI (m/z): 266, 248 [M-H2O] 
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4.18.2 N-{2-oxo-1-oxaspiro[4.5]decan-3-yl}acetamide 100 
O
O
NHAc
 
A spatula of Raney-Ni was added to a solution of compound 31c (210 mg, 1 mmol) in 
ethyl acetate (4 mL). The mixture was stirred vigorously under hydrogen at room 
temperature for 15 hours, then filtered through celite. The solvent was removed in 
vacuo. The residue was dissolved in dichloromethane (5 mL) and acetyl chloride (2 
equiv, 0.13 mL), triethylamine (2 equiv, 0.250 mL) were added. The reaction mixture 
was stirred at room temperature for 12 hours. The reaction mixture was washed with 
water (3×1.5 mL), dried over Na2SO4 and the solvent removed under reduced pressure. 
Column chromatography (dichloromethane/MeOH: 97/3) afforded 100 in 41% total 
yield 
White solid (dichloromehane) 
m.p.: 144.5-146 °C 
1
H NMR: 1.4-1.8 (m, 11H, Ciclohexyl and H-4 ); 2.0 (s, 3H, CH3); 2.7 (dd, J = 9.0, 
11.8, H-4); 4.75 (ddd, 1H, J = 6.0, 9.0, 11.8, H-3); 6.4 (d, 1H, J = 6.0, -NHAc) 
13
C NMR: d 22.4, 22.6 (Ciclohex); 22.8 (-CH3); 24.8, 35.9, 38.3 (Ciclohex); 40.8 (C-4); 
49.8 (C-3); 84.9 (C-5); 170.48, 174.87 (C=O) 
IR (Nujol): 2800 (vOH, νNH, OH, NH2), 1771 (νC=O, C=O) 1654 (ν NHC=O, C=O). 
4.18.3 (2S,3S,4R))-2,6-Diamino-3,4-dihydroxy-3-methyl-heptanoic acid 
methyl ester 92 
CH3 COOCH3
NH2 OH
HO CH3
NH2  
A spatula of Raney-Ni was added to a solution of compound 88, (0.1 mmol) in ethyl 
acetate (4 mL). The mixture was stirred vigorously under hydrogen for 2 h, then filtered 
through celite. The solvent was removed in vacuo and the residue was purified by 
means of flash chromatography (SiO2, ethyl acetate/methanol=95/5, developer: I2). 
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Waxy solid (25%).  
1
H NMR:  1.15 (d, 3H, J = 6.0, CH3-7); 1.3 (broad s, 1H, H-5); 1.33 (s, 3H, CH3-3); 
1.63 (broad, 6H, OH, NH2); 1.87 (broad m, 1H, H-5); 2.74 (m, 1H, H-6); 3.25 (broad s, 
1H, H-2); 3.31 (dd, J = 11.4, 4.9, 1H, H-4); 3.76 (s, 3H, OCH3).  
13
C NMR:  21.1, 21.9 (3-CH3, C-7); 39.3 (C-5); 49.6 (C-6); 52.1 (OCH3); 65.9 (C-2); 
70.2 (C-3); 73.6 (C-4); 171.3 (C=O).  
IR (Nujol): 3350 (vOH, νNH, OH, NH2), 1740 (νC=O, C=O). 
HRMS(FT-ICR)-EI
+
 (m/z): 204.1230 [M – NH3 +H]
+
. 
4.19 Synthesis of N-(((2S,5R)-2,5-dihydro-5-isopropyl-3,6-
dimethoxypyrazin-2yl) (phenyl)methyl)benzene amine 
112/113 
Ph
N
N
NH OCH3
CH3O
Ph
5
21'
 
Butyllithium (1.6 N solution in hexane, 1.45 mmol, 0.9 mL, 1.05 equiv.) was added to a 
solution of (R)-22 (1.4 mmol, 0.25ml, 1 equiv.) in anhydrous THF (3 mL) cooled at –
78°C, and the mixture was stirred for 45 min. Imine 108 (1.4 mmol, 0.250 mg, 1 equiv) 
in THF (3 mL) was added, and the mixture was stirred at –78 °C for 4 h. The reaction 
mixture was allowed to warm to -20 °C, after which a pH=7 phosphate buffer solution 
(10 mL) was added, and the mixture was extracted with AcOEt. The organic phase was 
separated and dried with Na2SO4, and the solvent was evaporated in vacuo. Adduct 
112/113 were purified by means of flash column chromatography 
(hexane/dichloromethane:1/1) and obtained in 60% total yield.  
1
st
 diast: Oil (36%) 
1
H NMR:  0.60 (d, 3H, J = 6.8, -CH3); 0.90 (d, 3H, J = 6.8, -CH3); 2.1 (m, 1H, 
CH(CH3)2); 3.1 (t, 1H, J = 3.6, H-5 pyr); 3.7 (s, 3H, -OCH3); 3.8 (s, 3H, -OCH3); 4.5 (t, 
1H, J = 3.6 H-2 pyr); 5.0 (d, 1H, J = 3.6 CH-NHPh); 6.5-6.6 (m, 3H, Ph); 7.05-7.15 (m, 
7H, Ph) 
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13
C NMR: 16.9, 18.8 (CH3); 31.1 (CH(CH3)2); 52.1, 52.5 (3- and 6 -OCH3); 58.3 (-
CH-NHPh) 59.8, 60 (C-2 and C-5 pyr);113.5, 117.1, 127.2, 127.7, 128, 129.1, 138.2, 
146.7 (Ph); 160.3, 164.9 (C-3 and C-6 pyr) 
[
25
D]  61.8 (CHCl3 c 1.04) 
 
2
nd
 diast: White solid (hexane) (24%) 
m.p. 88-90 °C  
1
H NMR:  0.65 (d, 3H, J = 6.8, -CH3); 0.95 (d, 3H, J = 6.8, -CH3); 2.2 (m, 1H, 
CH(CH3)2); 3.55 (t, 1H, J = 3.3, H-5 pyr); 3.68 (s, 3H, -OCH3); 3.72 (s, 3H, -OCH3); 
4.35 (t, 1H, J = 3.3 H-2 pyr); 5.0 (d, 1H, J = 2.5 CH-NHPh); 6.55 (d, J = 7.9 2H, Ph); 
6.6 (t, 1H, J = 7.3 Ph); 7.2-7.4 (m, 7H, Ph) 
13
C NMR 16.7, 19.0 (CH3); 31.7 (CH(CH3)2); 52.6 (3- and 6 -OCH3); 59.2 (-CH-
NHPh) 60.6, 60.7 (C-2 and C-5 pyr);113.8, 117.4, 127.2, 127.4, 128, 129.1, 140.4, 
146.9 (Ph); 161.4, 165.9 (C-3 and C-6 pyr) 
[
25
D] 92.3 (c 1.94, CHCl3). 
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5 INTRODUCTION 
Chiral allylsilanes are very useful intermediates in organic synthesis and they have been 
used as building blocks and as versatile intermediates for the synthesis of complex 
molecules.
113-116
 Their reactivity is due to the peculiar properties of the C-Si bond. The 
lower electronegativity of silicon (1.8) compared to carbon (2.5)
117
 causes a rise in the 
HOMO, making the allylsilane reactive nucleophiles. Moreover Si has a large atomic 
radius (110 pm versus 70 pm of C) and the bulkiness of a silyl group can control the 
stereochemistry of the reactions occurring in its immediate vicinity. In addition, silicon 
can be easily removed from the molecule after it exerted its influence on a synthetic 
sequence. Protodesilylation
118
 and oxidation
119, 120
 of the C-Si bond occur through initial 
reaction at silicon by electronegative atoms like oxygen and fluoride, with which it 
forms very strong bonds. 
Chiral allylsilane can react with a broad range of electrophiles leading to the formation 
of more complex products. Some of the more important and useful reactions are shown 
in Figure 33.
114
 Depending on the experimental conditions, reactions with carbonyl 
compounds and imines, can lead to the formation of carbocycles and five members ring 
heterocycles. However reactions with the same electrophiles, under different reaction 
conditions, provide homoallylic alcohol and amines. 
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Figure 33: Reactions of allylsilanes 
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5.1 Synthetic Methodologies for the Synthesis of Chiral Allyl 
Silanes 
Due to the importance of allylsilanes in organic synthesis, many research groups have 
studied different approaches to obtain them in high enantiomeric and diastereomeric 
purity. Hayashi and co workers in 1982 described for the first time an efficient synthesis 
of enatiomerically pure allylsilanes using a palladium-catalyzed asymmetric Grignard 
cross-coupling.
121
 As shown in Scheme 52, reaction between different allylbromides 
114 and Grignard reagent115 was catalyzed by PdCl2[(R)-(S)PFA], led to the formation 
of allylsilanes 116 in moderate to good yields and excellent e.e. 
R1
R2
Br
R1
R2 H
SiMe3
Ph
Me3SiCH(Ph)MgBr 115
PdCl2[(R)-(S)PPFA] 0.5 mol%
Et2O, 0-15 °C, 2-5 days
Fe
P
N
Pd
Cl
Cl
Me Me
Ph Ph
Me
[(R)-(S)-PPFA] =
a: R1=R2=H
b: R1=Me, R2=H
c: R1=Ph, R2= H
a: 42%, e.e. 95 5 
b: 77%, e.e. 85%
c: 93%, e.e. 95%
114 116
 
Scheme 52: Synthesis of allylsilanes proposed by Hayashi 
121
 
Other Pd catalyzed reaction that have been developed for the synthesis of chiral 
allylsilanes include the hydrosilalation of 1,3 dienes,
122, 123
 silylation of allylic 
chlorides
124
 and silaborations of allenes.
125
 However, in many cases products are 
obtained with less than 90% e.e. 
More recently, Oestrich described the synthesis of chiral allyl silanes through a copper 
catalyzed allylic substitution of an enantiomerically pure carbamate or carbonate 118a 
or b with bis(triorganosilyl) zinc 117 (Scheme 53).
126
 Allylsilanes were obtained in 
moderate to good yield and in high e.e., but this methodology was only applied to a 
limited number of substrates. 
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PhMe2Si OPO(OEt)2
Alkyl
SiMe2Ph
1-2 mol% 121
1-2mol% Cu salt,(Alkyl)2Zn
THF , -15 °C, 24 h
120
122
e.e: up to 98:2, yield 70%-94%
Alkyl: Et, Me, iPr, 
AcO(CH2)4
Ph Et
OR
Ph Et
SiMe2Ph
(Me2PhSi)2Zn 117
CuI (5 mol%)
THF:Et2O 6:1
0 °C
(S)-118a 98% ee
(S)-118b 91% ee
(R)-119
98% ee from (S)-118a
91% ee from (S)-118b
E,Z >98:2 E,Z >98:2
a: C(O)Ph
b: C(O)NHPh
Yield: 62-55%
 
Scheme 53: Syntheis of allylsilanes proposed by Oestrich
126
 
Hoveyda and co-workers developed the synthesis of tertiarty and quaternary allylsilanes 
using catalytic asymmetric allylic alkylation of organozinc reagents to Si substituted 
allyl phosphates 120.
127
 This transformation is catalyzed by chiral Cu complexes 
generated in situ from N-heterocyclic-carbenes ligands 121(Scheme 54). Tertiary 
allylsilanes 122 were obtained in high yields and excellent enantioselectivity. Moreover 
the reaction proved to have a broad scope, with allylsilanes containing different alkyl 
groups as methyl, ethyl, isopropyl, AcO(CH2)4- formed without any reduction in the 
enantioselctivity.  
 
 Scheme 54: Synthesis of tertiary allylsilanes proposed by Hoveyda
127
 
Moreover the same metal-ligand complex can be used for the synthesis of the more 
challenging quaternary allylsilanes starting from the sterically congested trisubstituted 
olefin 123. The quaternary allylsilanes 124 were again obtained in high yields and 
excellent e.e.
127
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PhMe2Si OPO(OEt)2
Alkyl
SiMe2Ph
2.5-5 mol% 121
2.5-5mol% Cu salt,(Alkyl)2Zn
THF , -15 °C, 24 h
123
124
ee: up to 92%, yield 75%-87%
Me
Me
Alkyl = Et, iPr, Me2CH(CH2)3-  
Scheme 55: Synthesis of quaternary allylsilanes proposed by Hoveyda 
127
 
 
In this work we aim to study a new route to enantiomerically enriched allylsilanes 
through the lithiation/borylation reaction developed within the Aggarwal group. The 
base of lithiation/borylation methodology is the study of the lithiation of carbamates, 
firstly developed by Hoppe. Therefore in the next section Hoppe’s work will be 
reviewed together with the functionalities allowed by the system. 
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5.2 Hoppe Carbamates and Functionalities Allowed 
Hoppe and co-workers first reported the asymmetric deprotonation of an O-alkyl 
carbamates in 1990.
128
 The carbamate 125 is easily synthesised through reaction of the 
corresponding alcohol with carbamoyl chloride in presence of a mild base as 
triethylamine
129
 or pyridine.
130
 The carbamate obtained may be deprotonated using or 
sBuLi at -78 °C, in presence of a diamine ligand. After a four hours deprotonation, the 
lithiated species 126 can react with a variety of electrophiles. This traps the lithiated 
intermediate with retention of configuration, providing the corresponding secondary 
alcohols 127 after deprotection of carbamate group (Table 19).
131
 
O
O
R2N
Li
EX
CbO CbO
E
HO
Cb-Cl
Base
-Cb
HO
EsBuLi
diamine
125 126 127
N N
R R R R REt2O, -78 °C
 
R EX Diamine Yield (%) % e.e. 
Methyl Me3SiCl TMEDA 70 - 
Methyl CO2 sparteine 75 >95 
Methyl Me3SnCl sparteine 73 >95 
Hexyl MeI sparteine 81 96 
Table 19: Examples of the deprotonation of alkyl carbamates followed by trapping with an 
electrophile 
131
 
The presence of the carbamate group has two important effects in the deprotonation 
reaction. Firstly, it acts as an electron withdrawing group making the alpha proton more 
acidic. Secondly it helps stabilize the lithiated intermediate, through the coordination of 
oxygen with lithium, as shown in Table 19. The lithiated carbamate is also stabilized by 
the diamine that chelates with the lithium. 
Hoppe and co-workers mainly used two carbamates groups (Figure 34). While the 
diisopropyl carbamate (OCb) can be removed with LiAlH4 or an excess of DIBALH, 
the oxazolidines carbamates (OCby and OCbx) can be removed through a easier 
acid/base hydrolysis using a mixture of MeSO3H and MeOH followed by Ba(OH)2.
131
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OCb =
O
O
N
OCby =
O
O
N O
OCbx =
O
O
N O
 
Figure 34: Carbamate groups employed by Hoppe, et al. 
A wide range of electrophiles have been used in this reaction, as MeI, CH2N2, Me3SiCl, 
acid chlorides, esters, ketones, aldehydes, allyl bromide an epoxides.
132 
In all cases the 
electrophile traps the lithiated carbamate with retention of configuration (Figure 35).  
R
H
OCb
Li
E+
E+
EX
R
E
H
OCbSEret
 
Figure 35: Mechanism of electrophile trapping by lithiated alkyl carbamates 
As previously mentioned, the presence of a secondary diamine, such as N, N, N’, N’ 
tetramethylethyldiamine (TMEDA, Figure 36), is needed for the stabilisation of the 
intermediate lithiated carabamate. When an achiral amine as TMEDA is used, the 
product obtained is in racemic form. However when a chiral diamine, like ()-sparteine 
(Figure 36) is used, enantioselective deprotonation can be induced. 
N
N
)-sparteine
N N
(+)-sparteine
surrogate
NN
TMEDA
 
 Figure 36: Diamines Employed in the Deprotonation of Alkyl Carbamate 
In the case of primary alkyl carabamates, treatment with sBuLi in presence of ()-
sparteine, leads to the preferential deprotonation of pro-S proton of 125, affording the 
product with an e.r. up to 99:1 (Scheme 56).
133
 Lithiated alkyl carbamates proved to be 
configurationally stable at -78 °C and so no equilibrium due to racemisation of the 
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organolithium occurs. Therefore the origin of enantioselectivity is a kinetically 
controlled process. It has been shown by quantum chemical DFT calculation that the 
transition state for pro-S deprotonation of ethyl carbamate by ()-sparteine-sBuLi 
complex is 2.75 kcal/mol lower in energy that the transition state fro pro-R-H. This 
difference of energy at – 78 °C corresponds to the observed enantiomeric ratio of 
99:1.
134
 
N N
R O
Li O
N
HRR OCb
sBuLi
()-sparteine
Et2O, -78 °C
HR HS EX
R OCb
E
125
 
Scheme 56: Enantioselective deprotonation of alkyl carbamates with (–)-sparteine•sec-BuLi 
complex 
The synthesis of the opposite enantiomer is achieved using (+)-sparteine surrogate 
(Figure 36), a ligand developed by O’Brien and co-workers.135 In fact, while ()-
sparteine is commercially available, its enantiomer is not. The use of (+)-sparteine 
surrogate in lithiated carbamate reactions leads to the exclusively deprotonation of pro-
R proton of 128, affording the product 129 with an e.r. of 95:5.
133
 
OCb
(sp).Li HS
OCb
sBuLi
()-sparteine
Et2O, -78 °C
HR HS
OCb
SnBu3Bu3SnCl
Ph Ph Ph
129
yield = 84%
e.r. = 95:5
128
 
Scheme 57: Use of O’Brien’s (+)-sparteine surrogate in lithiated carbamate chemistry 
Unlike the case of O-alkyl carbamates, the lithiated primary O-benzyl ones are not 
configurationally stable at -78 °C. Therefore when the deprotonation of 130 reaction is 
run in presence of ()-sparteine, the product 131 is recovered in racemic form (Scheme 
58).
136, 137 
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OCb
sBuLi, ()-sparteine
Et2O, -78 °C
HR HS
OCb
Li
OCb
SiMe3
yield = 87%
e.r. = 64:36
Me3SiCl
OCb
Li
130 131
 
Scheme 58: Deprotonation of benzyl carbamate in the presence of (–)-sparteine
136
 
Conversely, secondary benzyl carbamates proved to be configurationally stable at -78 
°C.
137 
Starting from enantiomerically enriched secondary benzylic carbamates 132, the 
electrophiles react with the lithiated form with complete retention or complete inversion 
of stereochemistry, depending on the nature of the electrophile (Table 20).
130
 
Electrophiles containing a Lewis basic site usually react with retention of configuration. 
This is thought to be due to precomplexation between the Lewis basic group and lithium 
which is Lewis acidic. Electrophiles without a Lewis basic site cannot precomplex with 
lithium and so reaction occurs with inversion of stereochemistry. In both cases, 
however, the products are obtained with e.e. up to 95%.  
  
  
130 
 
 
OCb
Li
EX
Me
SEinv
SEret
EXOCb
Li
Me
OCb
E
Me
OCb
E
Me
OCb
MeH
OCb
MeH
nBuLi
nBuLi
132
132  
EX Course Yield (%) % e.e. 
Me3SiCl Inversion 94 96 
Me3SnCl Inversion 92 ≥ 95 
PrBr Inversion 77 85 
MeOC(O)Cl Inversion 90 85 
(MeO)2CO Retention 85 94 
Me2CO Retention 71 54 
PhCHO Retention 69 > 95 
Table 20: Electrophiles which react with inversion and retention of configuration
130 
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5.3 Lithiation/Borylation Methodology 
In 1980 Matteson and co-workers reported a breakthrough in the synthesis of chiral 
boronic esters.
138
 They found that treatment of chiral boronic ester 133 with 
dichloromethyllithium led to the stereoselective formation of a boron “ate” complex. 
This intermediate, upon warming to room temperature, underwent a stereospecific 1,2-
metallate rearrangement to give -chloro-boronic ester 134. When the -chloro-boronic 
ester 134 was treated with another nucleophile, such as Grignard reagent, a second 
homologation occurred, providing 135 (Scheme 59). The presence of a chiral diol (eg. 
pinane diol) as the ester substituent causes both homologations to proceed in an 
excellent diasteresoselctivity.
138
 The stereochemistry of the “ate” complex is in fact 
controlled by the chiral environment provided by the boronic ester (substrate control) 
for the homologation of dichloromethyl lithium. Moreover the diastereomeric ratio can 
be improved up to >99:1 by adding zinc chloride to the solution.
139, 140
 
LiCHCl2
B
O
O H
Cl
Ph
MeMgBr LiCHCl2
OH
Ph
i) MeMgBr
ii) NaOH/
    H2O2
Ph
B
O
O H
B
O
O H
Ph B
O
O H
Cl
Ph
133 134 135  
Scheme 59: Homologation of pinane diol derived boronic esters 
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The homologation of the -chloro boronic ester with a nucleophile is a stereospecific 
reaction. The migrating group in the boron “ate” complex must be antiperiplanar to the 
leaving group (the chloride) for 1,2-metallate rearrangement to occur (Figure 37). 
BB
Nu
R''
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 Figure 37: Mechanism of 1,2-metallate rearrangement. X = leaving group 
The Matteson homologation has been used in total synthesis to form enantiomerically 
enriched secondary alcohols
141-146
 and allyl boronates for subsequent allylboration.
147-150 
 
A complementary method to the substrate controlled Matteson homologation, was first 
developed by Hoppe and co-workers.
151
 In this case they obtained the chiral boronic 
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ester 136 after reacting the chiral lithiated carbamate 128 with triisopropyl borate 
followed transesterification with pinacol. The lithiated carbamate dictated the 
stereochemistry of the product. Treatment of the boronic ester with Grignard reagents at 
-78 °C led to the formation of the “ate” complex 137. Upon warming at room 
temperature, this underwent 1,2-metallate rearrangement, with the expulsion of the 
carbamate moiety, affording to give the secondary boronic ester 138 (Scheme 60).
151
 
The corresponding alcohol 139 is obtained in excellent yield and e.r. 
OCb
HR HS
i) sBuLi
  ()-sparteine
  Et2O, -78°C
ii) B(OiPr)3
iii) pinacol, p-TsOH
    MgSO4, CH2Cl2
OCb
B
O O RMgX
Et2O
-78°C OCb
B
O
OR
R
B
O O
H2O2
NaOH
R
OH
136

137
138 139
yield = 50-70%
e.e. = >95%
128
 
Scheme 60: Formation of secondary boronic ester from chiral lithiated carbamate and 
subsequent 1,2-metallate rearrangement
151
 
This methodology was used in the total synthesis of (‒)-N-acetylcolchinol by Kocienski 
and co-workers (Scheme 61).
152
 During this work, it was found that the lithiated 
carbamate could be directly trapped with an aryl boronic ester to form the boron “ate” 
complex. 1,2-metallate rearrangement, promoted by magnesium bromide in refluxing 
1,2-dimethoxyethane (DME) provided the boronic ester, that was oxidized into alcohol 
140 in excellent enantioselectivity.  
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MeO
MeO
OMe
OCb
i) sBuLi, ()-sparteine
  Et2O, -78 C
ii) ArB(pin)
iii) MgBr2
     -78 C
iv) DME, reflux
v) H2O2, K2CO3
MeO
MeO
OMe
OH
OTBS
140
yield = 65%
e.r. = 98:2 HO
MeO
MeO
MeO
NHAc
()-N-Acetylcolchinol
OTBS
Ar =
 
Scheme 61: Synthesis of (‒)-N-Acetylcolchinol using lithiation/borylation 
Aggarwal and co-workers generalised this methodology making reactions directly the 
lithiated carbamates with boranes or boronic esters.
129
 Carbamate 125 was 
enantioselectively deprotonated with sBuLi in presence of ()-sparteine, leading to the 
formation of the chiral carbenoid 141. Addition of boranes or boronic esters afforded 
the boron “ate” complex with retention of configuration which underwent 1,2 metallate 
rearrangement upon warming. Subsequent oxidation of 142 led to the secondary 
alcohols 143 in excellent yield and e.r. (Table 21) .
129
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RCbO
HS HR
i) sBuLi, (-)-sparteine
   Et2O, -78°C
ii) BR'(R'')2
    Et2O, -78°C
iii) MgBr2, 40°C
RCbO
B
R''
R'
R' R
B(R'')2 H2O2
NaOH RR'
OH
R''
141
125 142 143
 
R R' (R'')2 Yield (%) e.r. 
Ph(CH2)2 Et Et2
a 91 98:2 
Ph(CH2)2 iPr 9-BBN
a 81 98:2 
Ph(CH2)2 Ph 9-BBN 94 97:3 
Ph(CH2)2 Et pinacol 94 98:2 
Me2C=CH(CH2)2 Et Et2
a 90 97:3 
Me2C=CH(CH2)3 Ph 9-BBN 71 95:5 
Me2C=CH(CH2)4 Et pinacol 75 98:2 
Me2C=CH(CH2)4 Ph pinacol 73 98:2 
TBSO(CH2)2C(CH3)2CH2 Et Et2
a 67 95:5 
TBSO(CH2)2C(CH3)2CH2 Ph 9-BBN 65 97:3 
TBSO(CH2)2C(CH3)2CH2 Ph pinacol 64 98:2 
iPr Ph 9-BBN 68 96:4 
iPr Ph pinacol 70 98:2 
Me Ph pinacol 70 97:3 
Table 21: Lithiation/Borylation reaction with alkyl carbamates. 
a
 No MgBr2 added.
129
 
As shown in Table 21, a broad range of alkyl carbamates can be employed together with 
a broad range of aryl and alkyl boronic esters, providing easy access to a wide variety of 
secondary alcohols. When boronic esters are employed, the addition of MgBr2 in Et2O 
at reflux is required to make the 1,2-metallate rearrangement to occur. Moreover it was 
shown that iterative homologation could be performed, with alcohols 145 obtained in 
excellent e.r. and d.r. (Scheme 62). The strength of this methodology lies in the 
possibility of obtaining all the fours alcohols stereoisomers through the appropriate 
choice of ()-sparteine or (+)-sparteine surrogate during deprotonation of the carbamate.  
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OCb
sBuLi
()-sp
Et-B(pin)
Ph
Ph
B(pin)
OCbPh
Li·sp
OCb
Li.()-sp
[()-sp]
OCb
Li.(+)-sp
[(+)-sp]
Ph
HO
Ph
HO
OCb
Li.()-sp
[()-sp]
OCb
Li.(+)-sp
[(+)-sp]
Ph
HO
Ph
HO
144
(78%, 98:2 e.r.)
64% 
>98:2 e.r. 94:6 d.r.
145
82% 
>98:2 e.r. 96:4 d.r.
OCb
sBuLi
(+)-sp
Et-B(pin)
Ph
Ph
B(pin)
OCbPh
Li·(+)sp
ent-144
(78%, 98:2 e.r.)
63% 
>98:2 e.r. 94:6 d.r.
63% 
>98:2 e.r. 90:10 d.r.
 
Scheme 62: Iterative homologation reaction of boronic esters 144 and ent- 144 
The lithiation/borylation of primary O-alkyl carbamates methodology was then applied 
in the synthesis of enantioenriched allyl boranes 146 (Scheme 63). These, however, 
were not isolated but underwent an in situ allylboration with aldehydes providing 
homoallylic alcohols 147 in high e.r. and d.r.
153
 
R1 OCb
1) sBuLi (1.4 equiv)
    ()-sparteine (1.5 equiv)
    Et2O, -78 °C, 5h
2) R2
9-BBN
(1.5 equiv.) -78 °C, 30 min
3) R3CHO (2 equiv), 
-78 °C
R3
R2
OH
+
R1
R3
R2
OH
R1
R1 R2
B
r.t
4) H2O2, NaOH, 
0 °C r.t146
147'147
e.r. up to 98:2
d.r. 147:147' >99:1
yield up to 90%  
Scheme 63: Lithiation/borylation/allylboration methodology to form homoallylic alcohols
153
 
A further application of this methodology was found in the synthesis of -hydroxy 
allysilanes 153.
154
 Lithium-tin exchange of stannane 148 afforded the lithiated 
carbamate 149. This reacted with retention of configuration with -silyl vinyl borane 
150 giving the “ate” complex 151, that upon warming underwent 1,2- metallate 
rearrangement. However, because the allyl boranes were not stable, 152 was trapped 
with aldehyde in situ, affording -hydroxy allysilanes 153 (Scheme 64).154 This 
versatile methodology has been applied in the formal synthesis of (‒)-decarestrictine D 
154
 and the total synthesis of solandelactone E.
155
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R SiMe3
R'
OH
Me3Si
9-BBN
yield = 74-96%, e.r. = > 94:6,
Z/E = >25:1, anti:syn = >25:1 
R' = Ph, Cy, nBu
OCb
SnBu3
Ph
B
OMe3Si R'
H
R
H
150
153
nBuLi, - 78 °C
Et2O
R OCb
Li
(1.5 eq),  -78 C
R OCb
B
Me3Si
R
B
SiMe3
ii) R'CHO (2 eq)
    -78 C  RT
iv) H2O2/NaOH
148 149
151 152
 
Scheme 64: Lithiation/borylation to form -hydroxy-allylsilanes 
154 
The lithiation/borylation methodology was also extended to the use of secondary 
benzylic O-lithiated carbamate.
156
 Reaction of the lithiated carbamate 154 with boron 
reagents formed the corresponding boron “ate” complex. Upon warming to room 
temperature 1,2-metallate rearrangement occurred to give the tertiary borane or boronic 
ester. Oxidative workup afforded tertiary alcohols 155 in excellent yields and e.r (Table 
22). The secondary alcohols, precursors of the carbamate, were easily made 
enantioselectively by Noyori transfer hydrogenation
157
 of the corresponding ketones or 
by enzymatic resolution
158
 of the racemic alcohols in an e.r. of up to >99:1.
156
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RB(R')2
Inversion B(R'2)
Ar OCb
R
R
Ar B(R'2)
R
Ar OHH2O2
NaOH

155
e.r. > 95:5
B(pin)
Ar
OCb
RB(pin)
Retention
R

R
Ar
B(pin)
R
Ar
OH
H2O2
NaOH
ent-155
e.r. > 95:5
H
Ar
OCb
sBuLi
Et2O
-78 °C
R
Li
Ar
OCb
154
e.r. = 99:1
"ate" complex
"ate" complex
 
Ar (e.r. of carbamate) R’ (R'’)2 Yield (%) e.r. 
Ph (99:1) Et Et2 91 99:1 
Ph (99:1) Et pinacol 95 1:99 
Ph (99:1) iPr 9-BBN 91 98:2 
Ph (99:1) iPr pinacol 70 4:96 
Ph (99:1) Hexyl 9-BBN 60 98:2 
Ph (99:1) Hexyl pinacol 85 4:96 
Ph (99:1) Cyclopropyl pinacol 85 3:97 
Ph (99:1) vinyl pinacol 75 2:98 
Ph (99:1) allyl pinacol 95 1:99 
Ph (99:1) pCl-C6H4 pinacol 97 1:99 
Ph (99:1) pMeO-C6H4 pinacol 92 2:98 
Ph (99:1) mCF3-C6H4 pinacol 92 1:99 
Ph (99:1) 2-furyl pinacol 94 2:98 
pCl-C6H4- (98:2) Et Et2 82 95:5 
pCl-C6H4- (98:2) Et pinacol 92 4:96 
pCl-C6H4- (98:2) Ph pinacol 89 4:96 
pMeO-C6H4- (98:2) Et Et2 87 96:4 
pMeO-C6H4- (98:2) Et pinacol 97 2:98 
pMeO-C6H4- (98:2) Ph pinacol 81 4:96 
Table 22: Lithiation/Borylation of secondary aryl carbamates
156
 
The lithiation/borylation methodology proved to be even more useful, because starting 
from the same enantioenriched carbamate, both enantiomers of the tertiary alcohol can 
be obtained. The reaction of boronic esters proceeded with retention of configuration of 
the lithiated carbamate whereas when boranes were used, the reaction occurred with 
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inversion of stereochemistry. This stereochemical outcome can be so explained: in the 
case of boronic ester, the oxygen of the ester complexes with the lithium of the 
metallated carbamate and so it is delivered from the same face as the carbanion (Figure 
38). In case of borane, precomplexation cannot occur and so the electrophile attack the 
face opposite to the lithium where there is significant electron density owing to the 
nature of the carbanion being between tetrahedron and trigonal biplanar (Figure 38).
156
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Figure 38: Explanation of whether electrophile reacts with retention or inversion of 
stereochemistry 
156
 
 
5.4 Aim of the Work 
On the base of the results previously obtained with lithiation-borylation methodology, 
we envisaged to extend it in the synthesis of tertiary and quaternary allylsilanes with 
high d.r. and e.r. In particular we thought that the lithiation-borylation of carbamate 156 
could afford intermediate 157, that could have been transformed into allylsilanes by 
means of Zweifel olefination (Scheme 65).  
Me3Si OCb Me3Si R
Bpin
Me3Si R
a)sBuLi
()-sparteine
157
()-Sparteine =
N
N
OCb =
O
O
N
Zweifell 
Olefination
b) RBpin
156
 
Scheme 65: Proposed used of lithiation/borylation in the synthesis of chiral allylsilanes 
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Zweifel and co-workers in 1967 described the synthesis of substituted alkenes via 
iodination of vinylboranes.
159
 It was proposed that initial addition of iodine to the 
double bond was followed by the migration of a R-group from the boron to the adjacent 
carbon atom to provide organoborane 158 (Scheme 66). Elimination to give alkene 159 
proved to be highly stereoselective and occurred when the boron group and the iodine 
were in a trans relationship . 
H6C4
H B
H
R
R
IH6C4
H
H
B
R R
OH
H6C4 RI
B
OHR1
HH
H6C4
H
R
H
NaOH/I2
158 159  
Scheme 66: Zweifel olefination mechanism 
159
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6 RESULTS AND DISCUSSION 
The first attempt in using lithiation/borylation methodology for the synthesis of 
allylsilanes envisaged the use of an -silyl carbamate.a We thought that trapping the 
enatioenriched lithiathed carbamate 160 with a boronic ester would have given, after 
formation of “ate” complex and 1,2-metallate rearrangement, the product 161 (Scheme 
67). Zweifel olefination of the newly formed boronic ester would have provided the 
allysilane 162. However this strategy proved unrewarding, because the intermediate 
lithiated silyl carbamate 160 was configurationally unstable,
160
 even when the reaction 
was performed at -100 °C, and led to racemic 161.  
Me3Si OCb Me3Si OCb
Li-sp
Me3Si Ph
Bpin
Me3Si Ph
a)sBuLi
()-sparteine b) PhBpin Lic)
d) I2, MeOH
NaOMe
160 161 162
()-Sparteine =
N
N
OCb =
O
O
N
 
Scheme 67: Lithiation/borylation of silyl carbamate to synthesise chiral allylsilanes 162 
We therefore considered an alternative approach. The lithiation of alkylcarbamate 
128a,b was carried out in the presence of chiral diamine (−)-sparteine and provided the 
enantioenriched lithiated carbamate 163a,b configurationally stable at -78 °C. The 
subsequent addition of the silaboronate 164 as the electrophile led to the formation of a 
boron “ate” complex” 165a,b, that upon warming underwent 1,2-metallate 
                                                 
 
a
 This work was published in Org. Lett. 2011, 13, 1490 by Aggarwal, V. K.; Binanzer, M.; De Ceglie, M. 
C.; Gallanti, M.; Glasspoole, B. W.; Kendrick, S. J. F.; Sonawane, R. P.; Vazquez-Romero, A.; Webster, 
M. P. Therefore this section is the result of the work of several persons. To be complete I included it all, 
even if I focused my attention on the derivatization of the allylsilanes and on their cyclization 
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rearrangement with migration of the silyl group and the expulsion of the carbamate 
group, providing the 1,1-silaboronates 166a,b (Scheme 68). Despite there being few 
reported examples
161-163
 of the migration of a silyl group in the literature, this strategy 
proved to be successful.  
a) sBuLi (1.4 equiv)
()-sparteine (1.4 equiv)
R OCb
R OCb
Lisp
128a,b 163a,b
R OCb
Bpinb) PhMe2SiBpin 164
(1equiv)
PhMe2Si
PhMe2Si R
Bpin
165a,b 166a,b
(68%)
a: R =PhCH2CH2
b: R =iPr
Et2O, - 78 °C, 4h -78 °C r.t, 14h
 
Scheme 68: Synthesis of silaboronates 166a,b through lithiation/borylation of carbamates 
128a,b  
The reaction was performed using two different R groups, the isopropyl group and the 
phenylethyl group. In both cases 166 was obtained in very good yields. Despite the 
silaboronate 164 being commercially available, we found that when the reactions were 
carried out using freshly synthesised 164 the yields were dramatically improved (from 
26% to 68%). Silaboranate 164 was synthesised according to the procedure reported by 
Suginome and co-workers (Scheme 69).
164
 Silyllithium 167 was prepared treating the 
corresponding chlorosilane with lithium. The resulting solution was then added to 
borane 168 and the desired silaboronate 164 was obtained in good yield after 
distillation.  
PhSiMe2Cl
Li0 (4 equiv)
PhSiMe2Li
B
O
O
O
Si B
O
O
Ph
Me
Me
THF THF/Hexane
168 (2equiv)
164 (66%)
167
 
Scheme 69: Synthesis of silaboronate 164 
164
 
In order to synthesise the desired allylsilanes, we applied modified condition of Zweifel 
olefination.
159, 165, 166
 It was found that I2/MeOH was superior to the more commonly 
employed conditions I2/MeONa/MeOH. Initially we focused our attention on the 
synthesis of vinylsilanes 172a,b. Treatment of silaboronates 166a,b with vinlyllithium 
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led to the formation of “ate” complex 169a,b (Scheme 70). The addition of iodine in 
methanol provided iodonium intermediate 170. This, upon warming, rearranged into 
intermediate 171. Anti elimination led to the formation of 172a,b in good yield and 
excellent e.r.  
PhMe2Si R
Bpin
166
M SiMe2Ph
B(pin)R
SiMe2Ph
B(pin)R
I
B(pin)
I
H
THF, -78°C
I2 in MeOH
-78°C
5% Na2S2O3
(work up)
0°C
HH
R
PhMe2Si
H
MeOH
169
170
171
H
PhMe2Si R
172a (81%, e.r.: 97:3)
172b (60% e.r.:  96:4)
a: R =PhCH2CH2
b: R =iPr
M = Li or MgBr
 
Scheme 70: Synthesis of allysilanes 172a,b through Zweifel olefination  
It should be noted that, in the case of boronate ester 166a, vinylmagnesium bromide 
was sufficiently nucleophilic to effect the “ate” complex formation but for the more 
hindered 166b vinyllithium was required. 
Encouraged by this result we directed our attention on the synthesis of more challenging 
crotylsilanes. Therefore silaboronates 166a,b were treated with Z-propenyllithium 173 
or E-propenyllithium 174 providing, respectively E-crotylsilanes 175a,b and Z-
crotylsilanes 176a,b in excellent yields, e.r and d.r.(Scheme 71).  
PhMe2Si R
Bpin Li
then I2/MeOH
166
174
PhMe2Si R
a: R =PhCH2CH2
b: R =iPr
PhMe2Si R
Li
173
then I2/MeOH
175a (94%, e.r: 97:3,
 d.r >25:1)
175b (80%, e.r: 96:4
 d.r >95:1)
0 °C- 78 °C 0 °C- 78 °C 176a (84%, e.r: 97:3,
 d.r >25:1)
176b (80%, e.r: 96:4
 d.r: 85:15)  
Scheme 71: Synthesis of crotylsilanes 175a,b and 176a,b through Zweifel olefination  
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In the case of the crotylsilanes, the fact that the elimination occurred exclusively when 
boron and iodine are in anti was important as it prevents the formation of a mixture of 
cis and trans isomers. Only in the synthesis of highly hindered Z-crotylsilane 176b was 
the E isomer visible in the crude NMR (d.r.: 85:15). In this case, the minor E-olefin 
presumably arose due to the severe steric clash in the conformation required for anti-
elimination which gives the Z-olefin. Therefore some syn-elimination occurs, providing 
the small amount of E-isomer (Scheme 72).  
PhMe2Si iPr
Bpin I2
MeOH
B
O
O
H
PhMe2Si
H I
Me
H
iPr
B
O
O
H
PhMe2Si
H H
I
iPr
Me
anti elimination
syn elimination
PhMe2Si
PhMe2Si
176b
175b
 
Scheme 72: Conformations that lead to the formation of cis-crotylsilane 176a and trans 
crotylsilane 175b 
All of the allysilanes synthesized were not able to be analyzed by chiral HPLC or chiral 
GC. Therefore, it was necessary to derivatize them without losing the e.r. achieved in 
the previous steps. While hydroboration
154 
and oxidation of the allyl silanes to the 
alcohol 177a,b (Scheme 73) proved to be a successful strategy for determine the e.r. of 
allilsilanes 172a,b, this was not the case for crotylsilanes 175a,b and 176a,b.  
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RPhMe2Si RPhMe2Si
HO
9-BBN (1eq) 
THF
NaOH/H2O2, 0 
oC
172a,b 177a,b
a: R =PhCH2CH2
b: R =iPr  
Scheme 73: Hydroboration of allylsilanes 172a, b 
Therefore, we applied the Tamao-Fleming oxidation of organosilane.
119, 167 
This reaction 
allows the conversion of the dimethylphenylsilyl group to an alcohol functionality with 
retention of configuration (Scheme 74). The authors propose that the phenyl ring is 
protonated giving the intermediate 178 and the trifluoroacetate anion attacks the silicon 
leading to the expulsion of benzene. Subsequently, fluorine attacks silicon kicking out 
the trifluoroacetate anion. Oxidation occurs when the peroxide anion attacks silicon 
providing the intermediate 179. This undergoes a stereospecific intramolecular 
rearrangement with retention of configuration which, after hydrolysis gives alcohol 180. 
R
Si
CF3COOH
R
Si
H
CF3COO
-
R
Si OCOCF3
R
Si OCOCF3
Bu4NF
R
Si F
-OOH
R
Si
F
O
R
O
SiF
intramol 
rearrang
R
OH
hydrolysis
R
OH
R
Si
Ph
1. CF3COOH
2. MeOH
TBAF (2eq)
KHCO3 (8eq)
H2O2 (12eq)
OH
178
179 180
180
 
Scheme 74: Mechanism of Tamao-Fleming oxidation 
119, 167
 
All the crotylsilanes previously synthesized were separately reduced to the saturated 
organosilanes 181a,b in presence of tosylhydrazide and triethylamine,
164
 before 
oxidation to the corresponding alcohols 182a, b (Scheme 75). The yields of these 
reactions were not optimised. 
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PhMe2Si R
Ts-NHNH
2 ; Et
3 N
1. CF3COOH
2. MeOH, 
KHCO3 ;TBAF 
H2O2
PhMe2Si R HO R
PhMe2Si R
Ts-
NH
NH 2
; E
t 3
N
175a,b
176a
181a,b 182a,b
yield: 15-20%
e.r. 96:4 to 97:3
a: R =PhCH2CH2
b: R =iPr  
Scheme 75: Tranformation of allysilanes 175a,b and 176a into alcohols 182a,b 
In case of the more encumbered crotylsilane 176b, hydrogenation reaction using PtO2 as 
catalyst was carried out (Scheme 76).
168
 All of the allylsilanes synthesised proved to 
have an excellent e.r as shown in Scheme 71. 
Si
Ph
H2 /PtO2 10%
MeOH, 5 h
Si
Ph
77 %176b  
Scheme 76: Reduction of allylsilane 176b 
Two PhD students in the group, Dr. Binanzer and Dr. De Ceglie, proved that the 
lithiation-borylation methodology could be extended to the synthesis of the more 
challenging quaternary allylsilanes. In this case, the sequence started with lithiation and 
silylation of carbamate 128a in presence of ()-sparteine as previously described by 
Hoppe,
169,170
 providing intermediates 183a,b (Scheme 77). Subsequent deprotonation 
with sBuLi/TMEDA followed by the addition of boronic ester 184 gave intermediate 
185. This intermediate was converted to the corresponding quaternary allylsilane 186, 
using the modified Zweifel olefination (see Scheme 70) in good yields and excellent e.r. 
(Table 23). The e.r. was determined by HPLC analysis, of the product derived from 
hydroboration/oxidation of 186a-c. The absolute configuration was assigned by X-ray 
analysis of the alcohol obtained from 186c by hydroboration/oxidation. All other 
assignments were made by analogy. 
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Li
I2, MeOH
Li
OCbR
1Me2Si
Ph
Bpin
OCbR
1Me2Si
Ph
R2
185a-c
c)
183a R1 = Me: 76 %
183b R1 = Ph: 85 %
b) sBuLi
TMEDA
R2Bpin
Bpin
R2 SiMe2R
1
Ph
R2 SiMe2R
1
Ph
H
OCbR
1Me2Si
Ph
a) sBuLi
()-sparteine
128a
H
OCbH
Ph
184
then
R1Me2SiCl
R2 = Me or Et
186a-c  
Scheme 77: Lithiation/borylation followed by Zweifel olefination for the synthesis of quaternary 
allylsilanes 186a-c 
 
 R1 R2 Yield of 185 Yield of 186 e.r. of 186 
a Me Et 94% 73% 97:3 
b Ph Me 52% 73% 97:3 
c Ph Et 76% 60% 97:3 
Table 23: Yields and e.r for lithiation/borylation/Zweifell olefination sequence  
Roush previously showed that quaternary allylsilane 187 can react with aldehydes 
through a [3+2] cycloaddition reaction, leading to the formation of a tetrahydrofuran 
188 in good yield and excellent diastereoselctivity (Scheme 78).
171
 
TBSO
OTBS
Pr
SiMe2Ph
OBn CHOBnO
2.0 equiv
SnCl4 (0.5 equiv)
Mol. Sieves, CH2Cl2, 
- 78 °C
O
OBnHTBSO
TBSO
OBn
PhMe2Si
52%
d.r. > 20:1
TBSO
Pr
OBn
OH
TBSO
OBn
+
23%
d.r. = 6:1
187 188
 
Scheme 78: Cyclization of quaternary allilsilane
171
 
This prompted us to synthesise quaternary allylslilane 193 (Scheme 79), according to 
the methodology shown in Scheme 77. Quaternary allylsilane 193 was obtained 
racemically starting from carbamate 189 (using TMEDA instead of ()-sparteine in the 
deprotonation step) in very good yield.  
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Bpin
SiMe2Ph
OCbPhMe2Si
OCb
1. sBuLi, TMEDA
2. PhMe2Si-Cl
OCb
SiMe2Ph 1. sBuLi, TMEDA
2. Bpin
Bpin
3. vinyl lithium
4. I2, MeOH
SiMe2Ph
193 (93%)
189 190 (91%)
192
 192 (84%)191
Bpin
SiMe2Ph
 
Scheme 79: Synthesis of quaternary allylsilane 193 through lithiation/borylation/Zweifel 
olefination sequence 
We thought that allylsilane 193 could undergo cyclization
114, 172, 173
 reaction with 
different electrophiles, providing natural product precursors (Scheme 80). For instance, 
reaction of 193 with benzaldehyde would provide 194, a motif that is found in the 
molecule of Iritectol B. Reaction with chlorosulphonyl isocyanate would lead to the 
formation of 195 that could be oxidized to the antifungal compound 196 or to lactam 
197. 
SiMe2Ph
N
PhMe2Si
H
O
O
PhMe2Si
O
O
Ph
SiMe2Ph
H
O
OH
OH
OHC
HO
PhCHO
ClSO2N=C=O
ClSO2N=C=O
Iritectol B
O
O
OH
Antifungal 196
from Mutisia Fresana
194 197
195
193
 
Scheme 80: Cyclization of allysilane 193 to provide useful molecules  
 
  
148 
 
Therefore, we reacted allysilane 193 with benzaldehyde in presence of different Lewis 
acids
171,172,174
 to obtain 194. However when BF3∙OEt2 or tris(pentafluorophenyl)borane 
were used, the reaction didn’t occur at low temperature and led to a mixture of 
undefined products when the temperature was raised (Table 24). 
 
 
SiMe2Ph Ph H
O
+ O
Ph
PhMe2Si
L.A.
193 194
 
Table 24: Attempted cyclization of 193 with benzhaldehyde using different Lewis acids  
Using SnCl4, the only product recovered from the complex reaction mixture was 201 
(Scheme 81). This product presumably derives from an initial Si-Sn exchange.
175
 The 
allylstannane 198 undergoes an internal rearrangement, providing 199. This latter reacts 
with benzaldehyde providing 200 and the alkoxide is trapped by silylchloride, giving 
201. 
 
Lewis Acid PhCHO Solvent Temperature Time Comment 
BF3OEt2 (1.3 eq) 1.3 eq DCM -78 °C 2 h No reaction 
BF3OEt2 (1.3 eq) 1.3 eq DCM -45 °C 3 h No reaction 
BF3OEt2 (1.3 eq) 1.3 eq DCM -30 °C 24 h No reaction 
BF3OEt2 (1.3 eq) 1.3 eq DCM -20 °C 20 h 
Complex reaction 
mixture 
tris(pentafluorophe
nyl)borane 
1.3 eq DCM -78 °C 3 h No reaction 
tris(pentafluorophe
nyl)borane 
1.3 eq DCM -30 °C 12 h No reaction 
tris(pentafluorophe
nyl)borane 
1.3 eq DCM -20 °C →0 °C 8 h 
Complex reaction 
mixture 
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SnCl3
+ ClSiMe2Ph
SnCl3
Ph
O
H
O-
Ph
ClSiMe2Ph
OPh SiMe2Ph193
201
SnCl4
SiMe2Ph Ph H
O
SnCl4 0.5 eq
+
2 eq CH2Cl2,
-78 °C  -20 °C, 12h
molecular sieves
198 199 200
 
Scheme 81: Proposed mechanism for the formation of 201 
We then turned our attention to the reaction with chlorosulphonyl isocyanate (CSI). 
This reaction between an allylsilane and CSI can give two possible products: the lactam 
204, if annulation occurred across the C=N bond of CSI, and the lactone 206 if 
cyclization occurred across the C=O bond (Scheme 82). Woerpel and co-workers 
proposed that electrophilic attack by CSI occurs antiperiplanar to the silyl group of 
allylsilane leading to -silyl carbocation 202.173 A subsequent 1,2-silyl migration occurs 
providing intermediate 203, that cyclises anti to the silyl group to give 4,5-trans-204 or 
205. According to Woerpel and co-workers,
176
 the steric size of the -substituent of the 
allylsilane exerts a strong influence on the annulations. The steric interaction between 
the -substituent R2 and the NSO2Cl group disfavours  the N-cyclization intermediate 
203b. However, intermediate 203b is favoured by repulsion between NSO2Cl and R1. 
On the other hand, O-cyclization intermediate 203a is favoured by steric repulsion 
between the α-substituent R2 and the NSO2Cl group but disfavoured by interaction of 
NSO2Cl and R1. Therefore an allyl silane with a large R2 group and a small R1 group 
prefers the O-cyclization pathway, leading to lactone precursor 205. In contrast, an 
allylsilane with a small R2 group and a large R1 group favours the N-cyclization 
pathway, to provide the lactam 204.  
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R2
PhMe2Si
ClSO2N=C=O
O
N
SO2Cl
PhMe2Si
R2 H
H
O
N
SO2Cl
H
N
SO2Cl
OR
PhMe2Si
O NR
PhMe2Si
SO2Cl
R1
H
PhMe2Si
N
O
R2
H SO2Cl
R1
R2
[1,2]-Si shift
Favored when:
 R1 = small
 R2 = large
Favored when:
 R1 = large
 R2 = small
203b203a
H
H
PhMe2Si
206
204
H
H+/THF
O OR
PhMe2Si
202
205
 
Scheme 82: Proposed mechanism of annulation and origin of the competion between C=N and 
C=O annulations
176
 
On the basis of this consideration, we reacted allylsilane 193 with CSI, expecting the 
lactone 208 as the main product. Instead, a mixture of lactam 207 and lactone 208 were 
formed. However, although different reaction conditions were tested
176, 177
 it was not 
possible to direct the reaction towards just one of the two products (Table 25). In all the 
reactions, the crude weight was less than the theoretical yield, suggesting that 
protodesilylation may have occurred in the reaction. 
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SiMe2Ph
+ ClSO2 N C O N
PhMe2Si
H
O
O
PhMe2Si
O
O °Cr.t., 12 h
193 207 208  
Conditions 207 208 
1) DCM, 1.2 eq CSI 0°C→r.t. 12 h 
2) Na2SO3 25%, r.t. 20 h 
20% 16% 
1) toluene, 1.5 eq CSI, 2.5 eq NaHCO3 
0°C→r.t. 12 h 
2) NaHSO3 std r.t. 20 h 
28% 18% 
1) toluene, 1.5 eq CSI 0°C→r.t. 12 h 
2) NaHSO3 std, r.t. 20 h 
15% 13% 
Table 25: Attempted cyclization with CSI 
At this point, my stay in Bristol ended. Due to the highly challenging nature of the 
cyclisation reactions investigated, no further work was carried out on this project. 
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7 CONCLUSION 
In summary, a simple method to obtain tertiary allyl- or crotyl silanes in excellent e.r 
and d.r was developed. This involved the extension of the lithiation borylation reaction 
developed within the Aggarwal group through reaction of primary lithiated alkyl 
carbamates with silaboronate 164 (Scheme 83). Zweifel olefination of the intermediate 
secondary silaboronate led to allyl and crotyl silanes. It was found necessary to 
derivatise the allyl silanes using either hydroboration/oxidation or Fleming-Tamao 
oxidation to obtain material which could be analysed by chiral HPLC. 
a) sBuLi (1.4 equiv)
()-sparteine (1.4 equiv)
R OCb
128a,b
b) PhMe2SiBpin 164
(1equiv)
a: R =PhCH2CH2
b: R =iPr
Et2O, - 78 °C, 4h
-78 °C r.t, 14h
PhMe2Si R
Bpin
166
PhMe2Si
R1
R2
R
172a,b: R1 =R2 = H
175a,b: R1 = Me, R2 = H
176a,b R1 = H, R2 = Me
Yields up to 84%, e.r. up to 97: 3, d.r. up to >25:1  
Scheme 83: Synthesis of tertiary allyl- and crotylsilanes through lithiation/borylation/Zweifel 
olefination 
 
Using a related strategy, a unique reaction sequence that leads to quaternary allylsilanes 
in similarly high e.r. was developed. This involved reaction of lithiated silacarbamate 
183a,b with alkyl boronic esters to give tertiary boronic esters (Scheme 84). Zweifel 
olefination led to quaternary allylsilanes in excellent e.r. and yield. 
Li
2) I2, MeOH
185
Yields up to 94%
183a, b 
a: R1 = Me
b: R1= Ph
1) sBuLi,TMEDA
2) R2Bpin
Bpin
R2 SiMe2R
1
Ph
R2 SiMe2R
1
Ph
H
OCbR
1Me2Si
Ph
R2 = Me or Et
1)
186
Yield up to 73%, e.r. up to 97:3
 
Scheme 84: Synthesis of quaternary allylsilanes through lithiation/borylation/Zweifel olefination 
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Attempts to react quaternary allyl silane 193 with aldehydes in the presence of a Lewis 
acid were unsuccessful. The allyl silane 193 did react with CSI, however, to give a 
mixture of lactam and lactone products. 
SiMe2Ph
+ ClSO2 N C O N
PhMe2Si
H
O
O
PhMe2Si
O
O °Cr.t., 12 h
QA273
207 208
O
Ph
PhMe2Si
X PhCHO 
Lewis Acid
+
 
Scheme 85: Attempted cyclization with benzaldehyde and with CSI 
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8 EXPERIMENTAL 
8.1 General information  
All reactions were carried out in oven-dried (180 ºC) glassware and under an Ar 
atmosphere using standard Schlenk techniques. Anhydrous solvents were prepared 
using anhydrous solvent drying columns. 
1
H- and 
13
C-NMR spectra were acquired at 
various field strengths as indicated, and were referenced to CHCl3 or TMS. 
11
B NMR 
spectra were recorded with complete proton decoupling using BF3·Et2O as an external 
standard. Low- and high-resolution mass spectra were recorded using Electron Impact 
(EI), Chemical Ionization (CI) or Electron-Spray Ionization (ESI) techniques. For CI, 
methane or NH4OAc/MeOH were used. Analytical TLC: aluminium backed plates pre-
coated (0.25 mm) with silica gel 60 F 254. Compounds were visualized by exposure to 
UV-light or by staining with 5% solution of (NH4)2Mo7O24∙4H2O in EtOH followed by 
heating. Flash chromatography was carried out using Merck silica gel 60, 0.040–0.063 
mm particle size. Melting points were determined with a Boetius hot stage apparatus 
and were not corrected. All IR data were obtained on a Perkin-Elmer Spectrum One FT-
IR spectrometer. N,N,N’,N’-Tetramethylethylenediamine (TMEDA) was purchased 
from Aldrich and (–)-sparteine was purchased from Alfa Aesar or Aldrich. Both were 
distilled under reduced pressure over CaH2 prior to use. Anhydrous methanol was 
purchased from Acros and used without further purification. sBuLi was purchased from 
Acros or Aldrich.  
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8.2 (R)-Dimethyl(phenyl)(3-phenyl-1-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)propyl)silane 166a  
PhMe2Si
B
OO
Ph  
Phenylpropyldiisopropylcarbamate 128a (0.50 mL, 1.89 mmol) and (–)-sparteine 
(0.45 mL, 1.89 mmol) were dissolved in diethyl ether (8 mL) and cooled to –78 °C. 
sBuLi (1.4 mL, 1.3 M solution in cyclohexane/hexane (92:8), 1.89 mmol) was added 
dropwise and the mixture was stirred at –78 °C for 5 hours. Silylboronic ester 164 
(0.35 mL, 1.32 mmol) was added dropwise and the resulting mixture was stirred at    –
78 °C for 1 hour, allowed to warm to 23 °C and stirred for an additional 18 hours. Water 
was added, the phases were separated, the aqueous phase was extracted three times with 
diethyl ether and the combined organic phases were washed with brine, dried (Na2SO4), 
filtered and concentrated. Column chromatography (silica gel, 5 % diethyl ether in 
petroleum ether) gave boronic ester 166a (344 mg, 69 %) as a colourless oil. The 
racemate was obtained with TMEDA instead of (–)-sparteine. 
Rf (5 % diethyl ether in petroleum ether): 0.2; [
23
D] = +24.0 (c = 1.0, CH3Cl); 
1
H NMR 
(CDCl3, 500 MHz): δ [ppm] 7.51–7.10 (m, 10 H), 2.70 (ddd, J = 13.4, 9.7, 5.0 Hz, 1 H), 
2.46 (ddd, J = 13.4, 9.7, 6.8 Hz, 1 H), 1.89 (dddd, J = 13.1, 12.0, 9.7, 5.0 Hz, 1 H), 1.64 
(dddd, J = 13.1, 9.7, 6.8, 2.9 Hz, 1 H), 1.23 (s, 6 H), 1.20 (s, 6 H), 0.71 (dd, J = 12.0, 
2.9 Hz, 1 H), 0.32 (s, 3 H), 0.31 (3 H); 
13
C NMR (CDCl3, 126 MHz): δ [ppm] = 142.6, 
138.8, 133.8, 128.8, 128.5, 128.2, 127.6, 125.6, 82.8, 39.4, 28.0, 25.2, 24.7, –2.3, –3.4; 
11
B (CDCl3, 96 MHz) δ [ppm] = 33.7; HRMS (ESI): calculated for C23H33BO2Si 
([M+Na]
+
): m/z = 403.2235, found: m/z = 403.2224; MS (ESI): m/z = 221.1, 303.2, 
373.2, 403.2; IR (~ /cm
-1
, neat): 3026, 2977, 2927, 2858, 1350, 1306, 1248, 1143, 
1111. 
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8.3 (R)-Dimethyl(2-methyl-1-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)propyl)(phenyl)silane 166b 
PhMe2Si
B
OO
 
Isobutyl diisopropylcarbamate 128b (1.41 g, 2.03 mmol) and (−)-sparteine (0.46 mL, 
2.03 mmol) were dissolved in diethyl ether (30 mL) and cooled to at −78 °C. sBuLi 
(1.56 mL, 1.3 M solution in cyclohexane/hexane (92:8), 2.03 mmol) was added 
dropwise and the mixture was stirred at −78 °C for 5 h. Boronic ester 164 (0.45 mL, 
1.57 mmol) was added dropwise and the resulting mixture was stirred at –78 °C for 1 
hour, allowed to warm to 23 °C and stirred for an additional 18 hours. Water was added, 
the phases were separated and the aqueous phase was extracted three times with diethyl 
ether. The combined organic phases were washed with brine, dried (MgSO4), filtered 
and concentrated. Column chromatography (silica gel, 4 % diethyl ether in pentane) 
gave boronic ester 166b (339 mg, 68 %) as a colourless oil. The racemate was obtained 
with TMEDA instead of (–)-sparteine. 
Rf (4 % diethyl ether in pentane): 0.4; [
23
D]  –5.0 (c = 0.63, CHCl3); 
1
H NMR (CDCl3, 
400 MHz) δ [ppm] = 7.57–7.32 (m, 5 H), 1.91 (dqq, J = 7.8, 6.7, 6.6 Hz, 1 H), 1.20 (s, 6 
H), 1.15 (s, 6 H), 0.99 (d, J = 6.7 Hz, 3 H), 0.89 (d, J = 6.7 Hz, 3 H), 0.66 (d, J = 7.8 
Hz, 1 H), 0.36 (s, 3 H), 0.34 (s, 3 H); 
13
C NMR (CDCl3, 101 MHz): δ [ppm] = 140.0, 
133.9, 128.5, 127.5, 82.6, 27.0, 26.4, 25.2, 24.9, 24.8, –1.3, –1.5; 11B (CDCl3, 96 MHz): 
δ [ppm] = 32.6; HRMS (CI): calculated for C18H31BO2Si ([M+H]
+
): 319.2265, Found: 
319.2257; MS (CI): m/z = 303.3 (85), 241.3 (100), 157.1 (80); MS (CI): m/z = 157.1, 
241.3, 303.3; IR (~ /cm
-1
, neat): 2977, 1304, 1247, 1142, 1110, 836, 815. 
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8.4 (S)-Dimethyl(phenyl)(5-phenylpent-1-en-3-yl)silane 172a  
PhMe2Si
 
Vinylmagnesium bromide (2.1 mL of 1 M solution in tetrahydrofuran, 2.1 mmol) was 
added dropwise to a stirred solution of boronic ester 166a (0.19 g, 0.5 mmol) in 
tetrahydrofuran (4 mL) at −78 °C. The reaction mixture was stirred for 30 minutes at 
−78 °C, and then a solution of iodine (0.54 g, 2.1 mmol) in methanol (4 mL) was added 
dropwise. The mixture was stirred for a further 30 minutes, and then allowed to warm to 
0 °C. Sodium thiosulfate (15 mL of 5% aqueous solution) was added, and the solvents 
were removed from the reaction mixture in vacuo. The mixture was then extracted with 
diethyl ether (3 × 20 mL) and the combined organic phases were washed with brine (60 
mL), dried (MgSO4) and concentrated in vacuo. The crude product was purified by flash 
chromatography (100 % petroleum ether)) to give allylsilane 172a (0.114 g, 81 %) as a 
colourless oil.  
Rf (100 % petroleum ether): 0.16; [
23
D] = +12.0 (c = 0.5, CH3Cl); 
1
H NMR (CDCl3, 500 
MHz): δ [ppm] =7.49–7.10 (m, 10 H), 5.67 (ddd, J = 17.1, 10.3, 9.2 Hz, 1 H), 5.00 (dd, 
J = 10.3, 1.9 Hz, 1 H), 4.89 (dd, J = 17.1, 1.9 Hz, 1 H), 2.75 (ddd, J = 13.9, 9.5, 4.6 Hz, 
1 H), 2.44 (ddd, J = 13.9, 9.5, 7.6 Hz, 1 H), 1.82–1.74 (m, 2 H), 1.72–1.62 (m, 1 H), 
0.28 (s, 3 H), 0.27 (s, 3 H); 
13
C NMR (CDCl3, 126 MHz) δ 142.6, 139.4, 137.6, 134.0, 
128.9, 128.5, 128.2, 127.6, 125.6, 113.1, 35.3, 33.9, 30.4, –4.4, –5.3; HRMS (EI, 
C19H24Si): calculated for ([M]
+
): m/z = 280.1647, Found: m/z = 280.1652; MS (EI): m/z 
= 135.1 (100), 83.9 (45); IR (~ /cm
-1
, neat): 2956, 2924, 2855, 1248, 1113, 895, 828, 
810. The enantiomeric purity of 172a was determined by HPLC analysis on a chiral 
stationary phase of the alcohol obtained by hydroboration with 9-BBN, followed by 
oxidation with H2O2/NaOH.
178
 Daicel Chiralpak IA column (25 cm), 1.0 % isopropanol 
in hexane, 0.7 mL/min, room temperature, 210.8 nm, tR = 26.0 minutes (minor), 27.5 
minutes (major), er = 97:3. 
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8.5 (S)-Dimethyl(4-methylpent-1-en-3-yl)(phenyl)silane 172b 
PhMe2Si
 
nBuLi (1.35 ml, 1.6 M in hexanes, 2.12 mmol) was added dropwise to tetravinyltin 
(0.20 ml, 1.07 mmol) at 23 °C. The mixture was stirred for 30 minutes during which 
white vinyllithium precipitated. The hexane was removed carefully by syringe, the solid 
was washed three times with hexane, dissolved in tetrahydrofuran (0.5 mL) and cooled 
to –78 °C. Then a solution of 166b (170 mg, 0.53 mmol) in tetrahydrofuran (4 mL) was 
added dropwise and the reaction mixture was stirred for one hour. Iodine (538 mg, 2.12 
mmol) in methanol (5 mL) was added dropwise, the reaction mixture was stirred for an 
additional 30 minutes at –78 °C and then warmed to 0 °C. The reaction was quenched 
by the dropwise addition of a 5 % aqueous solution of Na2S2O3 until the solution 
became colourless. The solvent mixture was removed in vacuo and the resulting residue 
was dissolved in ethyl ether. Water was added, the phases were separated and the 
aqueous layer was extracted three times with diethyl ether. The combined organic layers 
were washed with brine, dried (MgSO4) and concentrated in vacuo. The crude product 
was purified by flash chromatography (100 % petroleum ether) to give 172b (69 mg, 
60 %) as a colourless oil.  
Rf = 0.8 (100% petroleum ether); [α]D = +14 (c 1.0, CHCl3); lit. [α]D
20
 = +8.33 (c 0.840, 
CHCl3);
127 1
H (400 MHz, CDCl3): δ [ppm] = 7.56–7.49 (m, 2 H), 7.37–7.33 (m, 3 H), 
5.71 (apparent dt, J = 16.9, 10.3, 10.3 Hz, 1 H), 4.93 (dd, J = 10.3, 2.2 Hz, 1 H), 4.81 
(dd, J = 16.9, 2.2 Hz, 1 H), 1.93–1.80 (m, 1 H), 1.67 (dd, J = 10.3, 5.1 Hz, 1 H), 0.84 (d, 
J = 6.9 Hz, 6 H), 0.30 (s, 3 H), 0.27 (s, 3 H); 
13
C (100 MHz, CDCl3): δ [ppm] = 138.8, 
137.0, 134.0, 128.7, 127.6, 114.2, 42.7, 28.1, 23.8, 20.6, –3.0, –3.7; HRMS (CI, 
C14H22Si): calculated: m/z = 218.1491; found: m/z = 218.1483; MS (CI, C14H22Si): 
84.0, 135.1, 203.2; IR (~ /cm
-1
, neat): 2956, 1427, 1248, 1111; All data was consistent 
with that reported in the literature.
127 
The enantiomeric purity was determined by chiral 
HPLC analysis of the alcohol obtained by hydroboration of olefin with 9-BBN, 
followed by oxidation with H2O2/NaOH). 
178
 Daicel Chiralpak IB column (25 cm), 1.0 
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% isopropanol in hexane, 0.8 mL/min, room temperature, 210.8 nm, tR = 13.6 minutes 
(major), 15.3 minutes (minor): er = 96:4. 
8.6  (S,Z)-Dimethyl(phenyl)(1-phenylhex-4-en-3-yl)silane 176a  
PhMe2Si Ph  
tBuLi (1.25 mL of 1.6 M in pentane, 2.0 mmol) was added dropwise to a stirred solution 
of trans-1-bromo-1-propene (0.09 mL, 1.0 mmol) in tetrahydrofuran (2.0 mL) at 
−78 °C. The mixture was allowed to stir at −78 °C for 30 min, and then a solution of 
boronic ester 166a (0.099 g, 0.26 mmol) in tetrahydrofuran (1 mL) was added dropwise. 
The reaction mixture was stirred at −78 °C for a further 30 min, and then iodine 
(0.254 g, 1.0 mmol) in methanol (4 mL) was added dropwise. The reaction mixture was 
stirred at −78 °C for another 30 min, and then warmed to 0 °C and stirred for 1 h. 
Sodium thiosulfate (10 mL of a 5 % aqueous solution) was added and the mixture was 
allowed to warm to ambient temperature. The reaction mixture was concentrated in 
vacuo and then extracted with diethyl ether (3 × 10 mL). The combined organic phases 
were washed with brine (30 mL), dried (MgSO4) and concentrated in vacuo. The crude 
product was purified by flash chromatography (100 % petroleum ether) to give 
allylsilane 176a as a colourless oil (0.064 g, 84 % yield);  
Rf (100 % petroleum ether): 0.25; [
23
D]  = +33.0 (c 1.0, CHCl3); 
1
H NMR (CDCl3, 500 
MHz) δ [ppm] = 7.49–7.09 (m, 10 H), 5.49 (dqd, J = 10.8, 6.8, 1.0 Hz, 1 H), 5.21 (ddq, 
J = 11.0, 10.8, 1.7 Hz, 1 H), 2.71 (ddd, J = 13.7, 9.2, 4.5 Hz, 1 H), 2.39 (ddd, J = 13.7, 
9.2, 7.6 Hz, 1 H), 2.04 (dddd, J = 11.9, 11.0, 2.7, 1.0 Hz, 1 H), 1.81 (dddd, J = 13.7, 9.4, 
7.6, 2.7 Hz, 1 H), 1.56 (dddd, J = 13.7, 11.9, 9.4, 4.5 Hz, 1 H, ), 1.45 (dd, J = 6.8, 1.7 
Hz, 3 H), 0.28 (s, 3 H), 0.27 (s, 3 H); 
13
C NMR (CDCl3, 126 MHz) δ [ppm] = 142.6, 
137.9, 134.0, 131.8, 128.8, 128.6, 128.1, 127.6, 125.5, 122.7, 35.6, 31.8, 27.2, 13.3, –
4.4, –5.2; HRMS (EI, C20H26Si): calculated for ([M]
+
): m/z = 294.1798, found: m/z = 
294.1796; MS (EI): m/z = 294.1 (25), 135.1 (100); IR (~ /cm
-1
, neat): 3002, 2957, 2913, 
1427, 1247, 1111; The enantiomeric purity of 176a was determined by HPLC analysis 
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of the corresponding unsaturated alcohol, obtained by reduction of the double bond of 
the olefin with tosylhydrazide followed by oxidation of C-Si bond.
164
 Daicel Chiralpak 
IB column; hexane:iPrOH 95:5; flow: 0.7 ml/min; t
1
 = 10.1 min (major), t
2
 = 12.7 min 
(minor): er = 98:2. 
8.7 (S,Z)-Dimethyl(2-methylhex-4-en-3-yl)(phenyl)silane 176b 
PhMe2Si
 
tBuLi (1.25 mL of 1.6 M in pentane, 2.0 mmol) was added dropwise to a stirred solution 
of trans-1-bromo-1-propene (0.09 mL, 1.0 mmol) in tetrahydrofuran (2 mL) at −78 °C. 
The mixture was allowed to stir at −78 °C for 30 min, and then a solution of boronic 
ester 166b (0.114 g [70% pure by NMR], 0.25 mmol) in tetrahydrofuran (1 mL) was 
added dropwise. The reaction mixture was stirred at −78 °C for an hour, and then kept 
at –45 °C for an hour, before being cooled back to −78 °C. Iodine (0.254 g, 1.0 mmol) 
in methanol (4 mL) was added dropwise to the reaction mixture. The mixture was 
stirred at −78 °C for another 30 min, and then warmed to 0 °C and stirred for 1 hour. 
Sodium thiosulfate (10 mL of a 5 % aqueous solution) was added and the mixture was 
allowed to warm to ambient temperature. The reaction mixture was concentrated in 
vacuo and extracted with diethyl ether (3 × 10 mL). The combined organic phases were 
washed with brine (30 mL), dried (MgSO4) and concentrated in vacuo. The crude 
product was purified by flash chromatography (1 % ethyl acetate in pentane) to give 
176b (47 mg, 80 %) as a colourless oil.  
Rf (1 % ethyl acetate in pentane): 0.6; [
23
D]  = +22.5 (c = 0.71, CHCl3); 
1
H NMR 
(CDCl3, 400 MHz): δ [ppm] 7.47–7.25 (m, 5 H), 5.42 (dqd, J = 11.2, 6.7, 0.7 Hz, 1 H), 
5.28 (m, 1 H), 1.94 (ddqd, J = 11.8, 5.2, 0.9, 0.7 Hz, 1 H), 1.78 (qqd, J = 6.8, 6.7, 5.2 
Hz, 1 H), 1.38 (ddd, J = 6.7, 1.7, 0.9 Hz, 3 H), 0.77 ( d, J = 6.7 Hz, 3 H), 0.76 (d, J = 
6.7 Hz, 3 H), 0.24 (s, 3 H), 0.20 (s, 3 H); 
13
C NMR (CDCl3, 101 MHz): δ [ppm] 139.2, 
134.0, 128.8, 128.7, 127.5, 123.0, 35.0, 28.9, 23.9, 20.6, 13.0, –2.9, –3.7; HRMS (EI, 
C15H24Si): calculated: m/z = 232.1647 ([M]
+
), found: m/z = 232.1657; MS (EI): m/z = 
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232.1 (35), 135.0 (100), 83.9 (20); IR (~ /cm
-1
, neat): 3011, 2955, 2865, 1427, 1247, 
1111, 826, 812; The enantiomeric purity was determined by chiral GC analysis of the 
unsaturated alcohol, obtained by reduction of the double bond of 176b with H2/PtO2 
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followed by oxidation of C-Si bond.
119, 167
 (Supelco Betadex 120 column, 30.0 m × 250 
m × 0.30 m, 35 °C for 1 min, then 1.5 °C/min. Pressure: 20 psi. Flow rate: 2.1 
ml/min. t
1
 = 65.2 min (minor), t
2
 = 67.5 min (major): er = 96:4. 
8.8  (S,E)-Dimethyl(phenyl)(1-phenylhex-4-en-3-yl)silane 175a 
PhMe2Si Ph  
tBuLi (1.25 mL of 1.6 M in pentane, 2.0 mmol) was added dropwise to a stirred solution 
of cis-1-bromo-1-propene (0.09 mL, 1.0 mmol) in tetrahydrofuran (2.0 mL) at −78 °C. 
This mixture was allowed to stir at −78 °C for 30 min, and then a solution of boronic 
ester 166a (0.099 g, 0.26 mmol) in tetrahydrofuran (1 mL) was added dropwise. The 
reaction mixture was stirred at −78 °C for a further 30 min, and then iodine (0.254 g, 1.0 
mmol) in methanol (4 mL) was added dropwise. The reaction mixture was stirred at −78 
°C for another 30 min, then warmed to 0 °C and stirred at 0 °C for 1 hour. Sodium 
thiosulfate (10 mL of a 5 % aqueous solution) was added and the mixture was allowed 
to warm to ambient temperature before being concentrated in vacuo and extracted with 
diethyl ether (3 × 10 mL). The combined organic phases were washed with brine 
(30 mL), dried (MgSO4) and concentrated in vacuo. The crude product was purified by 
flash chromatography (silica gel, 1 % ethyl acetate in petroleum ether) to give 
allylsilane 175a (0.072 g, 94 %) as a colourless oil. 
Rf (1 % ethyl acetate in petroleum ether): 0.20; [
23
D]  = +8.0 (c 1.63, CHCl3); 
1
H NMR 
(CDCl3, 500 MHz): δ [ppm] 7.47–7.10 (m, 10 H), 5.30 (dq, J = 15.1, 4.8 Hz, 1 H), 5.25 
(dd, J = 15.1, 4.8 Hz, 1 H), 2.74 (ddd, J = 13.8, 9.4, 4.7 Hz, 1 H), 2.41 (ddd, J = 13.8, 
9.4, 7.1 Hz, 1 H), 1.74 (dddd, J = 13.0, 9.4, 7.1, 2.5 Hz, 1 H), 1.71 (d, J = 4.8 Hz, 3 H), 
1.69 (ddd, J = 11.4, 7.8, 2.5 Hz, 1 H), 1.59 (dddd, J = 13.0, 11.4, 9.6, 4.7 Hz, 1 H), 0.28 
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(s, 3 H), 0.27 (s, 3 H); 
13
C NMR (CDCl3, 126 MHz): δ [ppm] = 142.8, 138.0, 134.0, 
131.5, 128.8, 128.5, 128.1, 127.5, 125.5, 123.8, 35.4, 32.2, 31.0, 18.2, –4.2, –5.2; 
HRMS (EI, C20H26Si): calculated for: m/z = 294.1798 ([M]
+
), found: m/z = 294.1800; 
MS (EI): m/z = 294.1 (30), 135.1 (100); IR (~ /cm
-1
, neat): 3024, 2958, 2916, 2854, 
1427, 1247, 1111, 810; The enantiomeric purity of 175awas determined by HPLC 
analysis of the unsaturated alcohol, obtained by reduction of the double bond of the 
olefin with tosylhydrazide followed by oxidation of C-Si bond.
164
 Daicel Chiralpak IB 
chiral column; hexane:iPrOH 95:5; 0.7 ml/min; t
1
 = 10.1 min (major), t
2
 = 12.9 min 
(minor): er = 97:3.  
8.9 (S,E)-Dimethyl(2-methylhex-4-en-3-yl)(phenyl)silane 175b 
PhMe2Si
 
tBuLi (1.25 mL of 1.6 M in pentane, 2.0 mmol) was added dropwise to a stirred solution 
of cis-1-bromo-1-propene (0.09 mL, 1.0 mmol) in tetrahydrofuran (2 mL) at −78 °C. 
The mixture was allowed to stir at −78 °C for 30 min, and then a solution of boronic 
ester 166b (0.118 g [70 % pure by NMR], 0.26 mmol) in tetrahydrofuran (1 mL) was 
added dropwise. The reaction mixture was stirred at −78 °C for an hour, and then kept 
at –45 °C for an hour, before being cooled back to −78 °C. Iodine (0.254 g, 1.0 mmol) 
in methanol (4 mL) was added dropwise and the reaction mixture was stirred at −78 °C 
for another 30 min, warmed to 0 °C and stirred at 0 °C for 1 h. Sodium thiosulfate (10 
mL of a 5 % aqueous solution) was added and the mixture was then allowed to warm to 
ambient temperature. The reaction mixture was concentrated in vacuo and extracted 
with diethyl ether (3 × 10 mL). The combined organic phases were washed with brine 
(30 mL), dried (MgSO4) and concentrated in vacuo. The crude product was purified by 
flash chromatography (1 % ethyl acetate in pentane) to give allylsilane 175b (0.048 g, 
80 %) as a colourless oil;  
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Rf (1 % ethyl acetate in pentane): 0.6; [
23
D]  = −12.7 (c = 1.5, CHCl3); 
1
H NMR (CDCl3, 
301 MHz): δ [ppm] = 7.45–7.24 (m, 5 H), 5.25 (ddq, J = 15.0, 10.1, 1.1 Hz, 1 H), 5.14 
(dq, J = 15.0, 6.0 Hz, 1 H), 1.72 (qqd, J = 6.9, 6.7, 4.9 Hz, 1 H), 1.59 (dd, J = 6.0, 1.1 
Hz, 3 H), 1.51 (dd, J = 10.1, 4.9 Hz, 1 H), 0.74 (d, J = 6.9 Hz, 3 H), 0.75 (d, J = 6.9 Hz, 
3 H), 0.21 (s, 3 H), 0.18 (s, 3 H); 
13
C NMR (CDCl3, 76 MHz): δ [ppm] = 139.5, 134.0, 
128.9, 128.6, 127.5, 124.8, 40.7, 28.4, 23.8, 20.7, 18.2, –2.8, –3.6; HRMS (EI, 
C15H24Si): calculated: m/z = 232.1647 ([M]
+
), found: m/z = 232.1641; MS (EI): m/z = 
232.1 (35), 135.0 (100), 83.9 (35); IR (~ /cm
-1
, neat): 2956, 1428, 1247, 1111, 970, 
848, 812; The enantiomeric purity of 175b was determined by chiral GC analysis of the 
corresponding unsaturated alcohol, obtained by reduction of the double bond of the 
olefin with tosylhydrazide followed by oxidation of C-Si bond. 
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 Supelco Betadex 120 
column, 30.0 m × 250 m × 0.30 m, 35 °C for 1 min, then 1.5 °C/min. Pressure: 20 
psi. Flow rate: 2.1 ml/min, t
1
 = 65.1 min (minor), t
2
 = 67.8 min (major): er = 96:4.  
8.10 (1S)-3-Phenyl-1-(trimethylsilyl)propyl diisopropylcarbamate 
183a 
OCb
SiMe3
 
3-Phenylpropyl diisopropylcarbamate 128a (1.16 g, 4.4 mmol) and (–)-sparteine (1.31 
mL, 5.72 mmol) were dissolved in diethyl ether (25 mL) and the solution was cooled 
to–78 °C. sBuLi (4.4 mL, 5.72 mmol, 1.3 M in cyclohexane) was added dropwise and 
the reaction mixture was stirred for 5 h at –78 °C before TMSCl (0.73 mL, 5.72 mmol) 
was added dropwise. The mixture was allowed to warm to room temperature, stirred 
overnight and water (20 mL) was added. The layers were separated and the aqueous 
layer was extracted with diethyl ether (3 x 20 mL). The combined organic layers were 
dried (MgSO4) and concentrated in vacuo. The crude product was purified by flash 
chromatography (silica gel, 5 % ethyl acetate in petroleum ether) to give 183a (1.12 g, 
76 %) as a colourless oil. The racemate was obtained with TMEDA instead of (–)-
sparteine. 
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Rf = 0.7 (10 % diethyl ether in pentane); [α]
25
D
 = –5 (c = 1.0, CHCl3); 
1
H NMR (CDCl3, 
400 MHz): δ [ppm] = 7.30–7.26 (m, 2 H); 7.19–7.16 (m, 3 H); 4.80 (dd, J = 10.8, 3.5 
Hz, 1 H); 4.16 (br s, 1 H); 3.76 (br s, 1 H), 2.75 (ddd, J = 13.6, 11.3, 4.8 Hz, 1H); 2.61 
(ddd, J = 13.6, 10.8, 5.9 Hz, 1 H); 2.01–1.80 (m, 2H), 1.25 (br s, 12 H), 0.07 (s, 9 H); 
13
C NMR (CDCl3, 100 MHz): δ [ppm]: 156.3, 142.4, 128.3, 125.7, 68.5, 46.5, 44.9, 
33.9, 33.8, 21.8, 20.6, –3.3; HRMS (CI, C19H34NO2Si): calculated: m/z = 336.2359  
(M–H)+, Found: 336.2347; MS (CI): m/z = 336 (64), 320 (97), 292 (70), 244 (22), 218 
(59), 202 (83), 191 (21), 146 (86), 128 (44), 93 (25), 86 (26), 73 (100); IR (~ /cm
-1
, 
neat): 2965, 1682, 1430, 1331, 1298, 1281, 1248, 1219, 1157, 1132, 1048, 1034, 871, 
745, 697; The enantiomeric purity was determined by HPLC analysis (Daicel Chiralpak 
IB column; hexane:iPrOH = 99.5:0.5, 0.3 mL/min; t
1
 = 16.2 min (minor), t
2
 = 18.1 min 
(major): er > 99:1. All spectroscopic data was consistent with that reported in the 
literature.
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8.11 (1S)-1-[Dimethyl(phenyl)silyl]-3-phenylpropyl 
diisopropylcarbamate 183b 
PhMe2Si
OCb
 
3-phenylpropyl diisopropylcarbamate 128a (1.24 g, 4.7 mmol) and (–)-sparteine (1.4 
mL, 6.11 mmol) were dissolved in diethyl ether (25 mL) and colled cooled to –78 °C. 
sBuLi (4.7 mL, 6.11 mmol, 1.3 M in cyclohexane) was added dropwise and the resulting 
reaction mixture was then stirred at –78 °C for 5 h before chlorodimethylphenylsilane 
(1.03 mL, 6.11 mmol) was added. The mixture was allowed to warm to room 
temperature, stirred overnight and then quenched with water (20 mL). The layers were 
separated and the aqueous layer was extracted with diethyl ether (3 × 20 mL). The 
combined organic layers were dried (MgSO4) and concentrated in vacuo. The crude 
product was purified by flash chromatography (silica gel, 5 % ethyl acetate in petroleum 
ether) to give 183b (1.59 g, 85 %) as a colourless oil. The racemate was obtained with 
TMEDA instead of (–)-sparteine. 
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Rf = 0.6 (10 % diethyl ether in pentane); [α]
25
D
 = +2 (c = 1.0, CHCl3); 
1
H NMR (CDCl3, 
400 MHz): δ [ppm] 7.55–7.53 (m, 2 H), 7.37–7.32 (m, 3 H), 7.26–7.22 (m, 2 H), 7.17–
7.14 (m, 1 H), 7.11–7.09 (m, 2 H), 5.00 (dd, J = 10.7, 3.7 Hz, 1 H), 4.04 (br s, 1 H), 
3.79 (br s, 1 H), 2.69 (ddd, J = 13.6, 11.2, 4.8 Hz, 1 H), 2.53 (ddd, J = 13.7, 10.9, 5.9 
Hz, 1H), 2.00–1.78 (m, 2 H), 1.22–1.19 (m, 12 H), 0.37 (s, 3 H), 0.35 (s, 3 H); 
13
C NMR (CDCl3, 75 MHz): δ [ppm] 155.9, 142.2, 36.4, 134.1, 129.2, 128.3, 127.7, 
125.7, 67.8, 46.3, 45.1, 33.7, 21.6, 20.6, –4.5, –5.0; HRMS (CI, C24H35NO2Si): 
calculated: m/z = 398.2515 (M-H
+
), found: m/z = 398.2516; MS (CI, C24H35NO2Si): 
m/z = 398 (M)
+
 (4), 382 (29), 354 (28), 320 (100), 278 (10), 264 (14), 253 (10), 202 
(98), 146 (11), 135 (44), 128 (16), 114 (4), 91 (8), 86 (11); IR (~ /cm
-1
, neat): 3026, 
2966, 2932, 1682, 1428, 1331, 1298, 1282, 1249, 1156, 1132, 1114, 1047, 1033, 829, 
811, 776, 732. The enantiomeric purity was determined by HPLC analysis; Daicel 
Chiralpak IB column; hexane:iPrOH 99.5:0.5, 0.3 ml/min, t
1
 = 19.0 min (major), t
2
 = 
22.0 min (minor): er > 99:1. 
8.12 (1S)-1-Ethyl-3-phenyl-1-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)propyl]-(trimethyl)silane 185a  
Bpin
SiMe3
Ph  
(1S)-3-phenyl-1-(trimethylsilyl)propyl diisopropylcarbamate 183a (400 mg, 1.19 
mmol), and TMEDA (0.25 mL, 1.67 mmol) were dissolved in diethyl ether (6 mL) and 
cooled to –78 °C. sBuLi (1.28 mL, 1.67 mmol, 1.3 M in cyclohexane) was added 
dropwise and the reaction mixture was stirred at –78 °C for 5 h before EtBpin (0.30 mL, 
1.67 mmol) was added dropwise. After an additional hour at –78 °C, the mixture was 
allowed to warm to room temperature and stirred overnight. The reaction was quenched 
with water (5 mL), the layers were separated, the aqueous layer was extracted with 
diethyl ether (3 × 5 mL) and the combined organic layers were dried (MgSO4) and 
concentrated in vacuo. The crude product was purified by flash chromatography (silica 
  
166 
 
gel, 5 % ethyl acetate in petroleum ether) to give boronic ester 185a (390 mg, 94 %) as 
a colourless solid.  
Rf = 0.7 (5 % ethyl acetate in petroleum ether); [α]
25
D
 = –17 (c = 1.0, CHCl3); 
1
H NMR 
(CDCl3, 400 MHz): δ [ppm] = 7.30–7.26 (m, 2 H), 7.23–7.15 (m, 3 H), 2.67 (dt, J = 
12.6, 5.3 Hz, 1 H), 2.56 (dt, J = 12.6, 4.8 Hz, 1 H), 1.88–1.62 (m, 4 H), 1.25 (s, 12 H), 
1.01 (t, J = 7.4 Hz, 3 H), 0.07 (s, 9 H); 
13
C NMR (CDCl3, 100 MHz): δ [ppm] = 144.1, 
128.4, 128.2, 125.5, 82.6, 34.3, 33.3, 25.2, 25.1, 23.1, 12.0, 1.0. 
11
B NMR (CDCl3, 96 
MHz): δ [ppm]: 34.4; HRMS (CI, C20H35BO2Si): calculated: m/z = 346.2499, found: 
m/z = 346.2500; MS (CI): 347 (2), 331 (39), 275 (8), 255 (16), 249 (25), 247 (45), 245 
(34), 231 (15), 203 (9), 173 (29), 155 (46), 145 (14), 117 (19), 85 (100), 73 (22). IR    (
~ /cm
-1
, neat): 3027, 2954, 2869, 1453, 1368, 1341, 1297, 1260, 1245, 1143, 1123, 872, 
855, 740, 698; mp: 34–35 °C. 
8.13 Dimethyl[(1S)-1-methyl-3-phenyl-1-(4,4,5,5-tetramethyl-
1,3,2-dioxaborolan-2-yl)-propyl]phenylsilane 185b 
SiMe2Ph
Ph
Bpin
 
(1S)-1-[Dimethyl(phenyl)silyl]-3-phenylpropyl diisopropylcarbamate 183b (996 mg, 
2.0 mmol) and TMEDA (0.42 mL, 2.8 mmol) were dissolved in diethyl ether (10 mL) 
and cooled to –78 °C. sBuLi (1.3 M in cyclohexane, 2.1 mL, 2.8 mmol) was added 
dropwise and the mixture was stirred for 5 hours at –78 °C. MeBpin (398 mg, 2.8 
mmol) was added dropwise and the reaction mixture was stirred for 1 hour at –78 °C, 
allowed to warm to 23 °C, and stirred for an additional hour. Then magnesium bromide 
diethyl etherate (prepared by stirring 144 mg magnesium and 0.34 mL dibromoethane in 
10 mL diethyl ether for 4 hours) was added dropwise and the reaction mixture was 
stirred overnight. Saturated ammonium chloride was added, the phases were separated 
and the aqueous phase was extracted with diethyl ether (3 × 50 mL). The combined 
organic phases were washed with brine, dried (MgSO4) and concentrated in vacuo. 
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Flash column chromatography (silica gel, 10 % ethyl acetate in pentane) gave boronic 
ester 185b (410 mg, 52 %) as a colourless oil.    
[]23D (c = 1.7, CH2Cl2) = ‒8; 
1
H NMR (400 MHz, CDCl3): δ [ppm] = 7.54–7.50 (m, 2 
H), 7.36–7.22 (m, 5 H), 7.18–7.12 (m, 3 H), 2.66 (td, J = 12.7, 5.0 Hz, 1 H), 2.41 (td, J 
= 12.7, 4.2 Hz, 1 H), 2.03 (td, J = 12.7, 4.2 Hz, 1 H), 1.40 (td, J = 12.7, 5.0 Hz, 1 H), 
1.24 (s, 6 H), 1.22 (s, 6 H), 1.11 (s, 3 H), 0.34 (s, 3 H), 0.32 (s, 3 H);
13
C NMR (100 
MHz, CDCl3): δ [ppm] = 134.6, 137.5, 134.8, 128.7, 128.5, 128.2, 127.3, 125.5, 82.9, 
36.2, 34.3, 25.3, 24.9, 15.6, –4.5, –4.7; 11B NMR (128 MHz, CDCl3): δ [ppm] = 34.5; 
HRMS (CI, C24H35BO2Si): calc.: m/z = 417.2397 [M+Na
+
], found: m/z = 417.2400 
[M+Na
+
]; MS (CI, C24H35BO2Si): m/z = 84.0 (35), 93.1 (40), 135.1 (50), 202.1 (50), 
235.1 (50), 303.2 (40), 317.2 (100), 320.2 (95), 379.2 (30); IR (~ /cm
-1
, in CDCl3) = 
3675, 2988, 2901, 1393 1250, 1066; mp: 78‒79 °C (EtOAc). 
8.14 [(1S)-1-Ethyl-3-phenyl-1-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)propyl]- (dimethyl)phenylsilane 185c 
SiMe2Ph
Ph
Bpin
 
1-(Dimethyl(phenyl)silyl)-3-phenylpropyl diisopropylcarbamate 183b (150 mg, 0.38 
mmol) and TMEDA (79 μL, 0.53 mmol) were dissolved in diethyl ether (2 mL) and 
cooled to –78 °C. sBuLi (0.41 mL, 0.53 mmol, 1.3 M in cyclohexane was added 
dropwise and the resulting reaction mixture was stirred at –78 °C for 5 h before EtBpin 
(95 μL, 0.53 mmol) was added dropwise. The mixture was stirred for an additional hour 
at –78 °C and then allowed to warm to room temperature and stirred overnight. The 
reaction was quenched with water (5 mL). The layers were separated and the aqueous 
layer was extracted with diethyl ether (3 × 5 mL). The combined organic layers were 
dried (MgSO4) and concentrated in vacuo. The crude product was purified by flash 
chromatography (silica gel, 5 % ethyl acetate in petroleum ether) to give the product 
185c (390 mg, 76 %) as a colourless oil.  
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Rf = 0.6 (5 % ethyl acetate in petroleum ether); [α]
25
D
 = +11 (c = 1.0, CHCl3); 
11
B NMR 
(CDCl3, 96 MHz): δ [ppm] = 30.3; 
1
H NMR (CDCl3, 400 MHz): δ [ppm] 7.65–7.62 (m, 
2 H); 7.38–7.35 (m, 3 H), 7.31–7.27 (m, 2 H), 7.21–7.16 (m, 3 H), 2.65–2.51 (m, 2 H), 
1.98–1.81 (m, 3 H), 1.76–1.67 (m, 1 H), 1.26 (s, 12 H); 0.98 (t, J = 7.4 Hz, 3 H), 0.43 (2 
× s overlapping, 6 H); 
13
C NMR (CDCl3, 100 MHz): δ [ppm] = 144.0, 138.9, 134.7, 
128.7, 128.4, 128.2, 127.4, 125.4, 82.8, 33.9, 33.2, 25.2, 23.2, 118, -2.8, -2.9; HRMS 
(CI, C25H37BO2Si): calculated m/z = 408.2656 (M
+
), found: 408.2651; MS (CI, 
C25H37BO2Si): 408 (4), 393 (32), 331 (88), 308 (93), 293 (10), 277 (4), 259 (25), 249 
(100), 231 (81), 217 (95), 185 (8), 175 (15), 145 (69), 135 (96), 131 (29), 117 (11), 105 
(9), 91 (18), 85 (39), 83 (30), 69 (6); IR (~ /cm
-1
, neat): 2976, 1454, 1427, 1370, 1338, 
1298, 1248, 1143, 1109, 964, 852, 812, 769, 735. 
8.15 (1S)-1-Ethyl-1-(2-phenylethyl)prop-2-en-1-
yl](trimethyl)silane 186a 
SiMe3
Ph  
Boronic ester 185a (50 mg, 0.14 mmol) was dissolved in tetrahydrofuran (1 mL) and 
cooled to 0 °C. A freshly made solution of vinyllithium (see below) was added 
dropwise. After stirring for 30 minutes at 0 °C, a solution of I2 (179 mg, 0.70 mmol) in 
methanol (6 mL) was added dropwise over 10 minutes. The mixture was then allowed 
stirred at 0 °C for 20 min before a 5 % aqueous solution of Na2S2O3 was added until the 
red colour disappeared. The reaction mixture was concentrated in vacuo and the residue 
was taken up into diethyl ether (25 mL) and washed with H2O (3 × 10 mL). The organic 
layer was dried (MgSO4) and concentrated in vacuo. The crude product was purified by 
flash chromatography (silica gel, 100% petroleum ether) to give 186a (25 mg, 73 %) as 
a yellow oil.  
Preparation of vinyllithium solution: nBuLi (1.6 M in hexane, 350 μL, 0.56 mmol) was 
added dropwise at room temperature to tetravinyltin (51 μL, 0.28 mmol). After stirring 
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for 30 minutes, the liquid was removed and the white solid was dissolved in 
tetrahydrofuran.  
Rf = 0.6 (100 % pentane); [α]
25
D
 = –28 (c = 1.0, CHCl3); 
1
H NMR (CDCl3, 400 MHz) δ 
[ppm] = 7.32–7.28 (m, 2H), 7.21–7.17 (m, 3 H), 5.81 (dd, J = 17.6, 11.0 Hz, 1 H), 5.02 
(dd, J = 11.0, 1.5 Hz, 1 H), 4.80 (dd, J = 17.6, 1.5 Hz, 1 H), 2.55-2.51 (m, 2 H), 1.92-
1.84 (m, 1 H), 1.80-1.57 (m, 3 H), 0.95 (t, J = 7.5 Hz, 3 H), 0.02 (s, 9 H); 
13
C NMR 
(CDCl3, 100 MHz): δ [ppm] = 144.9, 143.6, 128.4, 128.3, 125.6, 110.8, 34.2, 30.8, 24.2, 
9.2, –2.9; HRMS (CI, C16H26Si): 246.1804 (M
+
), found: 246.1807; MS (CI, C16H26Si): 
246 (7), 231 (48), 173 (5), 155 (26), 191 (6), 73 (100); IR (~ /cm
-1
, neat): 3083, 3027, 
2962, 2863, 1619, 1454, 1247, 895, 749, 699; The enantiomeric purity was determined 
by HPLC analysis of the alcohol, obtained by hydroboration of the olefin with 9-BBN, 
followed by oxidation with H2O2. Daicel Chiralpak IB column, hexane:iPrOH = 95:5; 
0.7 ml/min, t1 = 13.9 min (minor), t2 = 15.8 min (major): er = 98:2.  
8.16 Dimethyl[(1S)-1-methyl-1-(2-phenylethyl)prop-2-en-1-
yl]phenylsilane 186b 
SiMe2Ph
Ph  
Boronic ester 185b (34 mg, 0.09 mmol) was dissolved in tetrahydrofuran (1 mL) and 
cooled to 0 °C. A freshly made solution of vinyllithium (see above) was added 
dropwise. After stirring for 30 minutes the mixture, a solution of I2 (140 mg, 0.54 
mmol) in methanol (3 mL) was added dropwise over 10 minutes. The mixture was 
stirred for an additional 20 min before Na2S2O3 (5 % in water) was added dropwise until 
the red colour disappeared. The reaction mixture was concentrated in vacuo and the 
residue was taken up into water (5 mL) and extracted with diethyl ether (3 × 25 mL). 
The combined organic layer was washed with brine, dried (MgSO4) and concentrated in 
vacuo. The crude product was purified by flash chromatography (silica gel, 100% 
pentane) to give 186b (19 mg, 73 %) as a colourless oil.  
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Rf = 0.3 (100% petroleum ether); [α]
25
D  = –30 (c = 1.0, CH2Cl2); 
1
H NMR (CDCl3, 
400 MHz): δ [ppm] = 7.41–7.39 (m, 2 H), 7.29–7.22 (m, 3 H), 7.20–7.15 (m, 2H), 7.11–
7.01 (m, 3 H), 5.75 (dd, J = 17.4, 10.8, Hz, 1 H), 4.97 (dd, J = 10.8, 1.5 Hz, 1 H), 4.69 
(dd, J = 17.4, 1.5 Hz, 1 H), 2.41 (dt, J = 13.3, 5.5, Hz, 1 H), 2.32 (dt, J = 13.3, 4.5, Hz, 
1 H), 1.70 (dt, J = 13.3, 4.5 Hz, 1 H), 1.59 (dt, J = 13.4, 5.5 Hz, 1 H), 1.02 (s, 3 H), 0.20 
(2 × s, overlapping, 6 H); 
13
C NMR (CDCl3, 125 MHz): δ [ppm] = 144.2, 143.4, 136.7, 
134.8, 128.9, 128.4, 128.3, 127.4, 125.5, 111.4, 37.8, 31.0, 30.0, 17.1, –6.11, –6.12; 
HRMS (CI, C20H26Si): calculated m/z = 294.1804 (M
+
); found: 294.1796; MS (CI, 
C20H26Si): 294 (22), 279 (66), 217 (94), 203 (44), 201 (8), 189 (3), 135 (100), 91 (3), 84 
(6); IR (~ /cm
-1
, neat): 3069, 3025, 2952, 2863, 1620, 1496, 1454, 1427, 1248, 1114, 
1004, 894, 829, 809, 772, 735, 699, 655; The enantiomeric purity was determined by 
HPLC analysis of the alcohol, obtained by hydroboration with 9-BBN, followed by 
oxidation with H2O2/NaOH. Daicel Chiralpak IB column; hexane:iPrOH 95:5; 0.5 
ml/min; t
1
 = 18.2 minutes (major), t
2
 = 22.1 min (minor); er = 97:3. 
8.17 (1S)-1-Ethyl-1-(2-phenylethyl)prop-2-en-1-
yl](dimethyl)phenylsilane 186c 
SiMe2Ph
Ph  
Boronic ester 185c (100 mg, 0.24 mmol) was dissolved in tetrahydrofuran (1 mL) and 
cooled to 0 °C. A freshly prepared solution of vinyllithium (see above) was added 
dropwise and after 30 minutes at 0 °C, a solution of I2 (305 mg, 1.20 mmol) in methanol 
(10 mL) was added dropwise over 10 minutes. The mixture was then stirred at 0 °C for 
20 min before a 5 % aqueous Na2S2O3-solution was added dropwise until the red colour 
disappeared. The reaction mixture was concentrated in vacuo and the residue was taken 
up with diethyl ether (25 mL), washed with H2O (3 × 10 mL), dried (MgSO4) and 
concentrated in vacuo. The crude product was purified by flash column chromatography 
(silica gel, 100 % petroleum ether) to give the product (44 mg, 60 %) as a yellow oil.  
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Rf = 0.3 (100 % pentane); [α]
25
D  = –6 (c = 1.0, CHCl3); 1H NMR (CDCl3, 400 MHz): δ 
[ppm] = 7.57–7.55 (m, 2 H), 7.42–7.35 (m, 3 H), 7.32–7.29 (m, 2 H), 7.23–7.19 (m, 1 
H), 7.17–7.15 (m, 2 H), 5.77 (dd, J = 17.6, 11.0, Hz, 1 H), 5.08 (dd, J = 11.0, 1.3 Hz, 1 
H), 4.80 (dd, J = 17.6, 1.3 Hz, 1 H), 2.53–2.48 (m, 2 H), 1.97–1.89 (m, 1 H), 1.83–1.60 
(m, 3 H), 0.93 (t, J = 7.5 Hz, 3 H), 0.38 (s, 6 H); 13C NMR (CDCl3, 100 MHz): δ 
[ppm] = 144.7, 143.5, 137.7, 134.7, 128.9, 128.31, 128.27, 127.4, 125.6, 111.5, 34.9, 
34.0, 30.7, 24.2, 8.9, –4.3; –4.5; HRMS (CI, C21H28Si): calculated m/z = 308.1960 
(M+), found: 308.1950; MS (CI, C21H28Si): 308 (6), 293 (16), 231 (22), 217 (12), 209 
(8), 135 (100), 91 (8), 85 (10), 75 (4); IR (
~
/cm-1, neat): 3068, 3026, 2961, 1619, 
1496, 1454, 1428, 1250, 1118, 1051, 829, 809, 790, 770, 735. The enantiomeric purity 
was determined by HPLC analysis of the alcohol obtained by hydroboration with 9-
BBN, followed by oxidation with H2O2/NaOH. Daicel Chiralpak IB column; 
hexane:iPrOH 95:5, 0.7 ml/min: t
1
 =15.2 min (major), t
2
 = 18.2 min (minor); er = 97:3. 
8.18 1-[Dimethyl(phenyl)silyl]ethyl diisopropylcarbamate 190 
OCb
SiMe2Ph
 
Ethyl diisopropylcarbamate 189 (1.88 mL, 10.0 mmol) and TMEDA (1.97 mL, 13.0 
mmol) were dissolved in diethyl ether (50 mL) and cooled to –78 °C. sBuLi (10.0 mL, 
13 mmol, 1.3 M in hexane/cyclohexane) was added dropwise and the reaction mixture 
was stirred at –78 °C for 5 hours. Then PhMe2SiCl (2.85 mL, 17.0 mmol) was added 
dropwise and the mixture was allowed to warm to 23 °C overnight. After the addition of 
saturated aqueous ammonium chloride solution the phases were separated and the 
aqueous phase was extracted with diethyl ether (3 × 25 mL). The combined organic 
layers were washed with brine, dried (magnesium sulfate) and concentrated in vacuo. 
Flash column chromatography (short silica plug, 100 % pentane) gave carbamate 190 
(2.971 g, 91 %) as a colourless oil. 
The silane was dissolve in dry toluene and the solvent was removed in vacuo to remove 
traces of water. This process was repeated two times and then a 0.2 M solution in dry 
diethyl ether was prepared and stored over activated 4 Ǻ molecular sieves. 
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Rf = 0.2 (5 % ethyl acetate in pentane); []
22
D = ‒24 (c = 3.2, CH2Cl2); 
13
C NMR (100 
MHz, CDCl3): δ [ppm] = 155.9, 136.3, 134.0, 129.2, 127.2, 63.6, 46.0 (br), 45.1 (br), 
21.1 (br), 16.3, ‒5.0, ‒5.4; 1H NMR (400 MHz, CDCl3): δ [ppm] = 7.56‒7.50 (m, 2 H), 
7.38‒7.50 (m, 3 H), 4.88 (q, J = 7.4 Hz, 1 H), 4.01 (br, 1 H), 3.72 (br, 1 H), 1.24 (d, 
J = 7.4 Hz, 3 H), 1.16 (d, J = 1.0 Hz, 6 H), 1.14 (d, J = 1.0 Hz, 6 H), 0.35 (s, 3 H), 
0.34 (s, 3 H); HRMS (CI, C17H29NO2Si): calc. [M+H
+
]: m/z = 308.2046, found: 
m/z = 308.2032; MS (CI, C17H29NO2Si): 39.1 (15), 128.1 (15), 220.1 (20), 230.2 (100), 
292.2 (30), 308.2 (20); IR (~ /cm
-1
, neat) = 2965, 1683, 1428, 1288, 1046, 771, 699;
 
8.19 [1,5-Dimethyl-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)hex-4-en-1- yl](dimethyl)phenylsilane 192 
PhMe2Si B O
O
 
A mixture of (1S)-1-[dimethyl(phenyl)silyl]ethyl diisopropylcarbamate (0.2 M in diethyl 
ether, 10 mL, 2.0 mmol) 190 and TMEDA (0.43 mL, 2.8 mmol) was cooled to –78 °C, 
sBuLi (1.3 M in cyclohexane, 2.15 mL, 2.8 mmol) was added dropwise and the mixture 
was stirred for 5 hours at ‒78 °C. Boronic ester 191 (1.0 M in diethyl ether, 2.8 mL, 2.8 
mmol) was added dropwise and 5 minutes after the end of the addition the reaction 
mixture was allowed to warm to 23 °C and was stirred overnight. Water was added and 
the aqueous phase was extracted with diethyl ether (3 × 25 mL). The combined organic 
layers were washed with brine, dried (magnesium sulfate) and concentrated in vacuo. 
Flash column chromatography (silica gel, 5 % ethyl acetate in pentane) gave the title 
compound (610 mg, 84 %) as a colourless oil. 
Rf = 0.4 (5 % ethyl acetate in pentane); 
11
B NMR (128 MHz, CDCl3): δ [ppm] = 35.0; 
13
C NMR (100 MHz, CDCl3): δ [ppm] = 137.7 (C), 134.8 (CH), 130.9 (CH), 128.7 
(CH), 127.3 (CH), 125.3 (Me2C=CH), 82.8 (BOC), 33.6 (CH2), 26.1 (CH2), 25.7 (CH3), 
25.2 (CH3), 25.0 (CH3), 17.6 (CH3), 15.5 (CH3), ‒4.5 (CH3), ‒4.7 (CH3); 
1
H NMR (400 
MHz, CDCl3): δ [ppm] = 7.54‒7.50 (m, 2 H, Ph), 7.34‒7.30 (m, 3 H, Ph), 5.10‒5.04 (m, 
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1 H, Me2C=CH), 2.09‒1.96 (m, 1 H, CH2), 1.84‒1.69 (m, 2 H, CH2), 1.65 (s, 3 H, CH3), 
1.56 (s, 3 H, CH3), 1.20 (s, 6 H, 2 × CH3), 1.17 (s, 6 H, 2 × CH3), 1.14‒1.06 (m, 1 H, 
CH2), 1.02 (s, 3 H, CH3), 0.32 (s, 3 H, SiMe3), 0.31 (s, 3 H, SiMe3); HRMS (ESI, 
C22H37BO2Si): calc.: m/z = 395.2548 [M+Na
+
], found: 395.2559 [M+Na
+
]; MS (CI, 
C22H37BO2Si): 93.1 (100), 135.1 (80), 203.2 (75), 303.3 (60), 357.4 (20), 371.4 (15); m. 
p.: 60‒62 °C (EtOAc); IR (~ /cm
-1
, in CDCl3) = 3067, 2975, 2945, 2862, 1449, 1371, 
1336, 1297, 1143, 1109;
 
8.20 3,7-Dimethylocta-1,6-dien-3-yl)dimethyl(phenyl)silane 193 
SiMe2Ph  
Tetravinyl tin (0.15 mL, 0.84 mmol) was cooled to 0 °C and nBuLi (1.6 M in hexane, 
1.05 mL, 1.68 mmol) was added dropwise. After 30 minutes the precipitating vinyl 
lithium was dissolved in tetrahydrofuran (1 mL) and added dropwise to a solution of 
[(1R)-1,5-dimethyl-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)hex-4-en-1-yl](di-
methyl)phenylsilane 192 (100 mg, 0.28 mmol) in tetrahydrofuran (2 mL) at 0 °C. After 
stirring for 40 minutes at 0 °C, a solution of I2 (426 mg, 1.68 mmol) in MeOH (4 mL) 
was added dropwise over 10 minutes. The mixture was then allowed to stir at 0 °C for 
25 min and Na2S2O3-solution (5 % in water) was added dropwise until the red colour 
disappeared. The organic solvents (hexane, tetrahydrofuran and methanol) were 
removed in vacuo and the concentrate was taken up into diethyl ether (25 mL). The 
aqueous phase was extracted with diethyl ether (3 × 25 mL). The combined organic 
layers were washed with brine, dried (magnesium sulfate) and concentrated in vacuo. 
Flash column chromatography (silica gel, pentane) gave the title compound 63 mg, 
93 %) as a colourless oil. 
Rf = 0.3 (100 % pentane); 
13
C NMR (100 MHz, CDCl3): δ [ppm] = 144.4 (CH), 137.0 
(C), 134.8 (CH), 131.1 (C), 128.9 (CH), 127.3 (CH), 125.1 (Me2C=CH), 110.9 
(H2C=CH), 35.4 (CH2), 30.8 (C), 25.7 (CH3), 22.2 (CH2), 17.6 (CH3), 16.9 (CH3), ‒6.1 
(2 × CH3); 
1
H NMR (400 MHz, CDCl3): δ [ppm] = 7.51‒7.46 (m, 2 H, Ph), 7.38‒7.30 
(m, 3 H, Ph), 5.74 (dd, J = 17.4, 10.7 Hz, 1 H, H2C=CH), 5.02 (dd, J = 7.2, 7.2 Hz, 1 H, 
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Me2C=CH), 4.97 (dd, J = 10.7, 1.5 Hz, 1 H, H2C=CH), 4.69 (dd, J = 17.4, 1.5 Hz, 1 H, 
H2C=CH), 1.92‒1.70 (m, 2 H, Me2C=CHCH2), 1.65 (d, J = 0.9 Hz, 3 H, CH3CCH3), 
1.53 (s, 3 H, CH3CCH3), 1.52‒1.44 (m, 1 H, Me2C=CHCH2CH2), 1.36 (ddd, J = 13.3, 
11.7, 5.5 Hz, 1 H, Me2C=CHCH2CH2), 1.01 (s, 3 H, CH3CSi), 0.263 (s, 3 H, SiMe3), 
0.260 (s, 3 H, SiMe3); HRMS (CI, C18H28Si): calc. [M
+
]: m/z = 272.1960, found: m/z = 
272.1948; MS (CI, C18H28Si): 39.1 (20), 135.1 (100), 203.2 (60), 257.2 (25), 272.2 (25); 
IR (~ /cm
-1
, in CDCl3) = 3675, 2967, 2902, 1620, 1409, 1248, 1066;  
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